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1 Introduction 
 
1.1 Polyketide natural products 
 
The polyketide natural products are a group of secondary metabolites that exhibits 
remarkable diversity both in terms of their structure and function. They represent a unique 
class of biologically active natural products.[1] These metabolites are ubiquitous in 
distribution and have been reported from organisms as diverse as bacteria, fungi, plants, 
insects, dinoflagellates, mollusks and sponges. In addition they boast a wealth of medicinally 
important activities including antibiotic, anti-cancer, antifungal, antiparasitic and 
immunosuppressive properties.[2] 
The wide spectrum of activity of polyketides makes them economically, clinically and 
industrially the most sought after compounds. Their diverse structures can be explained as 
being derived from poly-β-keto chains, formed by coupling of acetic acid (C2) units via 
condensation reactions. Thus polyketides are defined as a class of molecules produced 
through the successive condensation of small carboxylic acids.[3] 
 
The history of subsequent theorising on the biosynthetic pathway to the alkaloids was first 
led by James Collie, followed by Robinson’s and Arthur Birch hypotheses. The boost to the 
resurgence of polyketides came from Arthur Birch in the 1950s until the innovation of NMR 
took place. His contributions were crucial for two of the reasons. Firstly, he recognised that 
polyketones could be generated from acetate units by repetitive condensation reactions and 
secondly, he was willing to test his theory by supplying an isotopically labeled version of his 
proposed precursor to a suitable polyketides producing organism. He had chosen the 
aromatic polyketide 6-methylsalicylic Acid (6-MSA) (1) an antibiotic produced by the fungus 
Pencillium patulum, also an intermediate in the synthesis of toxic patulin (2).The mechanistic 
basis of his hypothetical proposal was the four acetate units linked ‘head-to-tail’ to generate 
a triketo acid with series of reactions leading finally to the six membered carbocyclic 
aromatic natural product (Figure 1).[4]  
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Figure 1: Birch’s proposed biosynthetic reaction sequence of 6-Methylsalicylic acid (1) 
He tested his ideas by feeding acetate labelled with 14C at C-1 (Figure 2). According to his 
hypothesis four sites in 6-MSA (1) should incorporate the radio activity as indicated. It was 
therefore essential to determine the pattern of labelling in the molecule to confirm his 
hypothesis. This analysis involved laborious experiments in which samples of acid were 
subjected to controlled chemical degradation to produce fragments that could be reliably 
correlated with specific sites in the natural product. The three of these fragments were 
isolated and subjected to radioactivity measurement to determine their ‘relative molar 
activity’ and the results were consistent to his predictions.  Feeding of the radiolabeled 
acetate to many organisms known to produce secondary metabolites yielded structures 
exhibiting a ‘measles pattern’ of isotopic spots. These experiments not only stood as a basis 
that many polyphenolic aromatic molecules were biosynthesized from acetate units 
according to Collie-Birch polyketide hypothesis but also that many non-aromatic compounds 
were also formed by further transformations of such products. 
 
Figure 2: Birch’s demonstration of 6-MSA (1) derived from four acetate units[4] 
Polyketides can be classified into aromatic and complex structural classes. The former are 
built mainly from acetate units through a reiterative process wherein the β–carbonyl groups 
formed after each condensation cycle are left largely unreduced.[5] Complex polyketides are 
composed of acetates, propionates or butyrates and the extent of β–carbonyl reduction 
varies from one cycle to the next. Some polyketides have more than one pharmacological 
effect. For instance, the antibiotic erythromycin (3)[6] induces gastric contractions and can act 
as a motilin agonist. Of the polyketides the smallest is 6-methylsalicylic acid (1)[4] whereas 
one of the the largest is brevetoxin B (4)[7] with 50 carbon atoms in its chain which are shown 
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in Figure 3. Many acetate-derived polyketides cyclize to form aromatic rings (e.g. 
anthracyclines) or lactone rings (e.g. macrolides, poly-enes). The majority of polyketides are 
produced by the actinomycetes as secondary metabolites.[8] The compounds are subdivided 
into structural subgroups: macrolides (e.g. spiramycin), polyethers (e.g. monensin), polyenes 
(e.g. amphothericin), and aromatic compounds (e.g. thysanone).[3]  
  
Figure 3: Some examples of polyketides  
Polyketides are a specific class of secondary metabolites that are produced by the 
polyketides synthases (PKSs) which iteratively construct the molecular framework from 
consecutive condensations of acyl units. Being structurally diverse, all polyketides are 
assembled by successive rounds of decarboxylative Claisen condensations between a 
thioesterified malonate derivative and an acyl thioester (Figure 4).[9]  
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Figure 4: Basic mechanism of decarboxylative Claisen condensations 
 
The enzymes that catalyze these condensations are referred to as polyketide synthases. 
PKS systems consist of reactive domains that modify a growing molecular structure in a 
similar fashion to an assembly line. PKSs are large multienzyme protein complexes that 
contain a coordinated group of active sites. The biosynthesis occurs in a stepwise manner 
from simple two, three, four carbon building blocks such as acetyl-CoA, propionyl-CoAa, 
butyryl-CoA and their activated derivatives, malonyl-CoA, methylmalonyl-CoA and 
ethylmalonyl-CoA. When the substrates are chiral like methylmalonyl-CoA, the 
corresponding acyltransferases exhibit strict stereospecificity. The α–carboxylated 
substrates (e.g.; malonyl-CoA and methylmalonyl-CoA) are sources of extender units, 
whereas neutral substrates such as acetyl-CoA are sources of primer units for polyketides 
chain synthesis (Figure 5a, 5b).[10] 
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Figure 5a: Polyketide synthase substrate routes having potential substrates boxed  
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Figure 5b: Polyketide synthase substrate routes having potential substrates boxed 
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Due to their mechanistic similarities[11,12] (Figure 6) in between the fatty acid biosynthesis and 
polyketides biosynthesis, PKS are classified using the nomenclature for types of fatty acid 
synthases with some modifications added according to its needs. 
PKSs are classified into three groups. 
Type I polyketide synthases 
Type II polyketide synthases 
Type III polyketides synthases 
Type I polyketides synthases are further subdivided into Iterative PKSs and Modular PKSs; 
whereas Iterative PKSs are still further subdivided into  
NR-PKSs – non reducing PKSs (Products: True polyketides) 
PR-PKSs – partially reducing PKSs  
FR-PKSs – fully reduced PKSs (fatty acid derivatives). 
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Figure 6: Generic reaction scheme for biosynthesis of both fatty acids and polyketides[11,12]  
 
The modular system is the classical bacterial type I PKS best exemplified by the PKS 
responsible for assembling 6-deoxyerythronolide B synthase (DEBS) for the biosynthesis of 
reduced polyketides (e.g. macrolides, polyethers and polyene) such as erythromycin A (3) 
(Figure 7). This PKS assembles seven precursors consisting of one propionyl-CoA starter 
unit and six methylmalonyl-CoA extender units into 6-DEB. The role played by each of these 
precursors in polyketide assembly is clearly apparent from the unit names: the starter unit is 
the initiating precursor for polyketides synthesis, while the extender units elongate the 
polyketides backbone to completion. A set of catalytic domains, grouped together as a 
“module,” controls the incorporation of each precursor into the polyketides backbone.[12] 
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Figure 7: Domain organization of the animal FAS and the DEBS modular PKS[12] 
 
For the modular type I PKSs, the number of modules is equivalent to the number of 
precursors incorporated into the polyketides. The modules incorporating the starter units can 
have variable catalytic domains, whereas the modules that incorporate the extender units 
typically consists of three core domains namely ketosynthase (KS), acyltransferase (AT), 
and acyl carrier protein (ACP) for polyketides extension and up to three auxiliary domains 
namely ketoreductase (KR), dehydratase (DH), and enoylreductase (ER) involved in β-keto 
processing. The AT domain is the “gate keeper” of the module and recognizes the specific 
extender units that incorporate into the polyketide chain and covalently attached to the 
malonyl derivative of the extender unit of the thiol group of the ACP domain. The KS domain 
catalyzes the carboxylative Claisen condensation between a neighbouring ACP-linked 
malonate derivative and an ACP-linked acyl thioester to extend the polyketide chain. The 
optional domains KR, DH, ER alter the oxidation state of the β-keto group formed after KS-
catalyzed condensations whereas the TE (thioesterase) domain is the termination or 
releasing module that hydrolyzes the completed polyketides chain from the ACP domain of 
the previous module.[9] 
Iterative type I PKSs utilize the same core catalytic domains as modular type I PKSs, but 
these domains occur in a single polypeptide that is used repetitively to generate the entire 
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polyketide backbone. Initially it was thought to be limited to fungal systems, but Iterative type 
I PKSs were also known to be found to be in many bacteria (e.g. dihydromonacolin L (5) an 
intermediate of lovastatin (6) Figure 8).[13]  
 
Figure 8: Structure of using Iterative type I PKS system for biosynthesis 
 
Type II PKSs contain similar core catalytic domains seen in type I PKSs, with the exception 
of having typically two KS domains, KSα and KSβ. The former is equivalent to the KS seen in 
the type I PKSs, while the later controls the length of the polyketide and the enzymatic 
activities that are typically present on individual proteins. The reductive processing of the β-
keto groups occurs only after the polyketide is fully synthesized (e.g. two anti cancer drugs 
daunorubicin (7) and doxorubicin (8) Figure 9).[14] 
 
Figure 9: Structure of using Iterative type II PKS system for biosynthesis 
Type III PKSs, similar to above type I and II PKSs condense a starter unit with a series of 
extender units to generate a poly-β-keto chain. However differs from the above type I and II 
PKSs by typically lacking multiple catalytic domains and utilize an ACP-independent 
mechanism[9] starting from the p-coumaroyl-CoA and acts directly on the acyl-CoA 
substrates (e.g. flavanone (9a) and resveratrol (9b) Figure 10).[15]  
Myxobacteria 
   
- 10 - 
 
 
 
Figure 10: Structures of type III PKS system for biosynthesis and starter unit 
 
Despite structural and mechanistic differences all types of PKSs biosynthesize polyketides 
by sequential decarboxylative Claisen condensation of the acyl-CoA precursors, and the 
ketoacyl synthase (KS) domain or subunit catalyzes the C-C bond-forming step. 
 
1.2 Myxobacteria 
 
Myxobacteria are obligate, aerobic Gram-negative mesophilic δ-proteobacteria, which are 
commonly isolated from soil, the bark of trees, decaying plant material, herbivore dung and 
the marine environment.[16,17] The discovery of novel myxobacterial species from moderately 
halophilic soil as well as marine environments, illustrates that they can adapt to a wider 
variety of environment conditions.[18] All known myxobacteria are united in the order 
Myxococcales, which can be further divided into the three suborders Cystobacterineae, 
Sorangiineae and Nanocystineae.[19] More than 7500 strains within the order Myxococcales 
have been already isolated by research groups at the Helmholtz centre for Infection 
Research (Braunschweig, Germany; formerly German Research Centre of Biotechnology 
(GBF)) and novel strains, species and even families are continually being discovered.[16,20]  
These fascinating microbes display several behavioural features that distinguish them from 
many other bacteria. For example, they move about on solid surfaces by gliding or creeping, 
in a similar way like how amoebas do.[21] They secrete exo-enzymes which allow them to use 
a range of biological macromolecules (e.g. cellulose) as food sources, but are also able to 
prey actively on whole microorganisms such as fungi and bacteria.[22] In addition to these, 
under starvation conditions, they implement a cooperative developmental program involving 
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hundreds of thousands of cells.[23] The cells aggregate to form a pseudoplasmodium-like 
slimy mass, which ultimately transforms into a complex, multi cellular fruiting body (as shown 
in the Figure 11) harbouring propagative spores. Another notable characteristic of the 
myxobacteria is their rich secondary metabolism, which places them among the best known 
natural product producers (i.e., actinomycetes, Bacillus species, pseudomonads, and 
fungi).[24] Furthermore, the genome of myxobacteria is one of the largest known from any 
bacterium having for e.g. 13.0 MBp for Sorangium cellulosum So ce56.[25]  
 
Figure 11: Fruiting bodies formation by Sorangium cellulosum (Sorangiineae).[26]  
 
1.2.1 Polyketides from Myxobacteria 
Myxobacteria are a particularly rich source of novel polyketides.[27] As mentioned above, in 
the last three decades, due to the trailblazer work of the groups of prof. Höfle and Prof. 
Reichenbach at the Helmholtz centre for infection research, an impressive number of 
structurally unique and biosynthetically diverse polyketides have been reported from these 
soil-living organisms. In total, they extend to a range of approximately 60 structurally new 
classes of polyketides and many structural variants.[28] Many of these compounds are 
associated with biological activities, including antiproliferative, antibiotic, antifungal or 
antiplasmodial activities. On a molecular level, a wide variety of molecular targets are 
specifically addressed, including the cytoskeleton, nucleic acid polymerases, respiratory 
chain, nuclear transport, microfilaments and protein or fatty acid synthesis. This 
demonstrates that these compounds are highly attractive targets for further development. 
 
Figure 12: Sorangium celluslosum a) colonies and (b, c) swamming growth patterns.[26]  
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Around hundred distinct core structures and multiples of derivatives are yielded from these 
above mentioned 7500 approximately identified myxobacterial strains.[29] The majority of 
these include polyketides, non-ribosomal polypeptides and their hybrids[24,30] whereas other 
structural types include terpenoids, phenyl_propanoids, and alkaloids. During the past 15 
years 15 constitutionally novel polyketides were reported from myxobacteria. The first 
myxobacerial natural product applied for clinical use was a semi synthetic epothilone B (10) 
derivative named Ixabepilone approved by FDA and marketed in the United States by 
Bristol-Myers Squibb (BMS) for chemotherapy against breast cancer in 2007 under the trade 
name Ixempra®.[31] In addition to epothilone the natural products from myxobacteria which 
interact with cytoskeleton are disorazol (11)[32] and rhizopodin (12)[33]. All these 3 compounds 
are potential candidates in cancer treatment. Some 29% of myxobacterial metabolites exhibit 
anti-bacterial activity.[34] Notably; Sorangium cellulosum (Figure 12) was the most productive 
myxobacterium with caroalcton (13),[35] etnangien (14),[36] and maracin(15) /maracen (16)[37] 
isolated from the various strains of this microorganism which are shown in the Figure 13. 
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Figure 13: A selection of polyketides from myxobacteria. 
 
1.3 Carolacton 
 
1.3.1 Biofilms and biological activity of carolacton  
Up to 60% of all human infections are caused by biofilms.[38] Biofilm is a slimy layer formed 
by bacteria adhering to a implanted medical device or damaged tissues which encase 
themselves in a hydrated matrix of polysaccharide and protein. Periodontitis, endocarditis 
and chronic lung infection in cystic fibrosis patients are well known examples of diseases 
that are generally associated with biofilms.[39] Additionally caries is also a disease that is 
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associated with biofilms. Bacterial biofilms often conceal from host defences and are 
inherently resistant to antimicrobial agents. These characteristics result directly in severe 
health treats. The eradication of biofilms became a major concern in clinical treatment. There 
is an urgent need to develop new methods or improved tools to ideally and selectively 
destroy clinically relevant biofilms as the antibiotic resistance of bacteria in biofilms is found 
to be approximately 1000 folds higher than in plankton form. Biofilm formation and quorum 
sensing are the central and often interconnected features of bacterial social life. The major 
classes of theses bacterial social behaviour, and the suggestion that quorum sensing 
enables bacteria to turn on and off the secretion of extracellular polymeric substances (EPS) 
so as to increase their competitive ability against other species and strains within biofilms 
was well addressed by Foster et al.[40] Quorum Sensing is defined as a process that many 
species which inhabit dense, surface-bound communities, termed biofilms, within which they 
communicate via signalling molecules and respond to local cell density. Quorum sensing 
systems might be promising targets in treating biofilm induced infections. Hence the 
development of anti quorum sensing drugs that specifically disable the virulence might 
represent an alternative to conventional antibiotic therapy, mainly considering the fact that 
these antibacterial compounds are less likely to induce the development of resistant 
bacteria.[41]  
Dental caries (Figure 14) and Periodontitis are caused by biofilms known as dental plaque 
that result from microbial colonization of the tooth surface or the subgingival margin. As said 
above novel strategies are necessary for battling the clinically relevant biofilms, especially 
based on the fact that two-thirds of human bacterial infections are caused by biofilm forming 
bacteria. Under these circumstances our cooperation partner Prof. Dr. Wagner-Döbler and 
co-workers worked on finding new inhibitors of biofilm formation of Gram positive facultative 
anaerobic bacterium Streptococcus mutans. It is known that more than 500 bacterial species 
are found in dental plaque. Out of these Streptococcus mutans is considered to be the 
principal pathogen responsible for the caries disease in human oral cavity.[41] During the 
metabolism of dietary carbohydrates Streptococcus mutans rapidly produce acid end 
products lowering the pH to approximately pH 3.5 resulting in demineralisation of dental 
enamel and caries formation.  
 
Figure 14: Caries cavities (arrows) left and right buccal view.[42]  
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In this project Prof. Dr. Wagner-Döbler et al. tested several secondary metabolites from 
Sorangium cellulosum on their effectiveness in the inhibition against biofilm formation which 
have shown no antifungal and antibiotic activity in previous studies. They found the 
secondary metabolite carolacton (Figure 15), produced by the Sorangium cellulosum, 
inhibits biofilm formation of Streptococcus mutans.[41] Figure 15 shows the structure of 
carolacton which was elucidated by Prof. Dr. Andreas Kirschning et al.[35] Carolacton induced 
the damage of Streptococcus mutans biofilms at nanomolar concentrations. Carolacton (13) 
is a myxobacterial secondary metabolite isolated in 1998 from Sorangium cellulosum, strain 
So ce960 by Höfle et.al. Carolacton proved to possess high activity against biofilm formation. 
Thereby Prof. Dr. Wagner-Döbler started the BIOINSYS project towards the studies of 
carolacton for further studies. This chapter deals with the discussion of the work of the Prof. 
Dr. Wagner-Döbler et al. recently published.[41]  
O O OMe
OH
OO
OH
OH
Carolacton (13)
 
Figure 15: Structure of carolacton[35]  
The effect of carolacton on planktonic culture and biofilms tested using LIVE/DEAD staining 
is shown in Figure 16. The results prove that it does not have any effect on the cells of 
planktonic culture of S. mutans, however, a considerable effect was observed on biofilms. 
The biofilms were cultivated under anaerobic conditions (80% N2, 10% H2, 10% CO2) on 
microtitre plates for 24 h at 37 °C. Attempts were made to quantify the extent of biofilm 
damage caused by carolacton by determining colony forming units (CFU), which was done 
by using the LIVE/DEAD BacLight bacterial viability staining as it was more sensitive and the 
fastest method. LIVE/DEAD BacLight bacterial viability staining kit consists of two stains, 
propidium iodide and SYTO9, which both stain nucleic acids. When used alone green 
fluorescing SYTO9 generally labels all bacteria in a population, whereas red fluorescing 
propidium iodide only penentrates bacteria with damaged membranes, causing a reduction 
in the SYTO9 stain fluorescence. Thus with an appropriate mixture of the SYTO9 and 
propidium iodide stains, bacteria with intact membrane stain green and bacteria with 
damaged membranes stain fluorescent red. Biofilm damage was calculated as the ratio of 
green versus red fluorescence of the biofilm cells normalized against the untreated control. 
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This shows the membrane integrity of the cells, as the red fluorescing dye can only enter 
cells with the damaged membranes.  
         
         
 Figure 16: In the above shown Fig  A, B are fluorescent contrast images of planktonically 
grown cultures and C, D are biofilm cells of Streptococcus mutans. After LIVE/DEAD 
staining A, C are without carolacton and B, D are with 5.3 µM carolacton.[41]  
The above figure 16 clearly illustrates that the majority of the biofilm cells of S. mutans 
grown anaerobically in the presence of 5.3 µM carolacton showed red fluorescence in Figure 
16 D, indicating damaged membranes and possibly death of cells, while planktonic cells are 
fluorescing green like in the untreated controls in Figure 16 B. Moreover changes in cell 
morphology were observed, both in planctonic culture and in biofilms. In carolacton treated 
planktonic cultures in Figure 16 B cells appeared elongated, tended to form longer chains 
and some cells formed bulges, both as individuals and when growing in chains, suggests 
that cell division or acid tolerance could be influenced by carolacton. Nearly all of the 
planktonic cells in Figure 16 A and B were stained green, including also most of the balloon-
like ones, which indicates that these cells are indeed viable. In addition, carolacton treated 
biofilm cells in Figure 16 D show similar morphological modifications, yet many of the cells 
including also most of the balloon-like ones, are stained red which is easier to distinguish 
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compared with Figure 16 B which is untreated biofilm. Thus it’s evident that membrane 
damage resulting from carolacton treatment appears to be specific for biofilm cells.[41]  
All together, it was shown that there is no significant effect of carolacton on actively growing 
cells at a pH of above 5.8. These results were concluded by observing the Figure 17 which 
shows the amount of biofilm cells determined by crystal violet staining. 
 
 
 
Figure 17: Effect of Carolacton on biofilm  
mass and corresponding pH.[43] 
 
 
From the (Figure 17) it is clearly evident 
that there is no difference between treated 
and untreated cells for the first 8 h. 
Between 8 h and 10 h the carolacton 
treated biofilms show a slightly reduced 
amount of cell mass compared to the 
controls. This difference could not be 
compensated during the remaining biofilm 
cultivation, leading to a slightly reduced 
amount of cell mass in the carolacton 
treated biofilms after 22 h of growth. 
Carolacton added to the buffers which are 
not able to grow caused no inhibition of 
biofilm viability, indicating that the growth 
of the biofilm is necessary for the inhibitory 
effect caused by carolacton. Therefore, it 
can be conclude at this point that there is 
no significant effect of carolacton on 
actively growing cells at a pH of above 
5.8. 
To demonstrate the influence of the 
growth rate on the activity of carolacton, 
the inhibitor was added to the medium at 
different growth phases of the planktonic 
cultures growing at an acidic pH.[43] 
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Carolacton was supplemented at the lag phase (condition 18 A), at the early exponential 
phase (condition 18 B), at mid-exponential phase (condition 18 C), at the onset of the 
stationary phase (condition 18 D) and at the stationary phase (condition 18 E).The above all 
cultures are incubated for another 20 h and inhibition of viability was determined by 
LIVE/DEAD staining illustrated in Figure 18.  
 
Figure 18: Role of growth phase in the membrane damaged caused by carolacton in 
palnktonic culture.[43]  
A: Inhibition of viability determined by LIVE/DEAD viability staining                                        
B: Growth of planktonic cells at pH 6 
Addition of carolacton to proliferating cells (conditions A, B and C) shows inhibition of 
viability, while stationary phase cells (conditions D and E) are not inhibited. It illustrates that 
the damage caused by carolacton was increased if the initial pH was lower, but only for the 
early stages of culture (conditions A and B). The data from Figure 18 show that there is no 
significant difference in the activity of carolacton between planktonic and biofilms cells 
indicating that both are affected while they are growing at low pH.[43]  
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Furthermore the effluence of a large mass consisting, of DNA and β-galactosidase enzyme 
into the supernatant of carolacton treated biofilms was identified which demonstrates the 
formation of the large holes in the bacterial membrane due to the sterically complex large 
molecules. Carolacton caused leakage of cytoplasmic content but no complete cell lysis. It is 
inferred that carolacton disturbs a process which coordinates cell wall metabolism rather 
than directly inhibiting a certain enzymatic step in the biogenesis of the cell wall. This 
process appears to be only during the cell wall formation, because the addition of carolacton 
after the growth of the cells did not show any inhibitory effect. This mode of action could be a 
new strategy for the effective antibacterial agents. Existing drugs target the disruption of the 
synthesis of DNA and proteins and are therefore active only on growing bacteria. This is also 
the case for carolacton but still it could be a promising application by being an active 
ingredient in the destruction of cell membrane.[43] 
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1.4 Published carolacton syntheses 
 
Since the date of patenting[44] the invention of the carolacton and its derivatives in 2009 by 
Wagner Döbler et al., followed by the structural elucidation in 2010 by Kirschning et al.,[35] 
the syntheses of carolacton was initiated. The first total synthesis[45] reported till date was by 
A. Kirschning et al. in 2012 and a partial synthesis, the precursor of carolacton was carried 
out by Yadav et al.[46]. Recently there was a longest linear sequence (14 steps) synthesis of 
carolacton reported by Phillips et al.[47] 
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Figure 19: Retrosynthetic scheme of carolacton (13) by the kirschning et al.[45] 
Kirschning et al. synthesized carolacton through a metal mediated C-C coupling reaction 
(Figure 19). The synthesis of carolacton was consummated by the macrolactonization of the 
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crucial intermediate seco acid 17. The advanced intermediate seco acid was divided into 
western and eastern fragments. The western fragment prepared by the building blocks 20 to 
22 by an aldol reaction according to Ley and an asymmetric Negishi reaction between the 
bromide and allyl chloride. The eastern fragment synthesized by series of two reactions; 
asymmetric Marshall reaction between propargylic mesylate and aldehyde obtained from the 
starting materials 1,2 dibromopropane and  3-hydroxy-2-methylpropionate respectively. The 
product then upon Duthaler-Hafner Aldol reaction with titanium enolate obtained from tert-
butyl acetate resulted in the eastern fragment.[45]  
Recently reported synthesis by Phillips et al. includes the longest linear sequence of 
reactions (Figure 20). The C12-C19 segment of the molecule was obtained from the starting 
material Gulono-lactone derived diol and the C1-C11 fragment including the side chain was 
initiated with the β-ketoimide using Evans auxiliary and Paterson aldol conditions. The two 
fragments acid and alcohol are coupled by Steglich-esterification to obtain the ester followed 
by the ring closing metathesis reaction (RCM) to obtain the lactone with the protecting 
groups. Later a series of reactions involving crucial selective hydrogenation, cleavage of the 
protecting groups followed by oxidation and removal of the acetonide group led to the 
carolacton.[47]  
 
Figure 20: Retrosynthesis scheme of carolacton (13) by Phillips et al.[47]  
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The other partial syntheses as shown in Figure 21 by Yadav et al.[46] in 2012 was initiated 
with  (-)-β-citronellene and D-Ribose as starting materials and Nozaki Hiyama Kishi reaction 
to prepare the intermediate and were in due to complete the total synthesis involving ring 
closing metathesis under Yamaguchi macrolactonization conditions. 
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Figure 21: Retrosynthesis scheme of carolacton (13) by Yadav et al.[46] 
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2 Aims of the thesis 
 
As described in the chapter 1 of this work, the synthesis of carolacton and its derivatives is 
of immense importance because the biological activity tests described defines for continuous 
access to sufficient quantities of substance. This goal was an important part of a project 
funded by the Federal Ministry of Education and Research in Germany under the name 
BioInSys ‘‘Medical systems Biology- MedSys’’ program.  
BioInSys project was a large joint project consisting of several working groups which were 
shown below in the schematic chart (Figure 22). 
 
Figure 22: Working groups in the project BioInSys (WP = work package).  
The work group of Prof Dr. An-Ping Zeng from the University of Hamburg works on the 
proteomics and metabolic analysis.[48] The changes in the metabolic, regulatory and 
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signalling networks can be made by having thorough knowledge on the metabolism and its 
modules as well as their regulation combined with computer stimulations and quantitative 
analysis of the metabolites. The research group of Prof. Dr. Andreas Kremling from 
Technical University of Munich deals with the systems Biology and dynamic models. Here 
we can understand the cellular behaviour effect by inclusion of the proteomic and metabolic 
analysis. The research of the workgroup of Prof. Dr. Wagner-Döbler from HZI (Helmholtz 
centre for Infections Research) is discussed in chapter 1.3. In order to test caries inhibiting 
effect not only on biofilms in vitro but also on the clinical trials (animal models), carolacton 
was applied to the teeth of mouse by mixing it in the drinking water carried out by the 
workgroups of Prof. Dr. Georg Conrads and Prof. Dr. Christian Apel in  the University Clinic 
of RWTH Achen. The effect of carolacton on the dental materials was tested by the dental 
company Voco Gmbh. Dr. Andree Barg deals with the composition of the coatings and 
fillings, which are added to carolacton to be subsequently introduced into human tooth. 
The aim of the project is the stereoselective synthesis of the side chain of carolacton and its 
derivatives. The synthesis of the methyl ester derivative of the carolacton and its role played 
by it in determining the biological activity of carolacton is also discussed. In addition to it the 
stability of the carolacton in different buffer solutions is determined using LC/MS.   
In this thesis, scheme for the synthesis should be developed to synthesize the carolacton 
side chain in a simple and stereoselective manner making it feasible to alter the functional 
groups in order to prepare derivatives of carolacton. To make it accessible to synthesize 
various derivatives of carolacton, carolacton was divided into three parts as shown in the 
Figure 23. Fragment 3 is the part of this wok whereas the synthesis of Fragments 1 and 2 
were carried by Insa Bergmann and are not reported here.  
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Figure 23: Retrosynthesis of carolacton. 
In the above retro synthesis the macrolide ring is synthesized from fragments 1 and 2. 
Fragment 1 is a isopropylidene acetal protected representing the corresponding annular 
section. The protecting groups were necessary, as the dihydroxy functional group could 
interfere with numerous reactions. Fragment 2 is coupled to the side chain by Nozaki-
Hiyama-Kishi reaction. The side chain could be added as vinyl iodide or enol triflate and 
need to be tested further for the applicability using the Nozaki-Hiyama-Kishi reaction. 
Esterification was done with the generated alcohol and the carboxylic acid functional group 
of Fragment 1. Later olefin metathesis reaction with the two terminal double bonds of the 
ester has to be done using Grubbs catalyst to obtain the macrolide followed by the 
deprotection of the isopropylidine acetal of the macrolide ring and the paramethoxybenzyl 
group of the side chain. Finally, oxidation of the primary alcohol of the side chain has to be 
done to obtain the desired carolacton in a stereoselective fashion. 
The synthesis of the side chain of carolacton is discussed in this thesis in detail, starting with 
the construction of the relative configuration anti(C-3, C-4) / anti(C-4, C-6) followed up by 
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synthesizing the side chain having absolute stereochemistry anti(C-3, C-4) / anti(C-4, C-6) 
as shown in the Figure 24. Both relative and absolute stereoselective synthesis of the side 
chain is discussed in detail in the following chapters.  
 
Figure 24: Structure of the carolacton side chain 
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3 Syntheses 
 
3.1 Synthesis of the side chain with defined relative configuration  
 
In this section the synthesis of the carolacton side chain in relative stereochemistry is 
described. The retrosynthesis of the carolacton side chain is illustrated in Figure 25. 
 
Figure 25: Retrosynthesis of the carolacton side chain in a relative configured fashion.  
The target compound 30 can be constructed from 3-pentanone (31) as core compound. 
Selective reaction on the two α-carbonyl positions with two C3 building blocks gives the 
target compound. One of these C3 building blocks should be able to be transferred into an 
acid. This can be done by transforming 1,3-propanediol (32). The other C3 building block 
requires a double bond on a proper leaving group at C2. This can be achieved by starting 
from allyliodide (33) or propylene oxide (34). 
 
The synthesis started from commercially available starting material 1,3-propanediol (32). 
The diol is selectively mono-protected using different protecting groups as tetrahydropyranyl, 
tert-butyldimethylsilyl, benzyl, and para-methoxybenzyl groups as shown in the Figure 26. 
The synthesis of monoprotected diols with various protecting groups was carried out in order 
to check the diasteromeric ratio (d.r.) of the aldol product of the corresponding protected diol. 
The protecting group best suited for the reaction was determined after determination of the 
ds ratio of the aldol product. The ease of removal of the protecting group was also assessed 
in later stages. 
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Figure 26: Mono protection of 1,3-propanediol (32) with different protecting groups 
 
All the monoprotected alcohols were obtained in good (THP, PMB/NaH) to excellent yields 
(TBDMS, Bz). The use of NaH in the later cases avoided the formation of the diprotected 
product.[49–52] The fair yield of the mono PMB ether was improved according to the method of 
Hunter[53] and Takano[54], further modified by Uguen[55] and F.M.Cordero[56], who used a two 
step procedure via opening of an acetal 35 formed from 1,3-propanediol (32) and para-
methoxybenzaldehyde. 
 
The mono protected diols are oxidised to their corresponding aldehydes using swern[57], 
Parikh-Doering[58] as well as IBX[59] oxidation procedures as shown in the Figure 27. The 
oxidation of mono protected propanediol 37 with para-methoxybenzyl group as protecting 
group with IBX resulted in the best yield (80%) compared to the Parikh-Doering (70%) or 
swern (68%) oxidation procedures. These aldehydes are used in the Aldol reaction to 
generate aldol products of their corresponding protecting groups. The benzyl and para-
methoxybenzyl protecting groups were shown to have good diastereoselective ratios 
compared to the other protecting group of the aldol products.  
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Figure 27: Oxidation of monoprotected alcohols to aldehydes  
 
 
In this thesis the para-methoxybenzyl protecting group was preferred over the benzyl group 
as the cleavage of para-methoxybenzyl group is relatively easier than that of the benzyl 
group. The stability of the para-methoxybenzyl groups is also greater in the reactions 
towards the synthesis of the side chain in later stages. Benzyl groups also need 
hydrogenation for cleavage. This is a problem because the olefin bond might get affected in 
the compound. Hence, the para-methoxybenzyl group as protecting group is well suitable in 
the compound to withstand the different chemical reaction environments encountered on the 
way to synthesize the desired compound of interest. The next step was the aldol reaction of 
the protected aldehyde with pentanone (31) to yield the aldol product in the desired relative 
configuration. 
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Figure 28: Reaction scheme in a relative configured fashion 
 
 
Reactions and conditions: a) NaH, DMF, PMBBr, 0 °C, rt, 5 h; b) IBX, DMSO, CH2Cl2,      
0 °C,  2 h; c) B(Cy)2Cl, TEA, THF, 0 °C 4 h, -78 °C 2 h, -20 to -32 °C 12 h, pH 7 buffer 
solution, MeOH/H2O2, 0 °C 1 h; d) ethylene glycol, cat. PTSA, toluene, 12 h reflux; e) Proton 
sponge, Me3OBF4, CH2Cl2, rt, 22 h; f) NaHMDS, THF, Allyliodide, -78 °C, 4 h; g) PdCl2, 
Cu(OAc)2, O2, atm. pressure, DMF/H2O 8:1, 4 d; h) KHMDS, Comin’s reagent, -78 °C;          
i) ethylene glycol, cat. PPTS, toluene, 12 h reflux; j) LDA, -78 °C, 3 h, 41, 2 h. 
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The enantioselective aldol reaction using L-proline as catalyst and water as additive was not 
successful to synthesize the aldol product.[60] Some other catalytic enantioselective aldol 
reactions were reported later by Trost et al.[61] using L-proline (>30 mol%) without additive, 
non-proline derived catalysts and by Reiser et al. [62] using cobalt(II)-proline catalyzed direct 
aldol reaction.  These methods were not tried.  
 
  
A racemic mixture of stereoisomers 45a was synthesized using LDA (lithium 
diisopropylAmide) as a base at -78 °C with aldehyde 41. Alternatively the reaction of 31 and 
the different protected aldehydes 41 using Paterson aldol reaction[63] conditions afforded the 
anti-aldol product in a stereoselective fashion. Under these conditions dicyclohexylboron 
chloride ((Cy)2BCl) is used as Lewis acid and triethylamine (TEA) as base. The synthesis of 
the aldol product with different protecting groups and their diastereoselectivity ratios are 
shown in the Figure 29. Although the diastereoselectivity of the aldol product containing the 
benzyl protecting group is higher than the aldol product containing a para-methoxybenzyl 
protecting group the latter was chosen for the next steps, because the removal of the 
protecting group is easier. The complete scheme of the reaction starting from the 1,3-
propanediol (32) is shown in the Figure 28. 
 
 
  
 
 Aldehyde 
                 
yield  d.e. 
     
Aldol product 
 
Protecting group 
 
      41 
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      42 
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TBDMS 
 
Figure 29: Aldol reaction with Paterson reaction conditions. Influence of the protecting 
group. 
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Relative stereocontrol usually arise from the enolization selectivity. In this thesis the boron 
mediated aldol reaction is discussed. This reaction proceeds through a chair like transition 
state as shown in the Figure 30, where (Z)-boron enolates give syn-aldol products and (E)-
boron enolates afford anti-aldol products.[64] Enolization selectivity is crucially important 
during the translation of the boron enolate geometry into aldol product stereochemistry. The 
(E)-enolate formation is favoured by the use of sterically demanding ligands on boron (e.g. 
cyclohexyl), poor leaving group (e.g. chloride) and a small amine base (e.g. triethylamine).   
 
 
Figure 30: Chair like transition state from (E)-boron enolate favouring the anti-aldol product. 
 
The stereochemical determination of the aldol condensation products was based on the 
“Stille-House” method.[65] This technique was based on the intramolecular hydrogen bond 
between the carbonyl oxygen and the β-hydroxyl proton. The hydrogen bond is thought to 
give rise to the predominant conformation that would lead to the observation of a 
corresponding predictable 3JHH coupling constant.[66] This rule states that the intramolecular 
hydrogen bond formed between the carbonyl oxygen and the β–hydroxyl substituent can 
allow the relative configuration between the two stereogenic centres to be determined by 
analysis of the 3JHH homo nuclear coupling constant between the α- and β- protons. 
 
The 3J4,5 homo nuclear coupling of the aldol product was found to be 9.1 Hz, measured in 
deuterated chloroform. Compared to the theoretical calculations within the range of 7-10 Hz 
predicted by the “Stille-House” method, this value is in agreement with the threo (anti) 
configured aldol product. The value found for erythro (syn) configured aldol products varies 
between 2 to 4 Hz.  
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Attempts to allylate the aldol 45 with allylbromide using LDA and LiHMDS[67] as base at -78 
°C were unsuccessful. Therefore 45 was methylated first and the allylation reaction was 
carried out in a later stage.  
 
 
 
Various attempts to methylate the aldol product as shown in Figure 31 resulted in the di- or 
tri-methylation of the aldol product rather than the methylation at the hydroxyl group. The 
keto group and the methylene group adjacent to keto group are methylated along with the 
hydroxyl group. The methylation of 48 can be accomplished, but the use of 45 with proton 
sponge was more effective. To circumvent this, the keto group of 45 was protected as acetal 
48 to minimise the methylating side reactions. Nevertheless the methylation of the aldol 
product 45 was successful with very good yield using proton sponge® as the base and 
Meerwein salt[68] as the methylating agent starting from 45 without the need of protecting the 
keto group as acetal 48. 
 
O OH
OPMB
O O
OPMB
Base, methylating agent
45 49
 
 
 
Base (No. of eq.) 
 
 
Methylating Agent 
(No. of eq.) 
 
Time 
 
yield 
NaH (1.1 eq) MeI (10 eq) rt 28 h     - 
NaH (4 eq) MeI (10 eq) rt 72 h     - 
NaH (1.1 eq)  MeOTf (10 eq) rt 4 h     - 
2,6-di-tert-butyl-4-methylpyridine (2 eq) MeOTf (2 eq) reflux 14 h     - 
Diisopropylethylamine (1.1 eq) Me3OBF4 (1.1 eq) rt 24 h     - 
Neutral alumina 1 g Me2SO4 (12 eq) rt 33 h     - 
NaOH 50 % aq. (1.7 eq) MeI (5 eq) rt 41 h     - 
          - CH2N2 (excess) rt 17 h     - 
Proton sponge (15 eq) Me3OBF4 (15 eq) rt 6 h  8 % 
Proton sponge (8 eq) Me3OBF4 (8 eq) rt 20 h 80 % 
 
Figure 31: Methylation of aldol product 45 with base and various methylating agents[68,69] 
The two α-methyl groups of the carbonyl group in the side chain of carolacton are 
stereochemically oriented towards each other in an anti-arrangement. Therefore, an 
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epoxide-opening reaction was advised to come to the γ–hydroxylcarbonyl arrangement of 
the target compound. A test reaction of the ketone 50 with epoxide 34 was carried out to find 
out the regio- and stereoselective outcome of the reaction. In this process the addition 
reaction of the metal enolate derived from the ketone 50 to the epoxide 34 gives γ–
hydroxyketones. The regioselective attack of the lithium enolate derived from ketone 50  to 
the unsymmetrical epoxide preferably on the less substituted oxirane carbon using LiHMDS 
as a base in the presence of the LiClO4 catalyst[70] afforded γ–hydroxy ketone 51  in 40% 
yield. The regio and stereoselectivity of the reaction was investigated as shown in the Figure 
32. It was observed there was no predominant formation of one stereo isomer over the other 
indicating a racemic mixture of the product 51 and no stereoselectivity in the reaction. 
 
 
 
Figure 32: Reaction of 50 with 2-methyloxirane (34) 
Based on the above result, another approach towards the side chain by proceeding with the 
alkylation of 49 with allyl Iodide 33 using NaHMDS as base was performed at -78 °C for 4 h 
to afford the allyl product 52 preferably as anti diastereomer in 40% yield with 91% (d.e.) 
(Figure 33). The sodium enolate of 49 showed good diastereoselectivity (major anti 
diastereomer) for alkylation presumably through a non-chelated intermediate.[71] The anti-
configured stereochemistry was confirmed by the NMR data analysis of NOESY spectra 
(Figure 34); clear indication of the close spatial arrangement of the methine proton at C-4 (δ 
2.69 ppm, J = 6.8 Hz) and methyl group at C-19 (δ 1.05 ppm, J = 6.8 Hz) as well as the 
methine proton at C-6 (δ 2.90 ppm, J = 7.1 Hz) and methyl group at C-20 (δ 0.95 ppm, J = 
6.8 Hz).  
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Figure 33: Reaction of 49 with allyliodide (33) 
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Figure 34: NOESY Spectra of 52 
The terminal alkene 52 established was the precursor of the methylketone 53. This 
functional group conversion can be performed by Wacker-Tsuji oxidation.[72] However the 
slight modification by SMITH et al.[73] to the Wacker oxidation by using copper acetate 
instead of copper chloride was considered in this reaction in order to replace the strongly 
acidic HCl formation with weakly acetic acid byproduct during the course of the reaction 
(Figure 35). The terminal alkene 52 upon Wacker oxidation was transformed with O2 at 
atmospheric pressure at room temperature for four days and resulted in the diketone 53 with 
50% yield. 
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Figure 35: Schematic diagram of the palladium catalyzed Wacker-Tsuji oxidation[73] 
The final transformation of the diketone 53 is formation of the triflate 55. Nevertheless, in 
triflate 55 the keto group is unprotected and might get prone to side reactions in further steps 
of the synthesis. To avoid this, the keto group of the allyl product 52 was protected without 
problem to the acetal 54. Wacker oxidation product 56 from 55 can be carried then to further 
steps selectively to the triflate 57 using KHMDS and comin`s reagent[74] without affecting the 
keto group adjacent to the methoxy group as shown in Figure 28.   
 
 
 
 
 
 
Synthesis of Chiral Ketones 
   
- 37 - 
 
3.2 Synthesis of Chiral Ketones 
 
The chiral ketones were synthesized to synthesize the side chain stereoselectively using 
either Enders SAMP/RAMP method or Evans protocol explained in the following sections. 
The use of the SAMP/RAMP method according to the Enders protocol is explained below. 
3.2.1 Synthesis of chiral ketone using Enders method 
Chiral ketone 60 was synthesized from the commercially available diethyl ketone 31, a core 
starting material. The great synthetic potential of metalated dimethylhydrazones as highly 
reactive intermediates in regio- and diastereoselective C-C bond formation reactions was 
well demonstrated by E. J. Corey and D. Enders in 1976.[75] They reported the asymmetric 
α–alkylation of ketones via the corresponding (S)-1-amino-2-methoxymethylpyrrolidine 
(SAMP) hydrazone 58a and (R)-1-amino-2-methoxymethylpyrrolidine (RAMP) 58b 
derivatives. The synthesis of chiral ketone 61 using Enders methodology is shown in the 
Figure 36. 
 
 
Figure 36: Reaction scheme for synthesis of the chiral ketones 61 and 62 using the SAMP 
pathway 
Reactions and conditions: a) (S)-1-amino-2-(methoxymethyl)-pyrrolidine, 60 °C, 21 h;       
b) LDA, Et2O, 0 °C, 4 h, allyl Iodide 33, -110 °C, 3 h; c)  MeI, 65 °C, 2 d, 4 N HCl, 5 min., 
pentane, 30 min.; d) CuCl2, THF, 1 d; e) LDA, Et2O, 0 °C, 4 h, 41, -78 °C, 2 h. 
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The SAMP chiral auxiliary can be obtained from (S)-proline[76] in four steps in 58% over all 
yields and its enantiomer RAMP can be obtained from (R)-glutamic acid[77] in six steps in 
35% yield. According to the Enders procedure the SAMP hydrazone was synthesized 
quantitatively by heating the ketone with SAMP at 60 °C for 21 h, followed by deprotonation 
with lithium diisopropylamide in THF. This leads to the formation of the Lithiated azaenolate 
that was trapped with the electophile allyl Iodide 33 at -110 °C. The reaction proceeds, from 
the sterically more accessible face with high diastereoselectivity as shown below to afford 
the allylated SAMP hydrazone (Z,S,S)-isomer 60 predominantly as a major isomer among 
the possible four stereoisomers, as shown in the Figure 37 with minor (E,S,S)-isomer, the 
geometric isomer of 60.[78] 
 
Figure 37: Possible four stereoisomers of allylated SAMP hydrazone 60[78] and transition 
state 
  
The major isomer (Z,S,S)-60 was obtained in 95% yield with 98% (d.e.) excess. Cleavage of 
the SAMP hydrazone can be done through various procedures. However, limitations apply in 
this case due to the presence of the terminal alkene. Two procedures, the salt method and 
cleavage with Copper mediated hydrolysis,[79] were carried out to check out the outcome of 
the enantiomeric excess of the desired chiral ketone 61. In the salt method the allylated 
SAMP hydrazone was treated with the excess of MeI at 60 °C leading quantitatively to the 
mixture of the methiodides 60a and b as shown in Figure 38, which were hydrolyzed without 
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further purification in a two phase system (3-4 N HCl/ n-pentane) to afford the (S)-chiral 
ketone 61. Surprisingly, the salt method furnished 61 with 60% yield and 90% ee compared 
to the 90% yield with 60% ee obtained with the copper mediated hydrolysis. In addition, to 
the above methods used for cleavage of the SAMP auxiliary, the enantiomeric excess (ee) 
could also be high by using saturated aqueous oxalic acid solution as the racemization free 
cleavage of the ketones. This method was widely reported to give excellent yields and high 
enantiomeric purity.[80] Moreover, the recovery of SAMP auxiliary would be possible with this 
procedure. 
 
 
Figure 38: Salt method in a two phase reaction to obtain a chiral ketone 61 
 
Efforts to synthesize the carolacton side chain using the intermediate 61 without cleavage of 
the SAMP auxiliary by aldol reaction in the presence of LDA were fruitless when the reaction 
was carried out at 0 °C with LDA followed by the addition of aldehyde at -78 °C to generate 
the enolate; however possible reaction with LDA at -78 °C followed by the addition of the 
aldehyde at the same temperature could possibly lead to the product β–hydroxyhydrazone 
62, as a similar reaction was reported by D. Enders et al.[81] Switching in between the SAMP 
and RAMP auxiliaries could possibly lead to the desired β-hydroxyhydrazone product 62 
bearing (3,4)-anti and (4,6)-syn relative configurations.[82] 
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3.2.2 Synthesis of chrial ketone using Evans auxiliary 
3.2.2.1 Synthesis of chiral ketone 61 with terminal alkene  
 
Because the SAMP/RAMP method proved unsuccessful, the Evans chiral auxiliary protocol 
was tried. The synthesis of chiral ketone 61, using Evans methodology was started with 
propionyl chloride (63) and Evans auxiliary 64,[83] the commercially available starting 
materials. The synthesis of the chiral allylketone 61 is as shown in the Figure 39. 
 
Figure 39: Reaction scheme of chiral ketone using Evans auxiliary 
 
Reactions and conditions: a) (R)-4-benzyl-2-oxazolidinone 64, THF, -78 °C, n-BuLi, 1 h,   
0 °C, 3h; b) THF, NaHMDS, -78 °C, 1 h, allyl bromide, -45 °C,  4 h; c) THF/H2O 3:1, H2O2, 
LiOH.H2O, 0 °C, 2 h, Na2S2O3, 0 °C, 20 min.; d) CH2Cl2, 1,1'-carbonyldiimidazole 68, 30 
min., rt, N,O-dimethylhyxdroxylamine hydrochloride 69, 20 h; e) EtMgBr 71, THF, -20 °C. 
 
The commercially available chiral auxiliary (R)-benzyl-2-oxazolidinone 64 was deprotonated 
and subjected to propionyl chloride 63 providing the N-propionyl oxazolidinone 65 in 
excellent yield[84] with 99% yield and 99% ee. Asymmetric alkylation[85] of the formed product 
65 was carried out in the presence of NaHMDS to form an sodium enolate and trapped with 
the electrophile allyl bromide which attacks from the less hindered bottom side of the 
enolate. The benzyl group shields the upward approach (Figure 40), to obtain the allylated 
product 66 in 94% yield with 99% (d.e.).  
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Figure 40: Reaction of the metal enolate with electrophile 
 
The cleavage of the Evans Auxiliary with LiOH/H2O2 hydrolysis[84,86] leads to the allylated 
enantiomeric acid 67 in 99% yield with 98% ee. Recovery of the Evans auxiliary without the 
loss of the enantioselectivity was possible by hydrolysis. The acid was treated with 1,1'-
carbonyldiimidazole (CDI) 68 at room temperature followed by the addition of N,O-
dimethylhyxdroxylamine hydrochloride 69 using Heathcock’s protocol[87] i.e; imidazolide 
precursor obtained from the carboxylic acid and Staab reagent (CDI) resulted in the Weinreb 
amide 70 in excellent yield upto 99% with 99% ee retaining the enantioselectivity. The 
Weinreb amide 70 upon Grignard reaction with ethyl magnesium bromide 71 below 0 °C 
afforded the desired allylated chiral ketone 61 in good yield 90% with 99% ee.[88,89]  
 
3.2.2.2 Synthesis of chiral ketone 80 with internal alkyne 
 
The synthesis of the chiral ketone 80 using Evans auxiliary with an internal alkyne was 
commenced by using pent-3-yn-1-ol (72) as the commercially available starting material. The 
alkyne chemistry using Evans auxiliary beside the alkene chemistry is carried out to study 
the introduction of the iodine group in the side chain instead of the triflate group. The 
schematic illustration of the synthesis of chiral ketone with alkyne chemistry consisting of 
internal alkyne was shown in Figure 41. 
Jones oxidation[90] of the pent-3yn-1-ol (72) at room temperature afforded the acid 73 in 
moderate yield of 60% with the inverse addition method.[91,92] Introduction of the Evans 
auxiliary 64 to the acid group via one pot reaction by insitu generation of the anhydride with 
PivCl 74 instead of the synthesis of the halide of the corresponding acid 73; and reaction of 
the anhydride with the lithiated species of the Evans auxiliary (R)-4-benzyl-2-oxazolidinone 
64 afforded the Evans auxiliary product 75 in only 36% yield whereas the major by product 
being the Evans auxiliary protected PivCl 76.[93]  
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Figure 41: Reaction scheme of chiral ketone 80 with internal alkyne using Evans Auxiliary 
 
Reactions and conditions: a) CrO3, icebath, H2SO4, acetone, rt, 15 h; b) THF, Et3N, PivCl 
74, -78 °C, 20 min., -78 °C to rt, 45 min., (R)-4-benzyl-2-oxazolidinone 64, THF, -78 °C, n-
BuLi, 15 min.; -78 °C to 0 °C, 3 h, 0 °C, 45 min., c) THF, NaHMDS, -78 °C, 1 h, MeI, -78 °C, 
5 h; d) THF/H2O 3:1, H2O2, LiOH.H2O, 0 °C, 2 h, Na2S2O3, 0 °C, 20 min.; e) CH2Cl2, 1,1'-
carbonyldiimidazole 68, 30 min., rt, N,O-dimethylhyxdroxylamine hydrochloride 69, 20 h;             
f) EtMgBr 71, THF, -20 °C. 
  
The Evans auxiliary product 75 was then first treated with the NaHMDS to generate the 
enolate. The alkylation with methyl iodide resulted in the isomerized product 82 with terminal 
alkyne instead of the internal alkyne 77. The reaction was not reliable, because often only 
starting materal was isolated. This led me to think over the change of the synthetic scheme 
to shift to the terminal alkyne instead of internal alkyne. It is explained below. 
 
3.2.2.3 Synthesis of chiral ketone 88 with terminal alkyne 
 
The synthesis of the chiral ketone with terminal alkyne as shown in Figure 42 was started 
with the commercially available starting material pent-4-ynoic acid 81. Introduction of the 
Evans auxiliary via one pot synthesis by insitu generation of the anhydride of the 
corresponding acid was done instead of traditional synthesis of the halide of the 
corresponding acid.[94] The anhydride was immediately at -78 °C treated with the lithiated 
species of the (R)-4-benzyl-2-oxazolidinone 64 to afford the Evans auxiliary product 82 in 
excellent 94% yield with 99% ee. Only traces of the byproduct 76 were formed. 
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Figure 42: Reaction scheme of chiral ketone 69 with terminal alkyne using Evans auxiliary 
 
Reactions and conditions: a) THF, Et3N, PivCl 74, -78 °C, 15 min., (R)-4-benzyl-2-
oxazolidinone 64, THF, -78 °C, n-BuLi, 30 min.; b) THF, NaHMDS, -78 °C, 1 h, MeI, -78 °C,   
4.5 h; c) EtOH, Ti(OEt)4 84, 20 h reflux; d) THF/H2O 3:1, H2O2, LiOH.H2O, 0 °C, 2 h, 
Na2S2O3, 0 °C, 20 min.; e) CH2Cl2, 1,1'-carbonyldiimidazole 68, 30 min., rt, N,O-
dimethylhyxdroxylamine hydrochloride 69, 20 h; f) EtMgBr 71, THF, -20 °C. 
 
Generation of the enolate of the Evans auxiliary with NaHMDS and then treated with methyl 
iodide at -78 °C resulted in the methylated product 83 in 85% yield with 99% (d.e.). 
However, treatment of propargyl bromide 89 with propionyl-oxazolidinone 65 in the presence 
of LDA and HMPA[95] afforded the product 90 with the syn configuration in 78% yield as 
single diastereomer; the absolute configuration was confirmed by the X-ray crystallography 
(Figure 43). By inversing the Evans auxiliary in the reaction with propargyl bromide 89 in the 
presence of LDA and HMPA would have afforded the desired configured alkylated product 
83.  
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Figure 43: X-ray crystal structure of methylated methylated Evans product 90  
 
The generated alkylated product 83 upon LiOH/H2O2 hydrolysis resulted in the cleavage of 
the Evans auxiliary 64 leaving acid 86 in 85% yield with 96% ee. The cleavage of the 
auxiliary 64 to obtain the ester 67 was done by refluxing the alkylated Evans product 83 with 
Ti(OEt)4 84 in ethanol, sacrificing the recovery of the Evans auxiliary 64 in 85% yield with 
99% ee. This was performed to check the ee. The analysis of the product by chiral GC 
allowed to check whether any epimerization during the hydrolysis reaction using LiOH/H2O2 
took place. Fortunately, as there was no any epimerized product formed during the 
hydrolysis reaction, this reaction scheme was carried further via acid 86. Transformation of 
the acid 86 into the Weinreb amide 87 using 68 and 69 afforded the amide 87 in 80% yield 
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with 98% ee. Grignard reaction of the product with ethyl magnesium bromide 71 afforded the 
chiral ketone 88 with terminal alkyne in 70% yield with 98% ee. 
 
The chiral ketone 80 with the internal alkyne was synthesized by isomerizing the chiral acid 
86 by treatment with KOtBu in DMSO[96] in 54% yield and without any observed racemization 
of the product (Figure 44). The isomerized chiral acid 78 with internal alkyne was 
transformed into the Weinreb amide 79 in 78% yield and 99% ee in micro scale (mg 
quantity). Grignard reaction of the amide with ethylmagnesium bromide 71 below 0 °C 
afforded the desired ketone 80 with internal alkyne in 50% yield. 
 
 
 
Figure 44: Reaction scheme for the chiral ketone 80 with internal alkyne by isomerization of 
the chiral acid 86 
 
Reactions and conditions: a) KOtBu, DMSO, rt; b) CH2Cl2, 1,1'-carbonyldiimidazole 68, 30 
min., rt, N,O-dimethylhyxdroxylamine hydrochloride 69, 20 h; c) EtMgBr 71, THF, -20 °C. 
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3.3 Absolute configuration 
 
The synthesis of the carolacton side chain was mentioned in chapter 3.1 with respective to 
the relative configuration whereas here the asymmetric synthesis of the side chain of 
carolacton with absolute configuration was reported. The synthesis started from utilizing the 
above synthesized (S)-chiral ketone 61 obtained from the SAMP methodology (chapter 
3.2.1) with achiral aldehyde 41 using Paterson aldol reaction[97] as shown in the Figure 45. 
 
Figure 45: Aldol reaction of chiral ketone 61 with achiral aldehyde 41 
 
Reactions and conditions: a) B(Cy)2Cl, TEA, THF, 0 °C, 4 h, -78 °C, 41, 2 h, -20 to -32 °C, 
12 h, pH 7 buffer solution, MeOH/ H2O2, 0 °C, 1 h.  
 
The aldol reaction of an aldehyde with metal enolate creates two new chiral centres in the 
product molecule; and this lead to the four possible steroisomers as shown in the Figure 46. 
 
 
 
Figure 46: Stereoisomers of the aldol product of chiral ketone 61 with achiral aldehyde 41 
 
The anti-configured stereoisomers 91 and 93 are the result of the boron mediated aldol 
reaction resulting from the (E)-enolate, whereas the stereoisomers 92 and 94 obtained from 
the (Z)-enolate show syn-configuration (Figure 46).  
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Figure 47: Chair conformations of the stereoisomers of the Aldol product 
 
From the above Zimmerman-Traxler model as shown in the Figure 47 the (Z)-enolate 
geometry tends to give 6,7-syn-product 92 & 94, whereas the (E)-enolate gives the 6,7-anti-
product 91 & 93. The rational of the high stereo-outcome is that the dicyclohexylboron 
enolate having relatively short metal-oxygen bonds and this is essential for maximizing the 
1.3-diaxial interactions in the transition states. The opmb–moiety occupies a more stable 
transition state, a pseudo equatorial position leading to the aldol product with high 
stereoselectivity preferably 91 in anti-configured and 94 in syn-configured. 
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Figure 48: Aldol reaction of chiral ketone 61 with achiral aldehyde 41 
  
The combination of the bulky boron ligands on cyclohexyl, a boron chloride derivative and an 
unhindered base such as triethyl amine proved to be optimal for the stereoselective 
synthesis of trans-enolates for wide variety of ketones reported by Paterson utilizing the 
Brown enolization procedure.[64] As shown in the Figure 48 enolization of (S)-chiral ketone 
61 with (c-C6H11)2BCl/Et3N affords trans-enolate which smoothly adds to the aldehyde 41 to 
give anti-aldol product 91 with the diastereoselectivity (d.r. = 2:1anti/syn). 
The configuration of the C-4 was retained as planned in the synthesis and the configuration 
of C-7 was assigned after the Mosher ester analysis. Based upon the configuration of the C-
4 and C-7 the possible configuration at C-6 is revealed by the relative configuration by the 
NMR vicinal (3J) coupling constants.  
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3.3.1 Assignment of the C-7 configuration of Aldol product via Mosher ester NMR analysis 
 
The absolute configuration at the hydroxyl group of the aldol product containing the two 
inseparable diastereomers was determined by synthesizing the Mosher esters with chiral 
derivatizing agents (CDA) (R)-MTPACl 95 and (S)-MTPACl 96 as shown in the Figure 49. 
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 Figure 49: Reaction of aldol product 91 with CDA’s to the corresponding Mosher esters 
 
MTPACl (α-methoxy-α-trifluoromethyl-α-phenylacetic acid chloride) is most commonly used 
derivatizing reagent for the determination of the absolute configuration of secondary alcohols 
by NMR. This methodology was first reported by Mosher in 1973.[98] The procedure starts 
with the esterification of the aldol product with the two enantiomers of the MTPACl. The aldol 
product was treated with (R)-MTPACl and (S)-MTPACl in the presence of triethyl amine and 
catalytic amount of DMAP to transform into the (S)- and (R)-esters, respectively.[99] The (S)-
ester 97 and the (R)-ester 98 were purified with flash column chromatography, followed by 
acquiring and comparing the NMR spectra of the two diastereomeric esters. 
The two substituent’s adjacent to each side of the MTPA chiral site at C-7 were designated 
as L1 (the side chain with allylic group with steric bulkier methyl groups) whereas L2 (the side 
chain with the protecting group para methoxy benzyl group) and the differences in the 
chemical shift were represented by ∆δ; a sign of the parameter either + or –, provides the 
information about the configuration. Later a new methodology called as the modified Mosher 
Method was developed by Kakisawa and coworkers to evaluate the ∆δRS data.[100] This 
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procedure involves the analysis of all of the protons in the molecule, so that a representative 
sign for ∆δRS of the substituents L1 and L2 can then be adopted based on the majority of the 
protons for each substituent.[101] 
 
 
 
Figure 50: Preferred conformation of product 91 with CDA’s 
 
In the above Figure 50 in the (S)-mosher ester the protons in the L1 portion are more highly 
shielded (and appear further up field), and those in the L2 moiety are less highly shielded 
(and appear further down field). The reverse is true in the case of (R)-mosher ester. Thus we 
expect ∆δRS to be negative for L2 and positive for L1. By the NMR interpretation it was clear 
that L1 substituent appear at upfield in the case of (S)-mosher ester whereas the L2 
substituent at downfield in the (S)-mosher ester. Calculating the ∆δRS values and using the 
Cahn-Ingold-Prelog (CIP)-convention the absolute configuration of the carbinol center in the 
aldol product was assigned as (S) configured, as shown below in Table 1 and Figure 51. The 
chemical shift of CF3 in 19F NMR was having δ value at -71.58 ppm for (R)-MTPA ester and  
-71.55 ppm for (S)-MTPA ester referring the integrals the d.e. was calculated as 24%. 
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Table 1: ∆δRS values of the MTPA ester 
 
L1: 
Allyl 
group 
   
  δ (ppm) 
L2: ethyl with 
PMB group 
 
 δ (ppm)  
 
  MTPA Config. 
 
 C3 
  1.82 
  1.75 
+0.07 
 
     C8 
  1.90 
  1.98  
-0.08 
        R 
        S 
 
 C4 
  2.70 
  2.68 
+0.02 
      
     C9 
  3.35 
  3.46 
-0.11 
        R 
        S 
 
 C10 
  1.06 
  1.03 
+0.03 
          R 
        S 
 
 C11 
  1.09 
  0.98 
+0.11 
          R 
        S 
 
 
 
 
Figure 51: ∆δRS values of the MTPA ester of aldol product 91 
  
The absolute configuration at C-7 was assigned as (S)-configured via modified Mosher 
method and the methyl group adjacent to the allyl group having (S) configured obtained from 
the (S)-chiral ketone 61 the assignment of the configuration at C-6 was (S). The 
diastereoselective aldol reaction produced the diastereomer with anti-configuration with    
3JH-6, H-7 = 7 Hz, Figure 52; shows the 1H-NMR spectrum of the aldol product 91 as proven by 
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the earlier reaction. The proton at C-6 at δ 2.79 ppm was relatively anti-configured with both 
of the protons at C-7 at δ 3.91 ppm and C-4 at δ 2.71 ppm having the coupling constant J = 
9.6 and 7.1 Hz respectively. 
 
 
 Figure 52: 1H-NMR of the aldol product 91 
 
A) Multiplet of H-7 at δ 3.91 ppm; B) doublet of H-12 (-OH group) at δ 3.27 ppm;                 
C) quartet of H-6 at δ 2.79 ppm ; D) Complete 1H-NMR spectrum of the aldol product 91. 
 
In the above spectra the multiplet (M06) of H-7 is having the splitting pattern of doublet of 
doublet of triplets (ddt) at δ 3.91 ppm with the coupling constant, J = 9.6, 7.1 and 2.5 Hz. 
The hydroxyl group (-OH) multiplet (M10) at δ 3.26 ppm shows the splitting pattern of 
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doublet (d), as well as the minor diastereomer at C-7 at δ 3.29 ppm; both isomers having the 
coupling constant, J = 4.5 Hz. The multiplet (M11) of the H-6 shows the splitting pattern of 
quartet of doublets (qd) at δ 2.79 ppm with coupling constant, J = 7.1 Hz. 
  
The aldol product 91 upon methylation[102] with the meerwein salt[103] and proton sponge 
afforded the methoxy product 99 in 80% yield. 
 
 
 
Figure 53: Reaction scheme for the side chain of carolacton via asymmetric synthesis 
 
Reactions and conditions: a) Proton sponge®, Me3OBF4, CH2Cl2, rt, 22 h; b) ethylene 
glycol, cat. PTSA, toluene, reflux; c) PdCl2, Cu(OAc)2, O2, atm. pressure, DMF/H2O 8:1; d) 
KHMDS, Comin’s reagent, -78 °C. 
 
The future prospects of the reactions are to protect the keto functional group of 99 as 
dioxalane 100 followed by Wacker oxidation to ketone 101 and finally the generation of the 
triflate 102[74] as shown in Figure 53; readily available for the Nozaki-Hiyama-Kishi 
reaction[104] with the aldehyde from fragment 2. 
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3.4 Synthesis of the carolacton side chain using epoxide pathway 
 
Another approach towards the side chain used an epoxyalcohol-aldehyde rearrangement as 
key step. The aldehyde 41 served as starting material in this alternative synthesis via 
Sharpless asymmetric epoxidation as shown in the Figure 54. 
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Figure 54: Reaction scheme of epoxide pathway via cis-α,β-unsaturated α-methyl ethyl 
ester 115 
 
Reactions and conditions: a) THF, 114, 0 °C, NaI, DBU, 10 min., -78 °C, 2 h; b) Et2O, 
LAH, 0 °C, 15 min.,Na2SO4, 0 °C, 15 min., c) DCM, 4 A° mol. sieves, Ti(OiPr)4, (-)-DET, -30 
°C, 30 min., TBHP, -20 °C, 3 h; d) DCM, 4 A° mol. sieves, DIPEA, rt, 10 min., TESOTf 118,  
-42 °C, 1.5 h; e)  boronated allene 120. 
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For the planned enantioselective Sharpless epoxidation a (Z)-configured ester was 
necessary. Therefore, the Still-Gennari procedure reported to be (Z)-selective was used. The 
required phosphonate was synthesized as shown in Figure 55. Dichloroethyl phosphite 103 
as starting material was reacted with triflouroethanol and triethylamine in THF, thus forming 
bis(triflouroethyl)ethylphosphonate 105. The second step involves the reaction of 105 by 
reacting it with an enolate formed from the reaction of ethyl chloroformate and a lithium 
amide to give bis(triflouroethyl)phosphonate ester 109; however by Michaelis-Becker 
synthesis[105] the commercially available triflouroethylphosphite 107 was directly converted to 
the ester 109. The ester upon Horner-Emmons reaction under Still-Gennari conditions[106] 
afforded the ester 115  giving only a 80:20 Z/E mixture. 
 
Figure 55: Reaction scheme for the synthesis of triflouroethyl-phosphonoate ester 109[105,107] 
  
Reactions and conditions: a) THF, 0 °C, Et3N, bis(2,2,2)-triflouroethanol (104), rt, 2 h 20 
min.; b) LiHMDS, THF, -78 °C, ethyl choroformate 106, -20 °C overnight; c) NaH, THF, 
HMPA, ethyl 2-bromopropionate 108, rt, 5 h. 
 
Because this was not sufficiently stereoselective, the method of Mori et al. as shown in 
Figure 56 was tried. The required reagent was synthesized by treating phosphonate 110 with 
phosphorous pentachloride at 75-80 °C overnight to afford phosphoryl chloride 112. o-Cresol 
113 was esterified with 112 in the presence of triethylamine to afford the desired tolyl-
phophonate ester 114. The aldehyde 41 upon Wittig Horner-Wadsworth-Emmons (HWE)-
reaction with phosphono acetate 114 in the presence of NaI and DBU afforded α,β-
unsaturated-α-methyl ethyl ester 115 in 84% yield with 99:1 Z/E mixture.[108]  
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Figure 56: Reaction scheme for the synthesis of tolyl-phosphonoate ester 114[109] 
  
Reactions and conditions: a) benzene, 0 °C, PCl5 111, 75 °C, 10 h; b) benzene, 0 °C, 
Et3N, o-cresol 113, rt, 1h. 
  
The ester upon reduction with lithium aluminium hydride in diethyl ether afforded the allylic 
alcohol 116 in excellent yield. The allylic alcohol 116 upon sharpless asymmetric 
epoxidation[110] with Ti(Oi-Pr)4 in the presence of t-BuOOH and (-)-DET afforded the epoxide 
117 in 70% yield with 96% ee. Opening of the epoxide and simultaneous protection of the 
hydroxyl group as triethyl silyl group and oxidation of the alcohol to aldehyde 119 in a one 
pot reaction was carried out with TESOTf 118 at -42 °C in dichloromethane and molecular 
sieves.[111] The aldehyde was synthesized in a micro scale reaction confirming the formation 
of the product through GC-MS analysis which needs to be scaled up for further analysis, as 
well as to forward the synthetic plan towards the side chain. 
The slight change in the synthetic scheme by switching over from cis-α,β-unsaturated-α-
methyl ethyl ester 115 to the trans-ester 124 was carried out as shown in the Figure 57. 
The aldehyde upon Wittig reaction with phosphonium ylide 123 afforded trans-α,β-
unsaturated-α-methyl ethyl ester 124 in 90% yield exclusively without any traces of the cis 
isomer.[112,113] The trans-ester upon reduction with Lithium aluminium hydride afforded the 
alcohol 125 in 87% yield. Sharpless asymmetric epoxidation[110] of the allylic alcohol afforded 
the epoxide 126 in 65% yield with 98% ee. Opening of the epoxide 126 with palladium 
catalyst 127 to 128 was not successful. Therefore, the hydroxyl group of the epoxide was 
protected with tert-butyldimethylsilyl group (129) to afford 130.[114] This time the opening of 
the epoxide carried out again with the palladium catalyst afforded the product 131 in micro 
scale in mg amounts which needs to be scaled up for further analysis and to forward the 
synthesis toward the side chain.[115] 
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Figure 57: Reaction scheme of epoxide pathway via trans α,β-unsaturated α-methyl ethyl 
ester 124 
Reactions and conditions: a) CH2Cl2, Ph3P=C(CH3)CO2Et 123, rt, 34 h; b) LAH, Et2O,       
0 °C, 15 min., Na2SO4, 0 °C, 15 min.; c) DCM, 4 A° mol. sieves, Ti(OiPr)4, L-(+)-DET, -30 °C, 
30 min., TBHP, -20 °C, 3 h; d) Pd(dba)3CHCl3 127, 1,4-dioxane, n-Bu3P, HCOOH, Et3N, rt, 
13 h, e) CH2Cl2, imidazole, TBDMSCl 129, rt, 3 h; f) Proton sponge, CH2Cl2, MeO3BF4, rt. 
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4 Role of the carboxylic moiety in carolacton activity  
 
Carolacton is a carboxylic acid and active at low pH. To address the question whether the 
activity depends on ion dissociation of the acid function, a methyl ester derivative 138 was 
needed. It is important to know whether the carboxylic acid group of carolacton is needed for 
activity. Therefore, the esterification of the acid group was investigated. A difficulty was that 
only few mg of carolacton were available. Therefore, aleuritic acid was used as model 
compound for the esterification process as well as for the analysis of the reaction products 
by HPLC/MS. Aleuritic acid contains some of the characteristic structural elements of 
carolacton, the diol group and the terminal acid function. In order to establish the carolacton 
methyl ester first the model compound aleuritic acid 135 (mol wt: 304.43) was first analyzed 
with HPLC/MS by preparing its methyl ester 137 (mol wt: 318.43) in micro scale apparatus 
(Figure 59) in mg amounts with diazomethane 136. The apparatus and the synthetic 
procedure utilized in the synthesis of carolacton methyl ester and aleuritc acid was much the 
same conditions as depicted below in the Figure 58. 
 
Figure 58: Conversion of aleuritic acid 135 to its methyl ester derivative 137.   
 
Figure 59: Apparatus for the generation of the diazomethane 136 for methylation.[116] a: 
Reaction vials mounted on a tripoid stand A:Reactor vial, B: trap and  C: collector vial. b: 
Line diagram of the described set-up. 
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Figure 60: HPLC-Chromatogram of aleuritic acid 135 at Rt: 9.14 min. and its mass 
spectrum. 
The HPLC-Chromatogram (Figure 60) using electro spray ionization (ESI) in positive 
ionization mode at Rt 9.14 min. shows the characteristic mass ions of of 135 at m/z = 305.20 
[M+H]+, 327.28 [M+Na]+, 327.43 [M+Na]+, 609.04 [2M+H]+, 630.92 [2M+Na]+. 
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Figure 61: HPLC-Chromatogram of aleuritic acid methyl ester 137 at Rt: 9.70 min. and its 
mass spectrum. 
The HPLC-Chromatogram (Figure 61) using electro spray ionization (ESI) in positive 
ionization mode at Rt 9.70 min. shows the characteristic mass ions of of 137 at m/z = 319.20 
[M+H]+, 341.32 [M+Na]+, 636.64 [2M]+, 658.48 [2M+Na-H]+. 
The methyl ester of carolacton 138 and carolacton 13 containing free carboxylic acid 
function were again tested for the effect on the biofilm damage of S.mutans as represented 
in Figure 62 B by the group of Wagner Döbler et.al.[43] The methyl ester of carolacton was 
tested in three different concentrations for its biological activity against S.mutans biofilms 
using LIVE/DEAD viability staining. 
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Figure 62: Influence of the carboxylic moiety on carolacton activity.[43]  
A) Change of the charge of the carboxylic acid function of carolacton upon decreasing pH.      
B) Inhibition of biofilm viability by carolacton and the carolacton methylester for 3 different 
inhibitor concentrations determined by LIVE/DEAD staining.                                                 
C) Conversion of carolacton into the corresponding carolacton methylester. 
Following the methylation procedure of aleuritic acid 135 to its methyl ester 137 (Figure 57), 
carolacton 13 (1 mg, mol.wt: 468.58) was utilized in this synthesis (Figure 62 C) with excess 
of diazomethane 136 for 1 h at 0 °C to generate the carolacton methyl ester 138 (mol. wt: 
482.58). Figure 62 shows that the inhibition of viability caused by carolacton methyl ester 
was the same as the natural carolacton molecule for concentrations 2.5 and 25 µg/mL. 
However for the lowest tested concentration of 0.025 µg/mL, the inhibition was slightly 
reduced to 35%. Hence it is assumed that no functional activation of the molecule at low pH 
occurs and carolacton is independent of its pH. By considering the above results it is evident 
that carboxylic group of carolacton doesn’t play a dominant role in its inhibitory activity. 
Recently, new results contradicted this report. The methyl ester 138 is easily cleaved by the 
bacteria to carolacton 13 (I. Wagner-Döbler, pers. commun.). Therefore, the acid function in 
carolacton 13 seems to be necessary. 
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 Figure 63: chromatogram of carolacton 13 at Rt: 9.03 min. and its mass spectrum. 
The HPLC-Chromatogram of 13 (Figure 63) using electro spray ionization (ESI) in negative 
ionization mode at Rt 9.03 min. shows the characteristic mass ions of 13 at m/z = 467.36 [M-
H]-, 512.48 [M+2Na-2H]-, 934.84 [2M-2H]-, 957.32 [2M+2Na-2H]-. 
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Figure 64: chromatogram of carolacton methyl ester 138 at Rt: 10.93 min. and its mass 
spectrum. 
The HPLC-Chromatogram of 138 (Figure 64) using electro spray ionization (ESI) in positive 
ionization mode at Rt 10.92 min. shows the characteristic mass ions of of 138 at m/z = 
483.24 [M+H]+, 505.40 [M+Na]+, 986.52 [2M+Na-H]+.  
In the previous studies towards the effectivity of carolacton it was concluded that the nature 
of the growth of cells play a major role along with the initial pH value of the relevant culture. 
Also the pH of the biofilm falls significantly faster than that of the planktonic cell cultures. The 
effect of carolacton on biofilms at pH above 5 has no significant effect while the addition of 
carolacton to the biofilms at pH below 5 leads to the significant damage of biofilms of S. 
mutans.  
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Figure 65: Verification of the insensitivity of a pknB-deficient strain to carolacton using 
LIVE/DEAD staining and fluorescence microscopy. Images of carolacton-treated and 
untreated biofilm cells of the wild type (A), the ∆pknB mutant (B), and the complemented 
strain (C).[43]  
The most important discovery of the working group was however the identification of the 
gene which is responsible for the activity of carolacton. Two-component systems (TCS), 
serine-threonine protein kinases (STPKs) and phosphatases were used by bacteria to 
detect, transmit and react to the signals by the outside world. Most of the bacterial STPKs 
were predicted to consist of an N-terminal kinase domain, and a C-terminal sensory domain 
located extracellularly. TCS widely occurred in prokaryotes; consist of a membrane-located 
sensor histidine kinase and a correspondence response regulator present in the cytoplasm. 
In response to an environmental signal, the histidine kinase (HK) protein is 
autophosphorylated on a histidine residue and in the later stage regulates the transcription of 
target genes. Similar to histidine kinases, STPKs are autophosphorylated, but on the serine 
or threonine residues. In contrast to two-component response regulators, STPKs exert their 
effect by phosphorylation of target proteins. Streptococcus mutans contains one serine-
threonine kinase, encoded by pknB. It was found that the pknB knockout mutant is 
insensitive to carolacton while the wild type and complementary strain shown to be effective 
upon treatment with carolacton as shown in the Figure 65.   
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Furthermore, the stability of the carolacton along with the standard reference aleuritic acid 
135 in water and different buffer solutions was tested. The samples were prepared (100 µg 
of 135 and carolacton 13 per 1mL buffer and unbuffered solutions) with buffer and 
unbuffered solutions. The samples were stored at room temperature and after 4 months 
analyzed with HPLC/MS. The results are presented in Figure (66-71). By analysis of the 
mass spectras of the HPLC-Chromatogram in all different media listed below it was clear 
that carolacton is quite stable in these solutions, without any degradation. The reference for 
the HPLC-Chromatogram of 13 is shown in Figure 63, using electro spray ionization (ESI) in 
negative ionization mode. The different solutions used are mentioned below. The analysis 
was performed under the same conditions as reported in Figure 58: 
1) Carolacton in water  
2) PBS (Phosphate Buffered Saline solution) 
3) THB (Todd Hewitt Broth unbuffered solution) 
4) THBS (Todd Hewitt Broth with 1% sucrose unbuffered solution)  
5) THB + Buffer solution pH 6.5 (75 mM Phosphate buffer Na2HPO4 and NaH2PO4) 
6) THB + Buffer solution pH 7.8 (75 mM Phosphate buffer Na2HPO4 and NaH2PO4)  
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Figure 66: HPLC-Chromatogram of carolacton 13 in water after 4 months.  
The HPLC-Chromatogram (Figure 66) using atmospheric chemical ionization (APCI) in 
negative ionization mode shows two peaks at Rt 7.09 min. and 8.96 min. representing the 
characteristic mass ion of aleuritic acid 135 which was used as internal standard at m/z = 
303.24 [M-H]- and carolacton 13 at m/z = 467.36 [M-H]- respectively. 
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Figure 67: HPLC-Chromatogram of carolacton 13 in PBS after 4 months. 
Ingredients in PBS (Phosphate Buffered Saline):  
137 mM NaCl 
2.7 mM KCl 
12 mM Phosphate 
 
The HPLC-Chromatogram (Figure 67) using atmospheric chemical ionization (APCI) in 
negative ionization mode shows the peak at Rt 7.09 min. representing the characteristic 
mass ion of 135 at m/z = 303.24 [M-H]-, and the other two peaks at 8.49 min. and 8.98 min. 
having the characteristic mass ion of 13 at m/z =  467.36 [M-H]-.  
Under these conditions it was observed the epimerization seems to take place at Rt 8.49 
min. with the halflife (t1/2) of approx. 120 days. The degree of epimerization of 13 in water 
(Figure 66) seems to be very less compared to the chromatogram in PBS. The ratio of the 
epimerized carolacton and carolacton in PBS was 1.0:1.27. 
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Figure 68: HPLC-Chromatogram of carolacton 13 in THB unbuffered solution after 4 
months.  
Ingredients in THB (Todd Hewitt Broth unbuffered solution): 
Heart Infusion 3.1 g/L 
Neopeptone 20 g/L 
Dextrose 2 g/L 
NaCl 2 g/L 
NaH2PO4 0.4 g/L 
NaHCO3 2.5 g/L 
 
The HPLC-Chromatogram (Figure 68) using atmospheric chemical ionization (APCI) in 
negative ionization mode shows the peak at Rt 7.10 min. representing the characteristic 
mass ion of 135 at m/z = 303.24 [M-H]-, and the other two peaks at 8.49 min. and 8.99 min. 
having the characteristic mass ion of 13 at m/z = 467.36 [M-H]-.  
The ratio of the epimerized carolacton and carolacton in THB was 2.6:1.0 compared to the 
chromatogram of 13 in PBS having the ratio of 1.0:1.27. There was a drastic increase in the 
epimerization of carolacton in THB compared to the degree of epimeriazation of carolacton 
in PBS (Figure 67). 
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Figure 69: HPLC-Chromatogram of carolacton 13 in THBS unbuffered solution after 4 
months.  
Ingredients in THBS (Todd Hewitt Broth in 0.5% sucrose unbuffered solution):  
Heart Infusion 3.1 g/L 
Neopeptone 20 g/L 
Dextrose 2 g/L 
NaCl 2 g/L 
NaH2PO4 0.4 g/L 
NaHCO3 2.5 g/L 
 
The HPLC-Chromatogram (Figure 69) using atmospheric chemical ionization (APCI) in 
negative ionization mode shows the peak at Rt 7.09 min. representing the characteristic 
mass ion of 135 at m/z = 303.24 [M-H]-, and the other two peaks at 8.49 min. and 8.96 min. 
having the characteristic mass ion of 13 at m/z = 467.36 [M-H]-.  
The ratio of the epimerized carolacton and carolacton in THBS was 1.0:1.22. The degree of 
epimerization was slightly higher with marginal increase of epimerized carolacton compared 
in PBS of ratio 1.0:1.27(Figure 67).   
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Figure 70: HPLC-Chromatogram of carolacton 13 in THB buffered solution pH 6.5 after 4 
months. 
The HPLC-Chromatogram (Figure 70) using atmospheric chemical ionization (APCI) in 
negative ionization mode shows the peak at Rt 7.08 min. representing the characteristic 
mass ion of 135 at m/z = 303.24 [M-H]-, and the other two peaks at 8.49 min. and 8.98 min. 
having the characteristic mass ion of 13 at m/z = 467.36 [M-H]-.  
The ratio of the epimerized carolacton to the carolacton in THB buffered solution pH6.5 is 
approx. 1.30:1.0 compared to the chromatogram having the ratio 2.6:1.0 n in THB 
unbuffered solution (Figure 68). The rate of epimerization was more in the THB unbuffered 
solution compared to the buffered solution of pH 6.5. 
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Figure 71: HPLC-Chromatogram of carolacton 13 in THB buffered solution pH 7.8 after 4 
months.  
The HPLC-Chromatogram (Figure 71) using atmospheric chemical ionization (APCI) in 
negative ionization mode shows the peak at Rt 7.10 min. representing the characteristic 
mass ion of 135 at m/z = 303.24 [M-H]-, and the other two peaks at 8.49 min. and 8.97 min. 
having the characteristic mass ion of 13 at m/z = 467.36 [M-H]-.  
Compared to the previous case the ratio of the epimerized carolacton to the carolacton in 
THB buffered solution of pH 7.8 was more enhanced 2.7:1.0. To sum up, the the rate of 
epimerization was more in the THB buffered solution of pH 7.8 and THB unbuffered solution 
compared to the THB buffered solution of pH 6.5 in a decreasing order. 
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5 Summary and Outlook 
 
The attempts to synthesize the carolacton side chain was discussed in the above chapter 3 
and the idea of synthesizing the carolacton side chain in using the above synthetic 
procedures was to synthesize various derivatives of carolacton by altering the functional 
groups with out deviating from the proposed synthetic reactions. 
Aldol reactions play a prominent role in securing the right stereochemistry of the side chain 
of carolacton. The synthesis was initiated with proline catalyzed enantioselective aldol 
reaction but it was later clear that there is the necessity of usage of the various 
ligands/substituents on the proline catalyst to achieve good enantioselectivities. Therefore, it 
was not explored further and new strategies developed for the synthesis. During the 
synthesis of the side chain with the relative configured sterechemistry in the chapter 3.1 
(Figure 28) optimization of reaction conditions were carried out in generating the methylated 
product and the best optimum yield and the etherification of the hydroxyl group was 
successfully carried out by using meerwein salt as methylating agent. The retrosynthetic 
approach towards the side chain was show in the Figure 72. 
 
Figure 72: Retrosynthetic approach towards the carolacton sidechain  
Finally, after generation of the diketone 53 based on the relative stereochemistry the 
synthesis of the side chain 30 with absolute configuration was carried out by synthesizing 
the chiral ketones with terminal alkene and alkyne groups using Evans auxialaries and 
SAMP methodology as discussed in chapter 3.2. The problems associated in the synthesis 
of the chiral ketone with internal alkyne were minimized by isomerizing the acid of terminal 
alkyne with KOtBu and DMSO at room temperature. However, the best yields were obtained 
with the ketones containinig terminal alkene instead of the terminal or internal alkynes. The 
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Evans methodology for generating the terminal alkene was preferred over the SAMP 
methodology due to its excellent enantioselectivities of chiral ketones. Various chiral ketones 
synthesized were shown in the Figure 73. 
 
 
Figure 73: Synthesized chiral ketones internal alkene 61 and internal and terminal alkynes 
80 and 88. 
The determination of the absolute configuration with MTPA esters 97 and 98 in this thesis 
chapter 3.3.1 required to analyze the 2D NMR data and the difference in the chemical shifts 
∆δRS values of the diastereomers were very close; musch easier method would be utilizing 
the α-methoxy-α-phenylacetic acid (MPA) as chiral derivatizing agents (CDA) (Figure 74), 
instead of the MTPA leading to assign the chemical shifts (δ) of either diasereomers of MPA 
ester 139 in a much uncomplicated way to give higher ∆δRS values that are more reliable 
and homogeneous in terms of distribution of the signs. The reason that MPA as CDA is 
much simpler than MTPA was due to the presence of three main conformers with similar 
populations. Also some of these conformers produce shielding effects and others 
deshielding effects on substituents L1/L2, resulting in the small ∆δRS values and sometimes 
abnormalities in the distribution of signs. In contrast to the above MTPA esters 140 (in 
general usage for different L1 and L2’s), MPA esters 139 have only two conformers and clear 
preference for one of these two conformers. This results in transmitting the shielding effect to 
the substituents to give high ∆δSR values, giving the edge for the MPA esters over the MTPA 
esters.[117] 
 
Figure 74: Esters 139 and 140 of the aldol product with different CDA’s 
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Various protecting groups were employed in the synthesis of protected Hydroxy propanal. 
The para-methoxy benzyl groups is the best out of them becase it with stands reactions in 
various reaction conditions. The easy removal of the protecting group (OPMB) with DDQ at 
the end of the final synthesis of the carolacton is also an advantage. The asymmetric aldol 
reaction can be carried out with a chiral ketone with an achiral aldehyde under Paterson 
Aldol conditions to obtain the aldol product in good yield with 2:1 anti/syn diastereomeric 
ratio. The diastereomeric ratio (d.r.) can still be enhanced by optimizing the reaction 
conditions. Aldol reactions with terminal and internal alkynes in similar fashion as like that of 
a chiral terminal alkene could be carried out in order to observe any variations in the 
steroselectivity ratio of the isomers. The internal alkyne aldol reaction on reaction with 
Schwartz’s reagent would provide vinyl iodide 122 and with terminal alkyne upon oxidation in 
the presence of Hg(OAc)2 would provide the diketone similar to the case of the terminal 
alkene synthetic pathway. 
In the chapter 3.4 as illustrated in the Figure 54 and 57 of the epoxide scheme the 
aldehydes 119 and 133 upon asymmetric allenyl boronation reported by Rousch et al.[118] 
leads to the internal alkyne product. Oxidation of these internal hydroxyl alkyne products 121 
and 134 afford the corresponding ketones and transformation of the internal alkyne to 
vinyliodide furnishes the desired product with good stereoselectivity. The allene was 
synthesized from the propargylic alcohol in two steps as shown in Figure 75. 
 
 
Figure 75: Proposed synthesis of boronated allene 120  
 
The aldehyde derived from 119 (Figure 54) and 133 (Figure 57) in the presence of 
phosphoric acid (R)-141 and boronated allene 120 would give rise to the alcohol with 3,6-syn 
and 4,6-anti related configurations (Figure 76). Oxidation of the hydroxyl group at C-5 to 
ketone followed by the protection of ketone as dioxalane and finally utilizing Schwartz’s 
reagent the desired molecule vinyl Iodide 122 can be synthesized.   
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Figure 76: Proposed synthesis of the side chain of carolacton via non aldol process 
(epoxide pathway)  
  
An other alternative pathway to the aldol reaction was the decarboxylative allylation reaction 
of the formed aldol product using the Evans auxiliary from propionyloxazolidinone and 
aldehyde to obtain the anti-configured aldol using Evans aldol reaction[119] followed by the 
cleavage of the auxiliary and generating the ketone with EtMgBr via Weinreb amide as 
shown in Figure 77 below. 
 
 
Figure 77: Proposed Evans aldol reaction with achiral aldehyde 
 
Later by using the palladium-catalyzed decarboxylative asymmetric allylic alkylation (DAAA) 
reaction conditions developed by Trost et al.[120] a new stereogenic center  with the allyl 
group adjacent to the keto group can be introduced to obtain 146. The reaction proceeds 
through the (Z)-enol carbonate 145 as shown in the Figure 78. 
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Figure 78: Proposed palladium-catalyzed decarboxylative asymmetric allylic alkylation 
(DAAA) 
Reactions and conditions: a) (PhMe2Si)2NLi, THF, -78 °C, allyl chloroformate; b) 
Pd2(dba)3CHCl3, Ligand (R,R)-144, dioxane, rt. 
 
The role of the caroboxylic acid in the side chain of carolacton in the biological activity of 
carolacton was clearly known by synthesizing its methyl ester derivative which explains it’s 
not the solely responsible factor for the activity of carolacton. Furthermore the stability of the 
carolacton in different buffered solutions of varied pH conditions was analyzed with 
HPLC/MS and it found to be stable in these solutions. Degedration of carolacton 13 was not 
observed in the HPLC-Chromatogram analysis, but under those conditions reported in the 
chapter 4 (Figure 66-71) slow epimerization seems to take with t1/2 approx. 120 days. It 
would be much interesting to synthesize a wide variety of derivatives and analogues of 
carolacton as shown in the Figure 79 to know the role played by them in various biological 
activities. The synthetic scheme mentioned in this thesis is quite flexible in altering the 
functional groups and very feasible once the conditions are better optimized in the key aldol 
reaction. 
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Figure 79: Derivatives of carolacton 13  
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6 Experimental procedures 
 
6.1 General Methods 
 
6.1.1 Chemicals 
Commercially available starting materials were purchased from Sigma-Aldrich Chemie 
GmbH (Germany), Fluka Chemie GmbH(Switzreland), Merck (Germany), Acros Organics 
(Belgium), TCI Organic Chemicals (Belgium), Janssen Chimica (Belgium) and Riedel de 
Haën AG (Switzerland) that were used without further purification except if otherwise stated. 
Technical solvents were distilled before use. For the reactions performed with dry solvents, 
THF was distilled over sodium and potassium with benzophenone, dichloromethane over 
calcium hydride, diethyl ether over LiAlH4, ethanol and methanol over magnesium. 
6.1.2 Reaction Conditions 
All reactions involving water-sensitive chemicals were carried out in overnight oven dried 
(100 °C) clean glass equipment which was further flame dried with Bunsen burner before the 
start of the reaction under vacuum, then switched to nitrogen atmosphere and magnetic 
stirring unless otherwise stated. 
6.1.3 Thin layer Chromatography and column chromatography 
TLC was performed on 0.2 mm pre-coated plastic sheets of Polygram® SIL G/UV254 plated 
purchased from Macherey-Nagel. Detection of compounds was performed by immersion in 
10% ethanolic solution of phosphomolybdic acid, Potassium permanganate solution or in 
detecting mixture containing 5 g K2CO3 and 5 ml 1 N NaOH in 300 ml water and followed by 
gentle heating with heat gun. The detection of compounds was also done under UV (254 
nm) light observation. 
Flash chromatography was performed on silica gel M60 (0.04-0.063 mm, 230-400 mesh 
ASTM) (Macherey-Nagel) under pressure with the eluent mentioned in the respective 
procedures. 
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6.1.4 Analytical techniques and devices 
6.1.4.1 Gas Chromatography/Mass Spectrometry 
 
GC-MS was performed on HP 6890 gas chromatograph coupled to an MSD 5973 (EI 70 ev) 
(Hewlett Packard) and on a GC 7890A coupled to an MSD 5975C (Agilent Technologies). 
Separation was performed in a fused-silica capillary columns BPX-5 (SGE Inc.; 25 mm x 
0.22 mm I.D. x 0.25 µm) and HP5-MS (Agilent Technologies, 30 m x 0.25 mm I.D. x 0.25 
µm). Instrument parameters were adjusted as follows: inlet pressure 77.1 kPa; He 23.3 
ml/min; injector 250 °C; injection volume 1 µl; transfer line 300 °C; electron energy 70 eV. All 
of the Synthetic samples were analyzed in split mode (ratio 20:1). The maximal heating 
temperature for the column was 320 °C. Helium was used as carrier gas with 1.1 mL/min. 
The standard heating method started from 50 °C, and allowed to stay for 10 min and raised 
10 °C/min until 320 °C and allowed to stay there for 5 min isothermal. The analysis was 
successfully carried out by using Enhanced Data Analysis D.02.00.237 program and NIST 
MS search 2.0 developed by the Agilent Company. 
6.1.4.2 Chiral Gas Chromatography  
 
Chiral gas chromatography was performed using a hydrodex-6-TBDMS phase (Macherey- 
Nagel, 25 m x 0.25 m I.D.), β-dex chiral column (length 30 m, diameter 0.32 mm, phase 
thickness 0.25 µm) and Lipodex-G chiral column; Length 50 m, diameter 0.25 mm, H2 flow 
1.2 mL/min.Temperature program is mentioned under the respective synthesis and analysis 
section of the compounds. Hydrogen was applied as carrier gas and compounds were 
detected with a flame ionization detector. Injector temperature 250 °C; detector temperature 
300 °C; injection volume 1 µl, inlet pressure 80.0 kPa; carrier gas flow 1 mL/min; gas velocity 
29 cm/sec. 
6.1.4.3 Analytical conditions for LC-MS:  
 
Coulmn: 150x2.1 mm, Hypersil Gold 3 µm C18 (Thermo); Inj. Volume: 10 µL, flowrate: 250 
µL/min-, Rt = 10.9 min;  
Solvents: Solvent A:[Blank], Solvent B [H2O], Solvent C [MeCN], Solvent D [2% HCOOH in 
MeOH/H2O 1:1],  
Elution: gradient from Solvent B 92.5% solvent C 2.5% Solvent D 5% within 6.5 min to 
Solvent B 2.5% Solvent C 92.5% Solvent D 5% .  
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6.1.5 1H NMR, 13C NMR experiments and optical rotations 
NMR spectra were obtained with the following instruments: BRUKER DPX-200 (1H 200 
MHz, 13C 50.5 MHz), DRX- 300 (1H 300 MHz, 13C 75 MHz), DRX- 400 (1H 400 MHz, 13C 101 
MHz), or AV II-600 (1H 600 MHz, 13C 151 MHz). Chemical shifts are reported in ppm relative 
to tetramethylsilane (TMS) as an internal standard (δ = 0 ppm). All compounds were 
dissolved in the respective deuterated solvents mentioned. The NMR data was analyzed 
using the software ACD/Labs 12.0 and TOPSPIN 3.2. Optical rotations were measured with 
PROPOL–Polarimeter purchased from Dr. Kernchen. The solvents used for the 
measurements were reported in the corresponding experimental sections. 
6.1.6 Derivatization procedures 
Carboxylic acids and alcohols were detected by GC-MS when derivatized with MSTFA or 
diazomethane. Micro scale synthesis of diazomethane in diethyl ether ((for mg amounts of 
analyte) was mentioned in the respective procedure and analysis section of the compounds. 
Derivatization with MSTFA (N-methyl-N-(trimethylsilyl) trifluoroacetamide) 
 
About 50 µL of MSTFA was added to the synthetic sample in dichloromethane (50 µL), 
followed by heating for 1 h at 60 °C. Then excess solvent and MSTFA was removed by a 
gentle stream of nitrogen. The residue was taken up in dichloromethane and analyzed by 
GC-MS. 
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6.2 Synthesis 
  
6.2.1 1-(Bromomethyl)-4-methoxybenzene (36) 
 
1
2
3
4
5
6
O
7
8
Br
 
Phosphorous tribromide (1.6 mL, 17 mmol) was slowly added to a solution of para-
methoxybenzyl alcohol (6.7 mL, 54 mmol) in dichloromethane (80 mL) at 0 °C and stirred for 
12 h. The reaction mixture was poured into aqueous sodium bicarbonate and extracted with 
dichloromethane. Removal of the solvent in vacuo from the organic phase gave a clear oil as 
the product which was used in the mono protection of 1,3-propanediol (32).[121]  
Yield: 10 g (50 mmol, 93%). 
EI-MS (70 eV): m/z (%): 202(14), 200(15), 157(4), 122(45), 121(100), 106(19), 91(43), 
90(14), 89(31), 81(8), 79(19), 78(98), 77(83), 74(7), 65(11), 63(28), 62(14), 52(41), 51(53), 
50(32), 39(16). 
1H-NMR (200 MHz, CHLOROFORM-d) δ [ppm] = 7.32 (dt, J = 8.6, 3.0 Hz, 2 H, H-2, 6), 6.86 
(dt, J = 8.6, 3.0 Hz, 2 H, H-3, 5), 4.50 (s, 2 H, H-7), 3.80 (s, 3 H, H-8). 
13C-NMR (50 MHz, CHLOROFORM-d) δ [ppm] = 159.7 (C-4), 130.4 (C-2, 6), 129.9 (C-1), 
114.2 (C-3, 5), 55.3 (C-8), 33.9 (C-7). 
6.2.2 2-(4-Methoxyphenyl)-1,3-dioxane (35) 
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To a solution of 1,3-propanediol 32 (8.7 g, 114 mmol) and para-anisaldehyde (14 mL, 115 
mmol) in toluene (18 mL), a catalytic amount of  PTSA (44 mg, 0.23 mmol) was added and 
the mixture was heated under reflux in a Dean stark apparatus for 21 h.[122] The solvent from 
reaction mixture was evaporated and the resulting dark brownish yellow colored crude acetal 
was reduced without further purification to the alcohol 37.  
Yield: 26 g (114 mmol, quant.). 
Rf = 0.38 (pentane/TBME 1:1) 
EI-MS (70 eV): m/z (%): 194(90) [M]+,  193 (98), 190 (1), 179(5), 177 (1), 165(4), 164 (17), 
163 (62), 153 (4), 152 (28), 151 (2), 138 (12), 137 (57), 136 (94), 135 (100), 133(5), 122(4), 
121 (38), 119 (8), 115 (1), 110 (4), 108 (56), 107 (45), 105 (28), 94 (26), 92(57), 91(15), 87 
(33), 79(17), 77(71), 73 (1), 65 (40), 63 (29), 59(13), 53(7), 51(26), 42(23), 39 (23). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.37 - 7.43 (m, 2 H, H-8, 12), 6.85 - 6.91 
(m, 2 H, H-9, 11), 5.45 (s, 1 H, H-2), 4.21 - 4.28 (m, 2 H, H-4), 3.92 - 4.01 (m, 2 H, H-6), 3.79 
(s, 3 H, H-14), 2.12 - 2.29 (m, 1 H, H-5), 1.42 (dtt, J=13.5, 2.6, 1.4 Hz, 1 H, H-5). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.9 (C-10), 131.3 (C-7), 127.2 (C-8, 12), 
113.5 (C-9, 11), 101.5 (C-2), 67.3 (C-4, 6), 55.2 (C-14), 25.7 (C-5). 
  6.2.3 3-((4-Methoxybenzyl)oxy)propan-1-ol (37)  
 
  
To a suspension of NaH (2.3 g, 57 mmol, 60 % in mineral oil, washed with dry hexane 
before use) in dry DMSO (30 mL) stirred at 0 °C under an inert atmosphere, 1,3-propanediol 
(32) (51 g, 67 mmol) was added dropwise while stirring. The resulting mixture was stirred for 
15 min and to this solution para-methoxybenzyl bromide (36) (7 mL, 48 mmol) was added 
dropwise and allowed to stir at room temperature for 18 h 30 min and monitored by TLC. 
The reaction mixture was quenched by adding 50 mL of water, extracted with TBME, and the 
organic phase was washed with brine, dried with MgSO4, and filtered. The solvent was 
removed under reduced pressure and the residue was purified by flash chromatography with 
2:1 pentane/TBME mixture as eluent to furnish the product 37 as colorless oil.[123] 
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Yield: 5 g (25 mmol, 53%).  
Reduction of acetal 35 to alcohol 37: 
To a solution of crude acetal 13 (3.3 g, 17 mmol) in toluene (6 mL) cooled in an ice/salt bath, 
DIBAL-H (19 mL, 1M in toluene) was added dropwise at such a rate as to maintain the 
reaction mixture temperature at 0 °C. The reaction mixture was stirred at room temperature 
overnight, diluted with toluene (5 mL), and cooled in an ice/water bath. Methanol (3 mL) was 
added dropwise at such a rate as to keep the temperature below 40 °C.[56]  Water (3 mL) 
was then added dropwise and the reaction mixture stirred at room temperature for 1 h. The 
white precipitate was filtered through a pad of celite and thoroughly washed with toluene. 
The filtrate was concentrated to give the crude yellow oil, purified by flash chromatography 
with 2:1 pentane/TBME mixture as eluent to furnish the alcohol 37 as colorless oil. 
Yield: 3 g (15 mmol, 90%). 
Rf = 0.12 (pentane/TBME 1:1).  
EI-MS (70 eV): m/z (%): 196(7) [M]+, 195(1), 177(1), 137(85), 135(6), 121(100), 109(11), 
107(7), 91(7), 89(59), 77(17), 65(4), 52(3), 41(2), 39(2). 
1H-NMR (200 MHz, CHLOROFORM-d) δ [ppm] = 7.25 (dt, J = 8.6, 2.8 Hz, 2 H, H-6, 10), 
6.88 (dt, J = 8.8, 2.8 Hz, 2 H, H-7, 9), 4.45 (s, 2 H, H-4), 3.80 (s, 3 H, H-11), 3.75 (t, J = 5.6 
Hz, 2 H, H-3), 3.63 (t, J = 5.8 Hz, 2 H, H-1), 2.43 (t, J = 4.8 Hz, 1 H, -OH), 1.84 (quin, J = 5.7 
Hz, 2 H, H-2).  
13C-NMR (50 MHz, CHLOROFORM-d) δ [ppm] = 159.2 (C-8), 130.2 (C-5), 129.2 (C-6, 10), 
113.8 (C-7, 9), 72.9 (C-4), 69.0 (C-3), 61.8 (C-1), 55.2 (C-11), 32.1 (C-2). 
6.2.4 3-((4-Methoxybenzyl)oxy)propanal (41) 
 
 
The alcohol 37 (5 g, 26 mmol) was dissolved in  dry DMSO (52  mL) and cooled to 0 °C prior 
to the addition of IBX (15 g, 52 mmol) portionwise while stirring under an inert atmosphere. 
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The reaction mixture was allowed to stir at RT and monitored with TLC until the starting 
material is consumed. The reaction is quenched by addition of water (70 mL) and the formed 
precipitate was filtered through a Buchner funnel using water jet pump. The aqueous extract 
was extracted thrice with diethyl ether. The combined organic extracts were washed with 
brine and dried with Na2SO4, filtered, and concentrated in vacuo to get the crude product as 
yellow colored oil. The crude product was purified by flash chromatography with 5:1 
pentane/TBME mixture as eluent to get the desired aldehyde 41 as light yellow colored oil. 
Yield: 4 g (21 mmol, 80%). 
Rf = 0.22 (pentane/TBME 1:1). 
EI-MS (70 eV): m/z (%): 194(13) [M]+, 176(1), 163(1), 149(1), 138(13),137(72), 135(7), 
122(11), 121(100), 109(16), 107(6), 94(9), 89(5), 78(17), 77(22), 65(5), 63(4), 55(2), 52(4), 
51(6), 41(2), 39(4).  
1H-NMR (200 MHz, CHLOROFORM-d) δ [ppm] = 9.78 (t, J = 1.9 Hz, 1 H, H-1), 7.25 (dt, J = 
8.8, 2.8 Hz, 2 H, H-6, 10), 6.88 (dt, J = 8.8, 2.8 Hz, 2 H, H-7, 9), 4.46 (s, 2 H, H-4), 3.80 (s, 3 
H, H-11), 3.78 (t, J = 6.3 Hz, 2 H, H-3), 2.67 (td, J = 6.1, 1.8 Hz, 2 H, H-2).   
13C-NMR (50 MHz, CHLOROFORM-d) δ [ppm] = 201.1 (C-1), 159.3 (C-8), 129.9 (C-5), 
129.3 (C-6, 10), 113.8 (C-7, 9), 72.9 (C-4), 63.5 (C-3), 55.2 (C-11), 43.8 (C-2). 
6.2.5 3-(Benzyloxy)propan-1-ol (38) 
 
 
To a solution of NaH (590 mg, 14.7 mmol, 60 % in mineral oil, washed with dry hexane 
before use) in dry DMF (78 mL) cooled at 0 °C under inert atmosphere, 1,3-propanediol  (32) 
(1 g, 13.4 mmol) was added dropwise while stirring and stirred for another 10 min. 
Benzylbromide  (1.6 mL, 13.4 mmol) was added dropwise cautiously and the mixture was 
allowed to warm up to room temperature and stirred for 16 h.[49] The reaction was quenched 
by addition of water (25 mL) and subsequently extracted four times with ethyl acetate. The 
organic layer was dried with MgSO4, filtered, and concentrated under reduced pressure to 
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afford a yellow oil. Flash chromatography with 5:1 hexane/ethyl acetate mixture resulted in 
the 3-benzyloxypropan-1-ol (38) as pale yellow oil. 
Yield: 2 g (12 mmol, 90%). 
Rf = 0.38 (hexane/ethyl acetate 1:1). 
EI-MS (70 eV): m/z (%): 166(2) [M]+, 147(3), 130(1), 120(2), 117(2), 108(8), 107(74), 105(9), 
92(17), 91(100), 89(8), 80(2), 79(23), 77(19), 65(24), 63(7), 57(4), 51(10), 50(6), 43(9), 
41(5), 39(12), 38(3). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.36-7.25 (m, 5 H, H(6-10)), 4.51 (s, 2 H, 
H-4), 4.20 (br, s, 1 H, OH), 3.77 (t, J = 5.8 Hz, 2 H, H-3), 3.64 (td, J = 6.2, 5.2 Hz, 2 H, H-1), 
1.85 (quint, J = 6.2 Hz, 2 H, H-2). 
13C-NMR (100 MHz, CHLOROFORM-d) δ [ppm] = 137.9 (C-5), 128.4 (C-7, 9), 127.6 (C-6, 8, 
10), 73.2 (C-4), 69.0 (C-3), 61.5( C-1), 31.9 (C-2). 
6.2.6 3-(Benzyloxy)propanal (42) 
 
 
To a solution of alcohol 38 ( 2 g, 12 mmol) in dichloromethane (11 mL) and DMSO (9 mL) at 
0 °C under an inert atmosphere and stirring, triethylamine (14.5 mL, 103 mmol) was added 
dropwise slowly. In a separate flask DMSO (19 mL) was added to pyridine- sulfurtrioxide 
complex (Py•SO3) (5 g, 31.2 mmol), stirred under an inert atmosphere for 15min, transferred 
to the flask containing alcohol 38 slowly and stirred again at 0 °C for 5 h. The reaction 
mixture was monitored by TLC, quenched by addition of water (30 mL) and diluted with ethyl 
acetate. The organic phase was extracted 4 times with ethyl acetate, washed with NH4Cl 
solution, brine, dried with MgSO4, filtered, and concentrated under reduced pressure to 
afford aldehyde 42 as a crude product. Flash chromatography of the crude product with 5:1 
hexane/ethyl acetate mixture afforded aldehyde 20 as colorless oil. 
Yield: 1.6 g (10 mmol, 80%). 
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Rf = 0.38 (hexane/ethyl acetate 3:1). 
EI-MS (70 eV): m/z (%): 164(1)[M]+, 146(1), 120(7), 108(12), 107(90), 92(15), 91(100), 
89(7), 79(38), 77(25), 73(4), 65(21), 63(7), 57(8), 51(16), 50(7), 45(4), 39(14), 38(3). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 9.78 (t, J = 1.8 Hz, 1 H, H-1), 7.37-7.25 
(m, 5 H, H(6-10)), 4.52 (s, 2 H, H-4), 3.8 (t, J = 6 Hz, 2 H, H-3), 2.68 (td, J = 6.1, 1.9 Hz, 2 H, 
H-2).   
13C-NMR (100 MHz, CHLOROFORM-d) δ [ppm] =   201.1 (C-1), 137.8 (C-5), 128.4 (C-7, 9), 
127.6 (C-6, 8, 10), 73.2 (C-4), 63.8 (C-3), 43.8 (C-2). 
6.2.7 3-((Tetrahydro-2H-pyran-2-yl)oxy)propan-1-ol (40) 
 
 
A solution of 1,3-propanediol (32) (4 g, 54 mmol) and 3,4-dihydro-2H-pyran (0.91 g, 10.82 
mmol) in dry dichloromethane (22 mL) was stirred with a catalytic amount of pyridinium-para-
toluene sulfonate (PPTS) (33 mg, 0.13 mmol) at room temperature for 4 h. The reaction 
mixture was quenched by addition of water (30 mL), and the aqueous phase was extracted 
(3 x 20 mL) with CH2Cl2. The organic phases were washed with brine, dried with MgSO4, 
filtered, and concentrated in vacuo to afford the crude alcohol.[124] Purification of the crude 
product by flash chromatography with 1:1 pentane/diethyl ether mixture as eluent provided 
alcohol 40 as colorless oil. 
Yield: 0.9 g (5.6 mmol, 52%). 
Rf = 0.20 (pentane/diethyl ether 1:1).  
EI-MS (70 eV): m/z (%): 160(1) [M]+, 159 (4), 115(1), 105(3), 102(5), 101(39), 87(26), 
85(100), 84(16), 83(6), 77(2), 75(1), 74(5), 73(1), 69(2), 67(16), 65(1), 59(27), 58(18), 
57(39), 56(31), 55(31), 53(6), 51(3), 47(4), 45(7), 44(11), 43(27), 42(12), 41(62), 40(6).  
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1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 4.57 - 4.62 (m, 1 H, H-5), 3.82 - 3.98 (m, 2 
H, H-9), 3.79 (td, J=6.1, 0.4 Hz, 2 H, H-1), 3.48 - 3.64 (m, 2 H, H-3), 2.51 (br. s., 1 H, OH), 
1.81 - 1.91 (m, 2 H, H-2), 1.66 - 1.80 (m, 2 H, H-6), 1.47 - 1.63 (m, 4 H, H-7, 8).  
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 99.1 (C-5), 66.2 (C-3), 62.5 (C-9), 61.4 (C-
1), 32.0 (C-2), 30.6 (C-6), 25.3 (C-8), 19.6 (C-7). 
6.2.8 3-((Tetrahydro-2H-pyran-2-yl)oxy)propanal (44) 
 
 
Oxalylchloride (0.809 g, 6.4 mmol) was dissolved in dichloromethane (29 mL), cooled to       
-78 °C, and stirred under an inert atmosphere. DMSO (1.04 g, 13.3 mmol) dissolved in 
dichloromethane (2 mL) was added slowly dropwise via syringe pump over a period of 10 
minutes to the reaction mixture and stirred for 30 minutes. The alcohol 40 (0.85 g, 5.3 mmol) 
dissolved in dichloromethane (9 mL) was added slowly via a syringe pump over a period of 
25 minutes. After stirring the solution for 1 h at -78 °C, triethylamine (2.15 g, 21.3 mmol) was 
added. The resulting thick white mixture was warmed to room temperature over a period of 1 
h followed by the addition of water (20 mL). The aqueous layer was extracted (3 x 20 mL) 
with dichloromethane. The separated organic phases were washed with water, saturated 
sodium chloride, dried with MgSO4 and filtered. After removal of the solvent under vacuo, the 
crude product was purified by flash chromatography on silica gel with 2:1 pentane/diethyl 
ether mixture as eluent to afford the desired aldehyde 44 as colorless oil. 
Yield: 0.67 g (4.25 mmol, 80%). 
Rf = 0.56 (pentane/diethyl ether 2:1). 
EI-MS (70 eV): m/z (%): 158(1) [M]+,  157(3), 140(1), 127(1), 113(1), 102(5), 101(53), 86(6), 
85(100), 84(16), 83(9), 81(1), 75(2), 74(16), 73(3), 72(15), 69(3), 67(20), 65(1), 57(80), 
56(54), 55(54), 53(9), 51(4), 45(10), 44(25), 43(55), 41(98), 39(42), 38(5). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 9.82 (t, J=1.9 Hz, 1 H, H-1), 4.63 (t, J=3.5 
Hz, 1 H, H-5), 4.10 (dt, J=10.2, 6.1 Hz, 1 H, H-3), 3.81 - 3.88 (m, 1H, H-9), 3.76 (dt, J=10.4, 
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6.0 Hz, 1 H, H-3), 3.49 - 3.56 (m, 1H, H-9), 2.70 (td, J=6.1, 1.9 Hz, 2 H, H-2), 1.62 – 1.83 (m, 
2H, H-6), 1.49 - 1.61 (m, 4H, H-7, 8). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 201.3 (C-1), 98.9 (C-5), 62.2 (C-9), 61.2 
(C-3), 43.8 (C-2), 30.4 (C-6), 25.3 (C-8), 19.3 (C-7). 
 6.2.9 3-((tert-Butyldimethylsilyl)oxy)propan-1-ol (39) 
 
 
To a suspension of NaH (344 mg, 8.6 mmol, 60 % in mineral oil, washed with dry hexane 
before use) in THF (20 mL) stirred under inert atmosphere, 1,3-propanediol (32) (654 mg, 
8.6 mmol) was added dropwise and stirred at room temperature for 45 min followed by the 
addition of TBDMSCl (1.3 g, 8.6 mmol) and stirred further 45 min at room temperature.[50,51] 
The resultant mixture was extracted (3 x 20 mL) with TBME, the organic phases were 
washed with 10 % aq. K2CO3, brine, dried with MgSO4, filtered, and concentrated in vacuo. 
The crude product was purified by flash chromatography with 4:1 pentane/ethyl acetate 
mixture as eluent to afford the alcohol 39 as colorless oil.  
Yield: 1.60 g (8.42 mmol, 98%). 
Rf = 0.41 (pentane/ethyl acetate 4:1). 
EI-MS (70 eV): m/z (%): 189((1) [M-1]+, 175(1), 147(2), 133(53), 117(7), 115(9), 105(91), 
101(7), 91(9), 87(13), 85(4), 76(21), 75(100), 73(24), 72(4), 61(9), 59(17), 57(12), 55(3), 
53(1). 
1H-NMR (200 MHz, CHLOROFORM-d) δ [ppm] = 3.70 - 3.79 (m, 4 H, H-1, 3), 2.58 (br. s., 1 
H, OH), 1.70 (quin, J=5.6 Hz, 2 H, H-2), 0.82 (s, 9 H, H-6), 0.00 (s, 6H, H-4). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 62.8 (C-1), 62.3 (C-3), 34.2 (C-2), 25.8 (C-
6), 18.2 (C-5), -5.5 (C-4). 
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6.2.10 3-((tert-Butyldimethylsilyl)oxy)propanal (43) 
 
 
Oxalylchloride (802 mg, 6.3 mmol) was dissolved in dichloromethane (29 mL) and cooled to 
-78 °C stirring under inert atmosphere. DMSO (1.03 g, 13.2 mmol) dissolved in 
dichloromethane (2 mL) was added slowly dropwise via syringe pump over a period of 10 
minutes to the reaction mixture and stirred for 30 minutes followed by the addition of alcohol 
39 (1 g, 5.3 mmol) dissolved in dichloromethane (8 mL) and slowly added via a syringe 
pump over a period of 25 minutes. After stirring the solution for 1 h at -78 °C, triethylamine 
(2.13 g, 21.1 mmol) was added. The resulting thick white mixture was warmed to room 
temperature over a period of 1 h followed by the addition of water (20 mL). The aqueous 
layer was extracted (3 x 20 mL) with dichloromethane. The separated organic phases were 
washed with water, saturated sodium chloride, dried with MgSO4 and filtered. After removal 
of the solvent under vacuo, the crude product was purified by flash chromatography on silica 
gel with 9:1 pentane/diethyl ether mixture as eluent to afford the desired aldehyde 43 as 
colorless liquid. 
Yield: 890 mg (4.73 mmol, 90%). 
Rf = 0.43 (pentane/diethyl ether 9:1). 
EI-MS (70 eV): m/z (%): 187(1) [M-1]+, 143(1), 133(9), 132(24), 131(100), 129(4), 117(18), 
115(9), 103(11),102(22), 101(100), 99(6), 89(6), 87(8), 85(5), 77(5), 76(7), 75(86), 73(20), 
71(6), 61(9), 60(7), 59(53), 58(8), 57(14), 55(5), 47(12), 45(22), 43(9), 42(4), 41(22). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 9.73 (t, J=2.1 Hz, 2 H, H-1), 3.92 (t, J=6.1 
Hz, 2 H, H-3), 2.53 (td, J=6.0, 2.1 Hz, 2 H, H-2), 0.81 (s, 9 H, H-6), 0.00 (s, 6 H, H-4). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 202.0 (C-1), 57.4 (C-3), 46.5 (C-2), 25.8 
(C-6), 18.2 (C-5), -5.5 (C-4). 
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6.2.11 5-Hydroxy-7-((4-methoxybenzyl)oxy)-4-methylheptan-3-one (45 a) 
 
 
Preparation of LDA solution: 
n-BuLi (1 mL, 1.7 mmol, 1.6 M in hexane) was slowly added dropwise to the solution of 
diisopropylamine (0.3 mL, 2.3 mmol) in dry THF (3 mL) at -78 °C and stirred for 30 minutes. 
To the freshly prepared LDA solution under inert atmosphere, diethylketone 31 (121 mg, 1.4 
mmol) in THF (2 mL) was added dropwise at -78 °C and stirred for 3 h followed by the 
addition of aldheyde 41 (398 mg, 2.05 mmol) in dry THF(5 mL) at the same temperature. 
The mixture was stirred for 2 h. The reaction mixture was quenched with saturated aqueous 
NH4Cl solution and extracted with ethyl acetate (3 X 30 mL). The organic phases were 
washed with brine, dried with MgSO4, filtered, and concentrated in vacuo. The crude product 
was purified by flash column chromatography with 5:1 pentane/ethyl acetate mixture as 
eluent to afford the aldol product (mixture of diastereomers) 45a as colorless oil. 
Yield: 290 mg (1 mmol, 75%, d.r. = 4:1).  
Rf  = 0.21 (pentane/ethyl acetate 2:1).  
EI-MS (70 eV) (MSTFA derivative): m/z (%): 352(1) [M]+, 334(1), 267(5), 262(3), 231(2), 
217(2), 215(8), 210(7), 209(32), 187(16), 177(20), 176(72), 175(7), 170(5), 159(5), 158(13), 
157(17), 144(9), 143(11), 141(18), 138(9), 137(55), 136(19), 135(28), 132(5), 131(30), 
130(19), 129(12), 127(8), 126(46), 125(11), 123(7), 122(52), 121(100), 117(8), 115(22), 
111(8), 109(11), 108(14), 107(9), 106(7), 103(14), 101(11), 97(17), 94(6), 92(6), 91(21), 
90(9), 89(10), 85(5), 79(8), 78(24), 77(32), 76(6), 75(48), 74(7), 73(48), 69(20), 67(6), 65(7), 
61(6), 59(10), 57(61), 44(10), 41(8). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.22 - 7.26 (2H, m, H-10, 14), 6.85 - 6.89 
(2H, m, H-11, 13), 4.44 (2H, s, H-8), 4.07 (1H, ddd, J5,6 = 9.8 Hz, J5,4 = 7.3 Hz, J = 3.3 Hz, H-
5, major ds), 3.90 (1H, dt, J5,6 = 7.8 Hz, J5,16 = 3.8 Hz, H-5, minor ds), 3.80 (3H, s, H-15), 
3.56 - 3.70 (2H, m, H-7), 3.38 (1H, d, J16,5 = 3.8 Hz, H-16), 2.62 (1H, dq, 3J4,5 = 7.3 Hz, 3J4,17 
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= 7.0 Hz, H-4), 2.51 (2H, dq, 2J = 17.8 Hz, 3J2,1 = 7.3 Hz, H-2), 1.47 - 1.95 (2H, m, H-6), 1.11 
(3H, d, 3J17,4 = 7.0 Hz, H-17), 1.03 (3H, t, 3J1,2= 7.3 Hz, H-1).  
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 215.6 (C-3), 159.2 (C-12), 130.0 (C-9), 
129.3 (C-10, 14), 113.8 (C-11, 13), 72.9 (C-8), 70.9 (C-5), 68.4 (C-7), 55.2 (C-15), 50.5 (C-
4), 35.4 (C-2), 33.7 (C-6), 11.1 (C-17), 7.5 (C-1). 
6.2.12 (4RS,5RS)-5-Hydroxy-7-((4-methoxybenzyl)oxy)-4-methylheptan-3-one (45) 
 
 
To a solution of dicyclohexylboron chloride (18 mL, 18 mmol, 1M in hexane) in dry diethyl 
ether (20 mL) stirred at 0 °C under inert atmosphere triethylamine (2.44 g, 24.10 mmol) was 
added dropwise. After stirring for 1 h diethylketone 31 (1.38 g, 16.05 mmol) in dry diethyl 
ether (18 mL) was added dropwise and stirred at 0 °C for 4 h. The reaction mixture was 
cooled to -78 °C, aldehyde 41 (4.4 g, 22.47 mmol) in dry diethyl ether (30 mL) was added 
dropwise over a period of 30 min and the mixture was stirred for 2 h. The reaction mixture 
was left overnight (16 h) in a freezer at -32 °C. The reaction mixture was quenched at 0 °C 
by addition of pH 7 buffer (30 mL) and extracted with diethyl ether (3 x 20 mL). The 
combined organic layers were concentrated in vacuo. The crude oil was suspended in 
methanol (25 mL) and pH 7 buffer (5 mL) followed by dropwise addition of hydrogen 
peroxide (1.5 mL, 30% aq.) under cooling at 0 °C. The reaction mixture was stirred for 2 h, 
then poured into water (20 mL) and extracted with dichloromethane (3 x 20 mL). The 
combined organic layers were washed with saturated aqueous NaHCO3 solution, brine, dried 
with MgSO4, filtered and concentrated in vacuo.[63] The crude product was concentrated by 
flash column chromatography (10:1 pentane/ethyl acetate mixture) to afford aldol product 45 
as colorless oil. The C4/C5 anti-arrangement can be deduced by the coupling constant 3J4,5 
= 9.1 Hz.  
Yield: 4 g (14.3 mmol, 89%, 96% d.e.). 
Rf  = 0.21 (pentane/ethyl acetate 2:1).  
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EI-MS (70 eV): m/z (%): 262(1) [M-18]+, 228(1), 217(1), 205(1), 197(1), 176(1), 161(1), 
138(2), 137(3), 136(5), 135(7), 127(3), 126(30), 124(3), 123(2), 122(16), 121(100), 116(1), 
113(3), 111(14), 108(3), 106(4), 97(15), 95(5), 91(6), 89(2), 83(2), 79(4), 78(7), 77(10), 
67(6), 65(4), 63(2), 57(4), 55(4), 43(2), 41(4), 39(4).  
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] =   7.13 - 7.17 (2H, m, H-14, 10), 6.76 - 6.81 
(2H, m, H-13, 11), 4.35 (2H, s, H-8), 3.82 (1H, dt, 3J5,6a = 12.4, 3J5,4 = 9.1 Hz, J = 7.1 Hz, H-5), 
3.71 (3H, s, H-15), 3.57 - 3.63 (1H, m, H-7), 3.50 - 3.57 (1H, m, H-7), 3.33 (1H, d, 3J16,5 = 4.3 
Hz, H-16, anti ds), 3.28 (1H, d, 3J16,5 = 2.5 Hz, H-16 syn ds), 2.57 (1H, dq, 3J4,5 = 9.1 Hz, 
3J4,17 = 7.1 Hz, H-4), 2.37 - 2.51 (2H, m, H-2), 1.67 - 1.76 (1H, m, H-6 b), 1.54 - 1.65 (1H, m, 
H-6 a), 0.98 (3H, d, 3J17,4 = 7.1 Hz, H-17), 0.95 (3H, t, 3J1,2 = 7.3 Hz, H-1). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 215.6 (C-3), 159.2 (C-12), 129.9 (C-9), 
129.2 (C-14, 10), 113.7 (C-11, 13), 73.04 (C-8), 73.02 (C-5), 68.2 (C-7), 55.1 (C-15), 51.1 
(C-4), 35.9 (C-2), 33.8 (C-6), 13.5 (C-17), 7.3 (C-1). 
6.2.13 (3RS,4RS)-4-(2-Ethyl-1,3-dioxolan-2-yl)-1-((4-methoxybenzyl)oxy)pentan-3-ol 
(48) 
 
 
Aldol product 45 (100 mg, 0.36 mmol) was dissolved in ethylene glycol (2 mL) and stirred 
under inert atmosphere at room temperature. To the above solution triethylorthoformate (267 
mg, 1.8 mmol) and a catalytic amount of p-toluenesulfonic acid monohydrate (1.5 mg) was 
added and stirred at room temperature for 2 h. The reaction mixture was quenched with 
saturated aqueous NaHCO3 and extracted with chloroform (3 x 20 mL), dried with Na2SO4, 
filtered, and concentrated. The crude product was purified by flash column chromatography 
with pentane/ethyl acetate mixture (gradient elution 10:1 to 2:1) to afford the 48 as colorless 
oil with fruity odour.  
Yield: 100 mg (0.31mmol, 86%). 
Rf  = 0.23 (pentane/ethyl acetate 2:1).  
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EI-MS (70 eV): m/z (%): 324(2) [M]+, 306(3), 295(2), 279(5), 278(6), 277(27), 261(15), 
250(16), 244(4), 221(6), 206(9), 203(15), 194(26), 189(12), 185(11), 176(24), 170(11), 
164(12), 159(48), 143(82), 141(71), 137(83), 135(48), 130(27), 126(57), 125(26), 122(72), 
121(98), 119(16), 115(19), 113(13), 109(34), 108(19), 107(25), 102(55), 101(100), 100(46), 
99(35), 97(20), 94(23), 91(41), 89(24), 87(63), 85(23), 79(17), 78(54), 77(60), 73(24), 
69(27), 65(17), 57(85), 55(21), 45(24), 43(17), 41(25), 39(10). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] =  7.10 - 7.23 (2H, m, H-18, 14), 6.71 - 6.87 
(2H, m, H-17, 15), 4.28 - 4.44 (2H, m, H-12), 4.09 - 4.25 (1H, m, H-3), 3.82 - 3.96 (4H, m, H-
10, 9), 3.72 (3H, s, H-19), 3.57 (2H, t, J = 6.6 Hz, H-1), 3.18 (1H, br. s., H-11), 1.82 - 1.91 
(1H, m, H-4), 1.72 - 1.82 (2H, m, H-2), 1.59 - 1.69 (2H, m, H-7), 1.18 (3H, t, J = 7.2 Hz, H-8), 
0.83 (3H, d, J = 7.2 Hz, H-5). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.0 (C-16), 130.5 (C-13), 129.2 (C-14, 
18), 114.5 (C-6), 113.7 (C-15, 17), 72.7 (C-12), 70.3 (C-1), 67.4 (C-3), 65.3 (C-10, 9), 55.2 
(C-19), 44.2 (C-4), 34.4 (C-2), 25.7 (C-7), 12.0 (C-5), 6.8 (C-8). 
6.2.14 (4RS,5RS)-7-(Benzyloxy)-5-hydroxy-4-methylheptan-3-one (46) 
 
 
To a solution of dicyclohexylboron chloride (0.5 mL, 0.5 mmol, 1M in hexane) in dry diethyl 
ether (1 mL) stirred at 0 °C under inert atmosphere triethylamine (64 mg, 0.63 mmol) was 
added dropwise. After stirring for 1 h the addition of diethylketone 31 (36 mg, 0.42 mmol) in 
dry diethyl ether (1 mL) followed and stirring continued at 0 °C for 4 h. The reaction mixture 
was cooled down to -78 °C, aldehyde 42 (114 mg, 0.6 mmol) in dry diethylether (1 mL) was 
added dropwise and the mixture stirred for 2 h. The reaction mixture was left overnight (16 h) 
in a freezer at approximate temperature -32 °C. The reaction mixture was quenched at 0 °C 
by addition of pH 7 buffer (2 mL) and extracted with diethylether (3 x 10 mL). The combined 
organic layers were concentrated in vacuo. The crude oil was suspended in methanol (5 mL) 
and pH 7 buffer (1 mL) followed by addition of hydrogen peroxide (1.5 mL, 30% aq.), added 
dropwise at 0 °C. The reaction mixture was stirred for 2 h, then poured into water (10 mL) 
and extracted with dichloromethane (3 x 10 mL). The combined organic layers were washed 
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with saturated aqueous NaHCO3 solution and brine, dried with MgSO4, filtered and 
concentrated in vacuo. The crude product was concentrated by flash column 
chromatography (pentane/ethyl acetae 10:1) to afford aldol product 46 as colorless oil. 
Yield: 86 mg (0.34 mmol, 82%, 98% d.e.). 
Rf  = 0.2 (pentane/ethyl acetate 2:1).   
EI-MS (70 eV) (MSTFA derivative): m/z (%): 322(2) [M]+, 307(1) [M-15]+, 293(1), 277(1), 
263(1), 249(1), 237(1), 232(1), 215(1), 201(1), 187(2), 173(4), 171(3), 158(3), 143(4), 
131(8), 126(5), 115(4), 107(8), 105(4), 101(3), 92(10), 91(100), 89(4), 65(17), 63(3), 59(4), 
57(24), 51(5), 45(8), 41(6), 39(7). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.28 - 7.38 (5H, m, H-10, 11, 12, 13, 14), 
4.51 (2H, s, H-8), 3.94 (1H, ddd, J = 7.8 Hz, 7.0 Hz, 4.0 Hz, H-5), 3.59 - 3.68 (2H, m, H-7), 
3.45 (1H, br. s., H-15), 2.67 (1H, quin, J = 7.1 Hz, H-4), 2.45 - 2.58 (2H, m, H-2), 1.65 - 1.77 
(2H, m, H-6), 1.08 (3H, d, J = 7.2 Hz, H-16), 1.04 (3H, t, J = 7.3 Hz, H-1). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 216.1 (C-3), 137.8 (C-9), 128.4 (C-11, 13), 
127.7 (C-12), 127.7 (C-14, 10), 73.3 (C-8), 70.4 (C-5), 68.6 (C-7), 51.1 (C-4), 36.0 (C-2), 
33.8 (C-6), 13.6 (C-16), 7.4 (C-1).  
6.2.15 (4RS,5RS)-7-((tert-Butyldimethylsilyl)oxy)-5-hydroxy-4-methylheptan-3-one (47) 
 
 
To a solution of dicyclohexylboron chloride (0.2 mL, 0.2 mmol, 1M in hexane) in dry 
diethylether (0.5 mL) stirred at 0 °C under inert atmosphere triethylamine (28 mg, 0.27 
mmol) was added dropwise. After stirring for 1 h the addition of diethylketone 31 (16 mg, 
0.18 mmol) in dry diethyl ether (0.5 mL) followed and stirring continued at 0 °C for 4 h. The 
reaction mixture was cooled down to -78 °C, aldehyde 43 (59 mg, 0.25 mmol) in dry 
diethylether (0.4 mL) was added dropwise, and the mixture stirred for 2 h. The reaction 
mixture was left overnight (16 h) in a freezer at approximate temperature -32 °C. The 
reaction mixture was quenched at 0 °C by addition of pH 7 buffer (1 mL) and extracted with 
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diethylether (3 x 5 mL). The combined organic layers were concentrated in vacuo. The crude 
oil was suspended in methanol (2 mL) and pH 7 buffer (0.4 mL) followed by addition of 
hydrogen peroxide (0.6 mL, 30% aq.), added dropwise at 0 °C. The reaction mixture was 
stirred for 2 h, then poured into water (6 mL) and extracted with dichloromethane (3 x 6 mL). 
The combined organic layers were washed with saturated aqueous NaHCO3 solution and 
brine, dried with MgSO4, filtered, and concentrated in vacuo to afford crude aldol product 47. 
Yield: 40 mg (0.15 mmol, 80%, 81% d.e.).  
Rf  = 0.15 (pentane/ethyl acetate 2:1).   
EI-MS (70 eV): m/z (%): 273(1) [M-1]+, 245(1), 229(1), 211(1), 201(2), 193(1), 189(1), 
176(1), 173(2), 171(2), 144(2), 143(8), 137(15), 135(3), 122(10), 121(100), 115(5), 109(4), 
107(2), 101(2), 99(2), 94(2), 91(6), 89(3), 78(10), 7(12), 75(27), 73(8), 57(20), 41(10), 39(4). 
6.2.16 (4RS,5RS)-5-Methoxy-7-((4-methoxybenzyl)oxy)-4-methylheptan-3-one (49) 
 
 
To a solution of proton sponge® (7.3 g, 34 mmol) and trimethyloxonium tetrafluoroborate (5 
g, 34 mmol) in dichloromethane (130 mL), a solution of aldol 45 (1.2 g, 4.25 mmol) in 
dichloromethane (8 mL) was added at room temperature. The reaction mixture was stirred 
for 18 h and saturated aqueous NaHCO3 was added. Diethyl ether was added until the 
organic layer stayed on top. Layers were separated and the aqueous layer was extracted 
with diethylether (3 x 100 mL).The combined organic layers were washed several times with 
an aqueous KHSO4 solution (1.5 M) until the color of the organic layer faded from brown to 
nearly colorless. Then the organic layer was washed with brine, dried with MgSO4 and 
concentrated in vacuo.[68] Purification by flash column chromatography with pentane/ethyl 
acetate 10:1 provided the methylated product 49 as colorless oil.  
Yield: 1 g (3.4 mmol, 80%). 
Rf = 0.68 (pentane/TBME 1:1).  
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EI-MS (70 eV): m/z (%): 294(1) [M]+, 262(2), 205(2), 176(11), 141(2), 138(2), 137(12), 
136(5), 135(11), 126(4), 124(5), 122(11), 121(100), 109(5), 107(4), 97(4), 92(4), 91(12), 
89(5), 86(2), 81(4), 79(13), 78(16), 77(22), 69(5), 67(11), 65(10), 63(9), 57(26), 53(10), 
51(11), 41(14), 39(22). 
1H-NMR (600 MHz, CHLOROFORM-d) δ [ppm] = 7.24 - 7.28 (2H, m, H-14, 10), 6.86 - 6.90 
(2H, m, H-13, 11), 4.43 (2H, s, H-8), 3.81 (3H, s, H-15), 3.58 (1H, dt, J = 8.1 Hz, 3.6 Hz, H-
5), 3.50 - 3.56 (2H, m, H-7), 3.27 (2H, s, H-16), 2.78 (1H, qd, J = 7.2 Hz, 2.6 Hz, H-4), 2.49 
(2H, dq, J = 7.3 Hz, 2.8 Hz, H-2), 1.84 (1H, dtd, J = 14.5 Hz, 7.2 Hz, 3.2 Hz, H-6a), 1.65 (1H, 
ddt, J = 13.9 Hz, 7.9 Hz, 6.0 Hz, H-6b), 1.04 (3H, t, J = 7.2 Hz, H-1), 1.00 (3H, d, J = 7.0 Hz, 
H-17).  
13C-NMR (150 MHz, CHLOROFORM-d) δ [ppm] = 214.1 (C-3), 159.2(C-12), 130.5 (C-9), 
129.2 (C-14, 10), 113.7 (C-13, 11), 79.9 (C-5), 72.6 (C-8), 66.0 (C-7), 58.1 (C-16), 55.3 (C-
15), 49.4 (C-4), 36.2 (C-2), 31.1 (C-6), 12.4 (C-17), 7.6 (C-1). 
6.2.17 6-Hydroxy-2,4-dimethylheptan-3-one (51) 
 
 
A flask containing LHMDS (12 mL, 12 mmol, 1M in THF) solution was treated under inert 
atmosphere stirring at 0 °C with a solution of ketone 50 (1 g, 10 mmol) in dry THF (2 mL), 
added dropwise during 15 minutes. After 30 minutes at the same temperature, a solution of 
epoxide 34 (232 mg, 4 mmol) in dry THF (4 mL) containing anhydrous LiClO4 (637 mg, 6 
mmol) was added dropwise in 10 minutes, and the resulting reaction mixture was stirred for 
72 h at room temperature.[70] After dilution with water, the mixture was extracted with diethyl 
ether, washed with brine, dried with MgSO4, filtered and concentrated to get the crude 
product which on further purification on flash column chromatography with 2:1 (pentane/ethyl 
acetate) afforded the γ-hydroxyl ketone 51 as colorless oil. 
Yield: 253 mg (1.6 mmol, 40%).  
Rf = 0.18 (pentane/ethyl acetate 2:1).  
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EI-MS (70 eV) (MSTFA derivative): m/z (%): 229(1) [M-1]+, 215(7) [M-15]+, 187(19), 172(12), 
159(9), 145(6), 131(26), 130(5), 129(12), 117(36), 115(8), 102(5), 100(8), 75(47), 74(9), 
73(100), 71(12), 69(30), 61(7), 59(7), 55(6), 47(7), 45(14), 43(41), 41(20).    
1H-NMR (200 MHz, CHLOROFORM-d) δ [ppm] =  3.89 - 4.39 (1H, m, H-6), 3.73 (1H, s, H-
10), 2.94 - 3.13 (1H, m, H-4), 2.72 - 2.88 (1H, m, H-2), 2.03 - 2.16 (1H, m, H-5), 1.80 - 1.94 
(1H, m, H-5), 1.15 - 1.23 (3H, m, H-7), 1.06 - 1.12 (6H, m, H-1, 9), 0.94 - 1.03 (3H, m, H-8). 
13C NMR (50MHz, CHLOROFORM-d) δ [ppm] = 218.6 (C-3), 65.0 (C-6), 41.8 (C-5), 40.2 (C-
4), 39.2 (C-2), 23.5 (C-7), 17.7 (C-1, 9), 16.4 (C-8).   
6.2.18 (4RS,6RS,7RS)-7-Methoxy-9-((4-methoxybenzyl)oxy)-4,6-dimethylnon-1-en-5-
one (52) 
 
 
To a solution of NaHMDS (0.6 mL, 1.22 mmol, 2 M in THF) in THF (0.7 mL) cooled down to  
-78 °C stirring under inert atmosphere, 49 (286 mg, 0.97 mmol) in THF (2 mL) was added 
dropwise and stirred at -78 °C for 1 h followed by the dropwise addition of allyl Iodide (0.22 
mL, 2.43 mmol), stirring continued at -78 °C for 3 h. Then the mixture was allowed to warm 
up to room temperature overnight. The reaction mixture was quenched with saturated 
aqueous NH4Cl solution at 8 °C and extracted with diethyl ether (3 x 20 mL) washed with 
brine, dried with MgSO4, filtered, and concentrated in vacuo. The yellow colored crude 
product was purified by flash column chromatography with 5:1 pentane/diethyl ether mixture 
as eluent to afford the allylated product 52 as colorless oil.   
Yield: 130 mg (0.4 mmol, 40%, 91% d.e.). 
Rf = 0.55 (pentane/ethyl acetate 2:1).  
EI-MS (70 eV): m/z (%): 334(1) [M]+, 302(1), 293(1), 257(1), 246(2), 213(2), 197(1), 181(1), 
177(2), 176(10), 166(2), 151(1), 137(9), 135(4), 125(3), 122(11), 121(100), 109(1), 107(1), 
99(2), 97(11), 91(5), 89(2), 78(7), 77(8) 72(3), 69(21), 57(2), 55(4), 51(2), 45(2), 43(3), 
41(25), 39(6). 
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1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] =  7.23 - 7.28 (2H, m, H-16, 12), 6.85 - 6.90 
(2H, m, H-15, 13), 5.71 (1H, dddd, J = 13.6 Hz, 10.4 Hz, 6.8 Hz, 3.5 Hz, H-2), 5.05 - 5.08 
(1H, m, H-1), 5.00 - 5.03 (1H, m, H-1), 4.43 (2H, d, J = 1.3 Hz, H-10), 3.80 (3H, s, H-17), 
3.57 (1H, m, H-7), 3.53 - 3.56 (2H, m, H-9), 3.25 (3H, s, H-18), 2.90 (1H, qd, J = 7.1 Hz, 1.5 
Hz, H-6), 2.69 (1H, sxt, J = 6.8 Hz, H-4), 2.34 - 2.48 (1H, m, H-3), 1.98 - 2.10 (1H, m, H-3), 
1.81 - 1.93 (1H, m, H-8a), 1.59 - 1.69 (1H, m, H-8b), 1.05 (3H, d, J = 6.8 Hz, H-19), 0.95 
(3H, d, J = 6.8 Hz, H-20). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 216.2 (C-5), 159.1 (C-14), 135.8 (C-2), 
130.5 (C-11), 129.2 (C-16, 12), 116.7 (C-1), 113.7 (C-15, 13), 80.1 (C-7), 72.6 (C-10), 66.0 
(C-9), 58.3 (C-18), 55.2 (C-17), 49.0 (C-6), 46.5 (C-4), 37.0 (C-3), 31.3 (C-8), 15.3 (C-20), 
12.4 (C-19). 
6.2.19 2-((2RS,3RS)-3-Methoxy-5-((4-methoxybenzyl)oxy)pentan-2-yl)-2-((R)-pent-4-en-
2-yl)-1,3-dioxolane (54) 
 
 
Allylated product 52 (30 mg, 0.091 mmol) was dissolved in ethylene glycol (0.1 mL) and 
stirred under inert atmosphere at room temperature. To the above solution triethyl 
orthoformate (0.1 mL, 0.6 mmol) and a catalytic amount of p-toluenesulfonic acid 
monohydrate (0.4 mg) was added and the mixture was stirred at room temperature for 2 h 
40 min. The reaction mixture was quenched with saturated aqueous NaHCO3 and extracted 
with chloroform (3 x 5 mL), dried with Na2SO4, filtered, and concentrated. The crude product 
was purified by flash column chromatography with pentane/ethyl acetate mixture (gradient 
elution 10:1 to 2:1) to afford the dioxalane 54 as colorless oil. 
Yield: 33 mg (0.087 mmol, 96%). 
Rf = 0.52 (pentane/ethyl acetate 2:1). 
EI-MS (70 eV): m/z (%): 334(3) [M-44]+, 302(8), 294(7), 293(30), 289(4), 257(6), 246(22), 
217(9), 213(25), 209(13), 205(13), 203(6), 197(12), 195(5), 190(4), 181(29), 177(42), 
176(87), 175(22), 169(16), 166(34), 165(9), 161(6), 151(16), 149(15), 145(13), 138(28), 
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137(83), 136(50), 135(64), 129(19), 125(38), 123(26), 122(84), 121(100), 119(15), 111(12), 
109(27), 107(25), 106(21), 99(31), 97(82), 94(16), 91(47), 89(27), 87(15), 78(55), 77(59), 
73(33), 72(35), 69(84), 67(24), 65(18), 55(23), 53(16), 51(10). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.16 - 7.22 (2H, m, H-21, 25), 6.77 - 6.83 
(2H, m, H-24, 22), 5.59 - 5.70 (1H, m, J = 14.2 Hz, 9.7 Hz, 7 Hz, H-8), 4.98 - 5.02 (1H, m, H-
9), 4.93 - 4.96 (1H, m, H-9), 4.36 (2H, s, H-19), 4.00 - 4.06 (2H, m, H-2), 3.85 - 3.90 (2H, m, 
H-3), 3.73 (3H, s, H-27), 3.52 - 3.56 (2H, t, J = 7.2 Hz, H-17), 3.37 - 3.51(1H, m, H-11), 
3.18(3H, s, H-13), 2.77 - 2.91 (1H, m, H-7b), 2.57 - 2.70 (1H, m, H-10), 2.26 - 2.40 (1H, m, 
H-7a), 1.92 - 2.03 (1H, dqd, J = 14.4 Hz, 7.4 Hz, 2.5 Hz, H-6), 1.75 - 1.87 (1H, m, H-16a), 
1.50 - 1.60 (1H, m, H-16b), 0.99 (3H, s, H-14), 0.89 (3H, s, H-15). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.1 (C-23), 135.8 (C-8), 130.5 (C-20), 
129.2 (C-25, 21), 116.7 (C-5), 115.1 (C-9), 113.7 (C-24, 22), 80.1 (C-11), 73.0 (C-19), 66.0 
(C-17), 63.9 (C-2, 3), 58.3 (C-13), 55.2 (C-27), 49.0 (C-10), 46.4 (C-6), 36.2 (C-7), 31.3 (C-
16), 15.3 (C-14), 12.4 (C-15). 
6.2.20 (4RS,6RS,7RS)-7-Methoxy-9-((4-methoxybenzyl)oxy)-4,6-dimethylnonane-2,5-
dione (53)  
 
 
Anhydrous palladium chloride (6 mg, 0.034 mmol) and anhydrous copper acetate (21 mg, 
0.11 mmol) were suspended in a mixture of DMF (4 mL) and water (0.5 mL) and O2 was 
bubbled through the reaction mixture at atmospheric pressure and stirred for 30 min. The 
addition of terminal alkene 52 (51 mg, 0.15 mmol) dissolved in DMF (1.5 mL) followed and 
the mixtrure was stirred for 4 d at room temperature. The reaction mixture was diluted with 
water and extracted with diethyl ether (3 x 10 mL). The combined organic layers were 
washed with saturated aqueous NaHCO3 solution, brine, dried with MgSO4, filtered, and 
concentrated in vacuo.  The crude product was purified by flash column chromatography 
with pentane/ethyl acetate mixture (gradient elution 10:1 to 2:1) to afford the diketone 53 as 
colorless oil.  
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Yield: 27 mg (0.11 mmol, 50%). 
Rf = 0.20 (pentane/ethyl acetate 2:1). 
EI-MS (70 eV): m/z (%): 350(1) [M]+, 332(1), 318(1), 274(1), 260(1), 209(1), 205(1), 182(5), 
181(2), 177(3), 176(17), 152(2), 137(9), 136(3), 135(6), 124(7), 122(12), 121(100), 113(15), 
109(3), 107(2), 97(4), 91(5), 89(3), 85(3), 78(8), 77(9), 73(3), 71(3), 69(5), 65(2), 58(3), 
55(3), 51(2), 45(2), 43(31), 41(5), 39(2).  
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.24 - 7.28 (2H, m, H-16, 12), 6.86 - 6.90 
(2H, m, H-15, 13), 4.43 (2H, s, H-10), 3.80 (3H, s, H-17), 3.59 (1H, ddd, J = 8.3 Hz, 7.1 Hz, 
3.3 Hz, H-7), 3.55 (2H, t, J = 6.1 Hz, H-9), 3.24 (3H, s, H-18), 3.07-3.16 (1H, m, H-4), 3.01 
(1H, dd, J = 16.4 Hz, 6.1 Hz, H-3), 2.91-2.98 (1H, m, H-6), 2.34 (1H, m, J = 8.6 Hz, 6.8 Hz, 
H-3), 2.14 (3H, s, H-1), 1.88 (1H, s, H-8b), 1.55 - 1.67 (1H, m, H-8a), 1.08 - 1.12 (3H, m, H-
20), 1.02 - 1.07 (3H, m, H-19). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 215.7 (C-5), 207.3 (C-2), 159.1 (C-14), 
130.6 (C-11), 129.2 (C-16, 12), 113.7 (C-15, 13), 79.4 (C-7), 72.6 (C-10), 66.0 (C-9), 58.4 
(C-18), 55.3 (C-17), 49.2 (C-6), 46.3 (C-3), 41.0 (C-4), 31.1 (C-8), 30.1 (C-1), 15.8 (C-20), 
13.0 (C-19). 
 6.2.21 (S)-2-(Methoxymethyl)-N-(pentan-3-ylidene)pyrrolidin-1-amine (59) 
 
 
To the flask containing SAMP 58a (1 g, 7.68 mmol) equipped with reflux condenser and 
drying tube, diethylketone 31 (660 mg, 7.68 mmol) was added dropwise and heated to 60 °C 
for 21 h monitored by TLC.[78] The mixture was poured into a solution containing 
dichloromethane/water 6:1. The organic phase dried with MgSO4, filtered, and concentrated 
in vacuo to afford the light yellow colored oil 59 after quick filtration over a short pad of silica 
gel.  
Yield: 1.52 g (7. 68 mmol, quant.). 
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Rf = 0.20 (pentane/diethyl ether 1:1). 
EI-MS (70 eV): m/z (%): 199(8) [M+1]+, 198(43) [M]+, 154(53), 153(99), 137(3), 114(5), 
113(12), 112(4), 98(10), 85(8), 84(47), 83(10), 82(18), 80(6), 58(10), 57(32), 56(100), 
55(54), 54(31), 53(22), 52(6), 51(5), 45(70), 43(27), 42(52), 41(76), 40(19), 39(51). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 3.36 - 3.42 (1H, m, H-12), 3.34 (3H, s, H-
13), 3.21 (1H, ddd, J = 9.3 Hz, 6.8 Hz, 2.5 Hz, H-2), 3.00 - 3.16 (2H, m, H-12, H-5), 2.34 - 
2.53 (3H, m, H-5, 8), 2.17 - 2.31 (2H, m, H-10), 1.93 - 2.04 (1H, m, H-3), 1.76 - 1.88 (2H, m, 
H-4), 1.59 - 1.73 (1H, m, H-3), 1.10 (3H, t, J = 8.0 Hz, H-11), 1.05 (3H, t, J = 7.6 Hz, H-7). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 173.5 (C-9), 75.4 (C-12), 66.0 (C-2), 59.1 
(C-13), 55.0 (C-5), 28.7 (C-10), 26.5 (C-3), 23.4 (C-8), 21.9 (C-4), 11.8 (C-11), 10.9 (C-7). 
6.2.22 (S,Z)-2-(Methoxymethyl)-N-((S)-4-methylhept-6-en-3-ylidene)pyrrolidin-1-amine 
(60) 
 
 
Preparation of LDA solution: 
n-BuLi (7.2 mL, 11.51 mmol, 1.6 M in hexane) was slowly added dropwise to the 
diisopropylamine (1.6 mL, 11.59 mmol) in dry diethyl ether (23 mL) at -60 °C and stirred for 
10 minutes warmed up to room temperature under water bath. The flask was cooled down to 
0 °C under ice bath and stirred for 1 h observing the formation of the light yellow colored 
solution. 
Compound 59 (1.52 g, 7.68 mmol) was added slowly dropwise to the freshly prepared LDA 
solution stirring at 0 °C under inert atmosphere. The resulting yellow colored solution slowly 
solidified into a semi solid and was stirred for 4 h at 0 °C. The reaction mixture was cooled 
down to -110 °C followed by the dropwise addition of allyl iodide 33 (1.42 g, 8.44 mmol) in 
diethyl ether (3 mL), stirred for 3 h and allowed to warm up to room temperature 
overnight.[78,125] The reaction mixture was poured into 2:1 diethyl ether/water mixture and the 
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aqueous layer washed with diethylether (2 x 30 mL). The combined organic layers were 
washed with water, dried with MgSO4, filtered, and concentrated in vacuo to get the yellow 
colored crude product. Purification of the crude product was done by flash column 
chromatography with 2:1 pentane/diethyl ether mixture as eluent afforded alkene 60 as light 
yellow colored oil. 
Yield: 1.92 g (8.08 mmol, 95%, 99% d.e.). 
[α]D21.5 = +140.8 (c 2.31, Et2O).  
Rf = 0.41 (pentane/diethyl ether 1:1). 
EI-MS (70 eV): m/z (%): 238(1) [M]+, 223(1), 209(1), 194(13), 193(77), 153(3), 151(4), 
142(2), 136(2), 125(23), 124(25), 97(6), 96(26), 84(10), 82(13), 70(12), 69(73), 69(100), 
68(20), 67(17), 45(38), 42(21), 41(99), 39(28). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 5.60 - 5.88 (1H, m, H-6), 4.92 - 5.09 (2H, 
m, H-7), 3.34 - 3.41 (1H, m, H-14), 3.33 - 3.34 (3H, s, H-15), 3.16 - 3.24 (1H, m, H-10), 2.95 
- 3.14 (2H, m, H-13, 14), 2.39 - 2.48 (2H, m, H-4, 13), 2.32 (2H, q, J = 7.8 Hz, H-2), 2.05 - 
2.21 (2H, m, H-5), 1.95 - 2.04 (1H, m, H-11), 1.76 - 1.88 (2H, m, H-12, 11), 1.59 - 1.72 (1H, 
m, H-12), 1.09 (2H, t, J = 7.8 Hz, H-1), 1.05 (3H, d, J = 6.8 Hz, H-8). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 174.8 (C-3), 137.3 (C-6), 115.6 (C-7), 75.4 
(C-14), 66.0 (C-10), 59.1 (C-15), 54.8 (C-13), 39.6 (C-4), 38.9 (C-5), 26.5 (C-11), 23.4 (C-2), 
21.9 (C-12), 19.0 (C-8), 11.0 (C-1). 
6.2.23 (S)-4-Methylhept-6-en-3-one (61) 
 
 
NaH/MeI Salt method:[78] 
To the flask containing 60 (94 mg, 0.40 mmol), iodomethane (282 mg, 2 mmol) was added 
and heated to reflux at 65 °C for 2 d. After cooling down to room temperature, 4 N HCl (2 
mL) (50 mL/10 mmol) was added and the mixure stirred for 5 min. The contents of the flask 
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were transferred into a Erlenmeyer flask followed by the addition of pentane (10 mL) and 
stirred vigorously for 30 minutes. The organic phase were separated, washed with saturated 
solution of NaHSO3 solution and pH 7 buffer solution, dried with Na2SO4, filtered, and 
concentrated in vacuo. The crude product was purified by flash column chromatography with 
5:1 pentane/diethyl ether mixture to afford ketone 61 as the colorless volatile fruity odour 
liquid.   
Yield: 30 mg (0.24 mmol, 60%, 90% ee). 
Copper Chloride cleavage method:[79] 
To the ice cooled solution of 60 (136 mg, 0.57 mmol) in THF (6 mL), copper chloride 1M  
aqueous solution (1 mL) was added dropwise and stirred for 1 d, monitored by TLC. After 
the consumption of the starting material aqueous NH3 (25% aq. 3 mL) was added dropwise 
and extracted with diethyl ether (3 x 10 mL). The organic phases combined washed with 
brine, dried with MgSO4, filtered, and concentrated in vacuo. The crude product was purified 
by flash column chromatography with 5:1 pentane/diethyl ether mixture to afford the chiral 
ketone 61 as colorless volatile fruity odour liquid.  
yield: 65 mg (0.51 mmol, 90%, 60% ee). 
Lipodex-G column, Injection mode: splitless; Temperature program: 50 °C for 1 min, then 
with 1 °C/min up to 210 °C; Rt: 12.46 min.(minor), 13.10 min.(major). 
Rf = 0.64 (pentane/diethyl ether 1:1).  
EI-MS (70 eV): m/z (%): 126(8) [M]+, 97(18), 69(72), 67(10), 57(100), 55(8), 53(11), 43(7), 
41(76), 40(6), 39(38).  
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 5.72 (1H, ddt, J = 17.1 Hz, 10.0 Hz, 7.0 
Hz, H-6), 4.99 - 5.06 (2H, m, H-7), 2.61 (1H, dq, J = 13.6 Hz, 6.8 Hz, H-4), 2.46 (2H, q, J = 
7.1 Hz, H-2), 2.35 - 2.42 (1H, m, J = 14.1 Hz, 7.3 Hz, 1.5 Hz, H-5), 2.09 (1H, dtt, J = 14.2 Hz, 
7.2 Hz, 1.3 Hz, H-5), 1.08 (3H, d, J = 6.8 Hz, H-8), 1.04 (3H, t, J = 7.3 Hz, H-1). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 214.1 (C-3), 135.5 (C-6), 116.3 (C-7), 
45.4 (C-4), 36.9 (C-5), 34.1 (C-2), 15.8 (C-8), 7.3 (C-1). 
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6.2.24 (R)-4-Benzyl-3-propionyloxazolidin-2-one (65) 
 
 
To the solution of (R)-4-benzyl-2-oxazolidinone 64 (767 mg, 4.33 mmol) in 35 mL anhydrous 
THF at -78 °C n-BuLi (2.9 mL, 4.72 mmol, 1.6 M in hexane)was added over a period of 15 
min dropwise and stirred under inert atmosphere for 30 min followed by the dropwise 
addition of the propionyl chloride 63 (437 mg, 4.72 mmol) via a syringe for 15  min. The 
reaction mixture was allowed to warm up to room temperature for 3 h and stirred at 0 °C for 
3 h followed by the quenching with saturated aqueous NH4Cl solution. The quenched 
reaction mixture was concentrated in vacuo and the residue extracted with dichloromethane. 
The organic layers were washed with 10 % aqueous NaOH solution and the aqueous layer 
was extracted with dichloromethane. The combined organic layers were washed with brine 
solution, dried with MgSO4, filtered, and concentrated under reduced pressure to give the 
crude product as light colored oil. Purification by flash chromatography with 5:1 
pentane/ethyl acetate mixture as eluent afforded the desired product 65 as a white 
needles.[84]  
Yield: 1 g (4.3 mmol, 99%, 99% ee). 
 [α]D20 = -102 (c 1.0, EtOH). 
Mp = 44-46 °C 
Rf  = 0.56 (pentane/ethyl acetate 5:1). 
EI-MS (70 eV): m/z (%): 234(2) [M+1]+, 233(15) [M]+, 148(5), 142(18), 134(4), 133(4), 
117(9), 116(7), 115(9), 103(2), 92(10), 91(42), 90(4), 89(7), 86(7), 78(4), 77(7), 65(22), 
64(2), 63(7), 58(6), 57(100), 56(3), 55(4), 52(3), 51(9), 50(3), 42(9), 41(5), 40(2), 39(11). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.30 - 7.37 (2H, m, H-9, 11), 7.24 - 7.30 
(1H, m, H-10), 7.18 - 7.23 (2H, m, H-8, 12), 4.67 (1H, dddd, J = 10.4 Hz, J = 9.7 Hz, J = 7.0 
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Hz, J = 3.4 Hz, H-4), 4.17 (2H, ddd, J = 9.1 Hz, J = 5.9 Hz, J = 3.6 Hz, H-5), 3.30 (1H, dd, J 
= 13.3 Hz, J = 3.2 Hz, H-6), 2.96 (2H, dqd, J = 9.3 Hz, J = 7.4 Hz, J = 1.3 Hz, H-14), 2.78 
(1H, dd, J = 9.7 Hz, J = 3.6 Hz, H-6), 1.21 (3H, t, J = 7.4 Hz, H-15).  
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 174.0 (C-13), 153.5 (C-2), 135.3 (C-7), 
129.4 (C-8, 12), 128.9 (C-9, 11), 127.3 (C-10), 66.2 (C-5), 55.1 (C-4), 37.9 (C-6), 29.2 (C-
14), 8.3 (C-15).   
6.2.25 (R)-4-Benzyl-3-((R)-2-methylpent-4-enoyl)oxazolidin-2-one (66) 
 
 
Compound 65 (1 g, 4.3 mmol) was dissolved in anhydrous THF (11 mL) while stirring under 
inert atmosphere at -78 °C. NaHMDS (3.4 mL, 6.85 mmol, 2 M in THF) along with anhydrous 
THF (3.2 mL) was added dropwise and allowed to stir for 1 h at -78 °C. Allyl bromide (1.8 
mL, 21 mmol) was added dropwise to the reaction mixture at -78 °C for 10 min and allowed 
to warm up to -45 °C. The reaction mixture was stirred at -45 °C for 4 h, followed by 
quenching with saturated NH4Cl solution. The aqueous phase was extracted twice with ethyl 
acetate and the combined organic layers were washed with brine, dried with MgSO4, filtered, 
and concentrated in vacuo to obtain the crude product as light yellow colored oil. Purification 
of the crude product with flash column chromatography using 10:1 pentane/ethyl acetate as 
eluent afforded the desired product 66 as colorless oil.[126] 
 Yield: 1.1 g (4.0 mmol, 94%, 99% d.e.). 
[α]D21 = -41.5 (c 0.9, CHCl3) , [α]D19 = -39 (c 1, CHCl3), lit.[127]  
Rf  = 0.23 (pentane/diethyl ether 2:1). 
EI-MS (70 eV): m/z (%): 274(3) [M+1]+, 273(13) [M]+, 187(3), 181(7), 178(10), 139(2), 
134(3), 132(5), 129(2), 127(3), 118(5), 117(34), 116(10), 115(18), 103(4), 98(6), 97(85), 
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96(17), 95(5), 92(21), 91(82), 90(4), 89(7), 86(22), 81(3), 78(5), 77(8), 70(8), 69(100), 
68(20), 67(23), 66(3), 65(22), 63(3), 57(3), 56(5), 55(7), 54(4), 53(12), 52(3), 51(5).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.30 - 7.37 (2H, m, J = 7.2 Hz, H-15, 17), 
7.26 - 7.30 (1H, m, J = 8.0 Hz, J = 6.8 Hz, H-16), 7.19 - 7.25 (2H, m, J = 8.1 Hz, H-14, 18), 
5.82 (1H, ddt, J = 17.0 Hz, J = 10.0 Hz, J = 7.0 Hz, H-4), 5.03 - 5.15 (2H, m, J = 16.1 Hz, J = 
9.1 Hz, J = 5.9 Hz, H-5), 4.68 (1H, ddt, J = 9.8 Hz, J = 7.0 Hz, J = 3.4 Hz, H-10), 4.12 - 4.23 
(2H, m, J = 9.1 Hz, J = 7.2 Hz, J = 3.6 Hz, H-11), 3.87 (1H, q, J = 6.8 Hz, H-2), 3.29 (1H, dd, 
J = 13.3 Hz, J = 3.2 Hz, H-12), 2.70 (1H, dd, J = 13.4 Hz, J = 9.8 Hz, H-12), 2.53 (1H, dtt, J 
= 13.8 Hz, J = 6.8 Hz, J = 1.3 Hz, H-3), 2.24 (1H, dtt, J = 13.9 Hz, J = 7.0 Hz, J = 1.2 Hz, H-
3), 1.19 (3H, d, J = 6.8 Hz, H-6).    
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 176.5 (C-1), 153.1 (C-8), 135.4 (C-4), 
135.2 (C-13), 129.4 (C-14, 18), 128.9 (C-15, 17), 127.3 (C-16), 117.2 (C-5), 66.0 (C-11), 
55.4 (C-10), 38.1 (C-3), 38.0 (C-12), 37.1 (C-2), 16.4 (C-6). 
6.2.26 (R)-2-Methylpent-4-enoic acid (67)  
 
 
To a solution of 66 (500 mg, 1.83 mmol) dissolved in 37 mL of 3:1 THF/H2O 30 % at 0 °C 
under stirring aqueous H2O2 (1.12 mL, 11 mmol) and LiOH monohydrate (88 mg, 3.6 mmol) 
were added portion wise and allowed to stir at 0 °C for 2 h. The reaction was controlled by 
TLC. The reaction mixture was quenched by the careful and slow addition of 2 M solution of 
aqueous Na2S2O3 after the consumption of the starting material. This was allowed to stir 
further for 20 min at 0 °C. The THF was evaporated in the rotavapor and the residue was 
extracted with dichloromethane 4 to 5 times. The combined organic layers were dried with 
MgSO4, filtered, and concentrated under reduced pressure to obtain the chiral auxiliary as 
light colored oil. Purification of the crude chiral auxiliary with pentane/ethyl acetate afforded 
64 as colorless crystals.[84,86,128] 
To the aqueous layer at 0 °C a saturated solution of NaH2PO4. H2O was added.[129] The 
reaction mixture was acidified at 0 °C to pH 1-3 with 1N HCl solution, followed by the 
extraction with diethyl ether five times. The combined organic layers were dried with MgSO4, 
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filtered, and concentrated under reduced pressure to obtain 67 as light yellow colored crude 
liquid. Purification of the crude product by flash column chromatography with 2:1 
pentane/diethyl ether mixture as eluent afforded the desired product 67 as colorless pungent 
odor liquid.  
yield: 206 mg (1.81 mmol, 99%, 98% ee). 
MSTFA derivative: Lipodex-G column; Injection mode: split ratio 20:1; Temperature program: 
50 °C for 5 min, then with 10 °C/min up to 210 °C; Rt: 70.97 min.(minor), 72.40 min.(major).  
[α]D21 = +28.75 (c 2.0, CHCl3). 
Rf = 0.46 (pentane/diethyl ether 1:1). 
EI-MS (70 eV): m/z (%): 114(6) [M]+, 99(16), 81(3), 74(4), 73(5), 71(6), 70(8), 69(85), 68(15), 
67(13), 58(2), 56(11), 55(15), 54(4), 53(14), 51(4), 50(3), 45(17), 44(4), 43(11), 42(14), 
41(100), 39(51), 37(3). 
EI-MS (70 eV) (MSTFA derivative): m/z (%): 186(3) [M]+, 171(14), 81(2), 77(3), 76(5), 
75(67), 74(10), 73(100), 69(4), 68(11), 67(4), 61(6), 59(4), 58(2), 55(3), 53(3), 47(11), 
45(23), 44(2), 43(7), 42(2), 41(22), 39(11).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 5.77 (1H, ddt, J = 16.7 Hz, J = 10.2 Hz, J = 
6.8 Hz, H-4), 5.03 - 5.13 (2H, m, H-5), 2.56 (1H, q, J = 7.0 Hz, H-2), 2.45 (1H, ddd, J = 13.6 
Hz, J = 6.8 Hz, J = 4.2 Hz, H-3), 2.21 (1H, ddd, J = 14.2 Hz, J = 9.5 Hz, J = 6.8 Hz, H-3), 
1.19 (3H, d, J = 7.0 Hz, H-6).   
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 182.1 (C-1), 135.1 (C-4), 117.2 (C-5), 39.0 
(C-2), 37.4 (C-3), 16.3 (C-6). 
6.2.27 (R)-N-Methoxy-N,2-dimethylpent-4-enamide (70) 
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To the solution of 67 (126 mg, 1.1 mmol) in dichloromethane (5 mL) stirring at room 
temperature under inert atmosphere 1,1'-carbonyldiimidazole 68 (179 mg, 1.1 mmol) was 
added and allowed to stir for 30 min. To the reaction mixture N,O-dimethylhyxdroxylamine 
hydrochloride 69 (108 mg, 1.1 mmol) was added in one portion and stirred overnight for 
approx. 20 h, monitored by the TLC for the consumption of the acid. The reaction mixture 
was diluted with dichloromethane and the combined organic layers washed with 0.25 M HCl 
solution, saturated NaHCO3 solution, brine solution, dried with MgSO4, filtered and 
concentrated under reduced pressure to obtain crude amide 70 as fruity odor colored liquid. 
Purification of the crude product with flash column chromatography using gradient elution 
from 10:1 to 3:1 pentane/diethyl ether mixture as eluent afforded the desired amide 70 as 
fruity odor colorless liquid.[130] 
Yield: 174 mg (1.1 mmol, 99%, 99% ee). 
Lipodex-G column; Injection mode: split ratio 20:1; Temperature program: 50 °C for 1 min, 
then with 1 °C/min up to 210 °C; Rt: 32.71 min.(minor), 33.99 min.(major).  
[α]D20 = +12.41 (c 1.16, CHCl3).  
 Rf = 0.27 (pentane/diethyl ether 1:1).  
EI-MS (70 eV): m/z (%): 142(1) [M]+, 127(3), 126(7), 112(4), 98(3), 97(35), 96(2), 88(2), 
81(1), 73(1), 70(8), 69(100), 68(5), 67(10), 66(1), 65(3), 62(2), 61(14), 60(5), 58(5), 56(7), 
55(7), 54(3), 53(10), 51(2), 50(1), 46(4), 45(4), 43(3), 42(10), 41(86), 40(4), 39(24), 38(2).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 5.70 (1H, ddt, J = 16.7 Hz, J = 10.2 Hz, J = 
7.0 Hz, H-4), 4.88 - 5.05 (2H, m, H-5), 3.62 (3H, s, H-8), 3.12 (3H, s, H-7), 2.90 (1H, dqd, J = 
9.1 Hz, J = 6.6 Hz, J = 4.4 Hz, H-2), 2.36 (1H, dddt, J = 14.0 Hz, J = 7.5 Hz, J = 6.5 Hz, J = 
1.3 Hz, H-3), 2.05 (1H, dddt, J = 14.0 Hz, J = 7.0 Hz, J = 4.4 Hz, J = 2.3 Hz, H-3), 1.06 (3H, 
d, J = 7.0 Hz, H-6). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 177.3 (C-1), 136.2 (C-4), 116.4 (C-5), 61.5 
(C-8), 37.8 (C-3), 36.1 (C-2), 29.7 (C-7), 17.0 (C-6).  
 
 
Experimental procedures 
   
- 109 - 
 
6.2.28 (R)-4-Methylhept-6-en-3-one (61)  
 
 
To a stirred solution of 70 (100 mg, 0.64 mmol) in anhydrous THF (2 mL) at -20 °C under 
inert atmosphere ethyl magnesium bromide 71 (0.4 mL, 0.96 mmol, 3 M in diethyl ether) was 
added dropwise. Stirring was continued at -20 °C until the consumption of the amide was 
detected by TLC. The reaction mixture was quenched by slow addition of saturated NH4Cl 
solution and extracted three to five times with diethyl ether. The combined organic layers 
were dried with MgSO4, filtered, and concentrated in rotavapor to obtain the crude chiral allyl 
ketone. Purification of the crude product by flash chromatography with 5:1 pentane/diethyl 
ether mixture as eluent afforded (R)-chiral allyl ketone 61 as fruity odor colorless volatile 
liquid.[88]   
Yield: 72 mg (0.57 mmol, 90%, 99% ee). 
Lipodex-G column; Injection mode: split ratio 20:1; Temperature program: 50 °C for 1 min, 
then with 1 °C/min up to 210 °C; Rt: 12.46 min.(minor), 13.10 min.(major).  
 Rf  = 0.64 (pentane/diethyl ether 1:1).   
EI-MS (70 eV): m/z (%): 127(3) [M+1]+, 126(24) [M]+, 111(8), 108(2), 99(3), 98(4), 97(42), 
93(2), 85(2), 84(3), 83(5), 79(4), 77(3), 70(11), 69(90), 68(13), 67(22), 65(5), 63(2), 58(10), 
57(100), 56(9), 55(15), 54(7), 53(18), 52(3), 51(6), 50(3), 43(11), 42(10), 41(76), 40(6), 
39(41), 38(3).  
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 5.72 (1H, ddt, J = 17.1 Hz, 10.0 Hz, 7.0 
Hz, H-6), 4.99 - 5.06 (2H, m, H-7), 2.61 (1H, dq, J = 13.6 Hz, 6.8 Hz, H-4), 2.46 (2H, q, J = 
7.1 Hz, H-2), 2.35 - 2.42 (1H, m, J = 14.1 Hz, 7.3 Hz, 1.5 Hz, H-5), 2.09 (1H, dtt, J = 14.2 Hz, 
7.2 Hz, 1.3 Hz, H-5), 1.08 (3H, d, J = 6.8 Hz, H-8), 1.04 (3H, t, J = 7.3 Hz, H-1). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 214.1 (C-3), 135.5 (C-6), 116.3 (C-7), 
45.4 (C-4), 36.9 (C-5), 34.1 (C-2), 15.8 (C-8), 7.3 (C-1). 
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6.2.29 Pent-3-ynoic acid (73) 
 
 
To the solution of CrO3 (3 g, 30 mmol) in diluted solution containing concentrated H2SO4 (2 
mL) and water (7.6 mL) under ice bath (-5 to 0 °C), pent-3-yn-1-ol 72 (1 g, 11.9 mmol) in 
acetone (119 mL) was added slowly dropwise via a dropping funnel. The reaction mixture 
was allowed to stir at room temperature for 15 h. The reaction was monitored by TLC and 
quenched with isopropanol to destroy excess Jones reagent. The mixiture was filtered over a 
pad of celite and washed with diethyl ether. The organic extract was washed with brine, 
dried with MgSO4, filtered, and concentrated under reduced pressure. Purification of the 
crude product by flash column chromatography using 20:1 dichloromethane/methanol 
mixture as eluent afforded the desired acid 73 as white crystalline powder.[91,92] 
Yield: 695 mg (6.7 mmol, 60%). 
Rf  = 0.29 (dichloromethane/methanol 20:1). 
EI-MS (70 eV): m/z (%): 98(22) [M]+, 70(6), 69(4), 55(5), 54(49), 53(84), 52(39), 51(81), 
50(100), 49(30), 48(5), 45(78), 44(11), 43(2), 42(12), 41(9), 40(4), 39(54), 38(17), 37(23), 
36(6).   
EI-MS (70 eV) (MSTFA derivative): m/z (%): 155(35) [M-15]+, 128(4), 127(12), 126(14), 
117(7), 111(25), 99(11), 83(12), 75(40), 73(100), 61(6), 59(7), 53(34), 51(21), 50(16), 47(7), 
45(34), 43(16), 41(5).  
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 10.59 (1H, br. s., -COOH), 3.32 (2H, s,   
H-2), 1.84 (3H, s, H-5). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 175.4 (C-1), 79.9 (C-4), 69.7 (C-3),     
25.8 (C-2), 3.7 (C-5). 
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6.2.30 (R)-4-Benzyl-3-(pent-3-ynoyl)oxazolidin-2-one (75) 
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To the solution of pent-3-ynoic acid 73 (654 mg, 6.66 mmol) in freshly distilled THF (36 mL) 
under inert atmosphere at -78 °C, Et3N (809 mg, 7.99 mmol) and Pivaloyl chloride (74) (965 
mg, 8 mmol) was added dropwise. The resulting mixture was stirred for 20 min at -78 °C, 
warmed to 0 °C, and allowed to stir for 45 min at this temperature. Meanwhile, to the solution 
of (R)-4-benzyl-2-oxazolidinone 64 (1.18 g, 8 mmol) in freshly distilled THF (29 mL) at -80 °C 
under inert atmosphere, n-BuLi (5 mL, 8 mmol, 1.6 M in hexane) was added dropwise. The 
resultant solution was transferred via cannula to the mixed anhydride, allowed to stir for 15 
min, warmed to 0 °C within 3 h and stirred for 45 min at 0 °C. After quenching with saturated 
NH4Cl solution, the mixture was extracted 5 times with TBME. The combined organic 
extracts were washed with water and dried with MgSO4. The solution was filtered and 
concentrated in vacuo. Purification of the crude product by flash chromatography using 
gradient elution 10:1 to 2:1 pentane/TBME mixture as eluent afforded the product 75 as 
colorless solid.[93] 
Yield: 616 mg (2.4 mmol, 36%, 99% ee). 
Rf = 0.41 (pentane/TBME 1:1). 
EI-MS (70 eV): m/z (%): 258(8) [M+1]+, 257(40) [M]+, 256(33), 178(13), 166(6), 128(5), 
122(36), 118(6), 117(39), 116(8), 115(23), 103(7), 92(20), 91(100), 90(6), 89(13), 86(22), 
81(15), 80(20), 79(8), 78(12), 77(17), 65(39), 63(13), 58(6), 53(49), 52(36), 51(40), 50(18), 
43(10), 42(14), 41(11), 39(23).    
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.16 - 7.22 (2H, m, H-14, 16), 7.09 - 7.16 
(1H, m, H-15), 7.03 - 7.08 (2H, m, H-13, 17), 4.53 (1H, dddd, J = 9.5 Hz, J = 7.2 Hz, J = 6.8 
Hz, J = 3.2 Hz, H-9), 4.00 - 4.12 (2H, m, H-10), 3.74 (2H, quin, J = 2.4 Hz, H-2), 3.18 (1H, 
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dd, J = 13.4 Hz, J = 3.2 Hz, H-11), 2.63 (1H, dd, J = 13.3 Hz, J = 9.6 Hz, H-11), 1.73 (3H, t, J 
= 2.5 Hz, H-5).   
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 168.3 (C-1), 153.1 (C-7), 135.0 (C-12), 
129.4 (C-13, 17), 129.0 (C-14, 16), 127.4 (C-15), 80.4 (C-4), 69.9 (C-3), 66.4 (C-10), 55.4 
(C-9), 37.6 (C-11), 28.0 (C-2), 3.7 (C-5).  
6.2.31 (R)-4-Benzyl-3-pivaloyloxazolidin-2-one (76) 
 
 
EI-MS (70 eV): m/z (%): 261(7) [M]+, 204(6), 170(12), 142(6), 117(15), 116(8), 115(16), 
92(16), 91(84), 90(8), 89(14), 86(27), 85(14), 78(4), 77(10), 70(5), 69(8), 65(36), 63(8), 
58(7), 57(100), 56(14), 55(12), 53(4), 51(9), 42(16), 41(85), 40(9), 39(41). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.32 - 7.36 (1H, m, H-10), 7.25 - 7.31 (2H, 
m, H-9, 11), 7.19 - 7.24 (2H, m, H-8, 12), 4.70 (1H, ddt, J = 9.6 Hz, J = 7.3 Hz, J = 3.2 Hz, H-
4), 4.11 - 4.24 (2H, m, H-5), 3.23 (1H, dd, J = 13.4 Hz, J = 3.4 Hz, H-6), 2.77 (1H, dd, J = 
13.3 Hz, J = 9.6 Hz, H-6), 1.40 (9H, s, H-15). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 178.5 (C-13), 152.3 (C-2), 135.5 (C-7), 
129.4 (C-8, 12), 128.8 (C-9, 11), 127.2 (C-10), 66.1 (C-5), 57.4 (C-4), 41.7 (C-14), 37.8 (C-
6), 26.3 (C-15). 
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6.2.32 (R)-4-Benzyl-3-((R)-2-methylpent-3-ynoyl)oxazolidin-2-one (77) 
 
 
To the solution of 75 (627 mg, 2.44 mmol) in freshly distilled THF (8 mL) under inert 
atmosphere at -78 °C, NaHMDS (4.6 mL, 4.6 mmol, 1 M in THF) was added dropwise using 
a syringe pump over 20 min and allowed to stir for 45 min at -78 °C. Methyl iodide (0.8 mL, 
12.2 mmol) was added slowly dropwise and stirred for 5 h at -78 °C, quenched with 
saturated NH4Cl solution, water and extracted five times with TBME. The combined organic 
extracts were washed with water and brine, dried with MgSO4, filtered, and concentrated in 
vacuo. Purification of the crude product by flash column chromatography with 5:1 
pentane/ethyl acetate mixture as eluent afforded the desired product 77 as colorless oil with 
the isomerized product from internal alkyne to terminal alkyne. 
6.2.33 (R)-4-Benzyl-3-(pent-4-ynoyl)oxazolidin-2-one (82) 
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To a stirred solution of pent4ynoic acid 81 (1 g, 10 mmol) in freshly distilled THF (100 mL) at 
-78 °C under inert atmosphere, Et3N (1.5 mL, 10.5 mmol) was added, followed by the 
dropwise addition of pivaloyl chloride (74) (1.3 mL, 10.5 mmol). The resulting mixture stirred 
at -78 °C for 15 min and allowed to warm to room temperature within 4 hours. The reaction 
mixture was further stirred for 30 min at room temperature and re-cooled to -78 °C. Mean 
while, a solution of (R)-4-benzyl-2-oxazolidinone 64 (1.77 g, 10 mmol) in freshly distilled THF 
(50 mL) was cooled to -85 °C and treated slowly with a 1.6 M solution of n-BuLi(6.8 mL, 11 
Experimental procedures 
   
- 114 - 
 
mmol). The resulting solution was stirred at -78 °C for 15 min and then added via cannula 
into the solution of the mixed anhydride. The reaction mixture was stirred for 30 min at -78 
°C and allowed to warm up to room temperature followed by quenching with saturated NH4Cl 
solution and extracted with ethyl acetate. The combined organic layers were washed with 
brine, dried with MgSO4, filtered, and concentrated in vacuo to obtain the crude product as 
dark brown colored oil. Purification of the crude product by flash column chromatography 
using gradient elution 20:1 to 4:1 pentane/ethyl acetate mixture as eluent afforded the 
desired product 82 as white solid.[94] 
Yield: 2.4 g (9.4 mmol, 94%, 99% ee). 
M.pt. = 87-90 °C. 
[α]D20 = -98.4 (c 1.8 dichloromethane).  
Rf = 0.32 (pentane/ethyl acetate 2:1).  
EI-MS (70 eV): m/z (%): 258(2) [M+1]+, 257(12) [M]+, 256(5), 172(8), 166(18), 156(3), 
140(4), 134(5), 133(6), 128(3), 124(2), 118(5), 117(17), 116(8), 115(14), 105(2), 103(3), 
92(14), 91(55), 90(5), 89(7), 86(12), 82(6), 81(100), 79(5), 78(5), 77(9), 70(3), 66(2), 
65(27),64(3), 63(8), 62(2), 58(3), 55(4), 54(6), 53(88), 52(20), 51(26), 50(11), 44(3), 43(3), 
42(14), 41(8), 40(3), 39(23), 38(4). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] =  7.31 - 7.37 (2H, m, H-13, 17), 7.24 - 7.30 
(1H, m, H-15), 7.18 - 7.24 (2H, m, H-14, 16), 4.64 - 4.75 (1H, m, H-9), 4.16 - 4.27 (2H, m, H-
10), 3.30 (1H, dd, J = 13.4 Hz, J = 7.8 Hz, H-11), 3.20 (2H, ddd, J = 7.2 Hz, J = 3.8 Hz, J = 
1.5 Hz, H-2), 2.80 (1H, dd, J = 13.3 Hz, J = 9.6 Hz, H-11), 2.60 (2H, td, J = 7.1 Hz, J = 2.7 
Hz, H-3), 2.00 (1H, t, J = 2.7 Hz, H-5). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 171.2 (C-1), 153.4 (C-7), 135.1 (C-12), 
129.4 (C-13, 17), 128.9 (C-14, 16), 127.4 (C-15), 82.6 (C-4), 69.0 (C-5), 66.3 (C-10), 55.1 
(C-9), 37.8 (C-11), 34.7 (C-2), 13.5 (C-3). 
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6.2.34 (R)-4-Benzyl-3-((R)-2-methylpent-4-ynoyl)oxazolidin-2-one (83) 
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To the flask containing 82 (1 g, 3.9 mmol) dissolved in anhydrous THF (42 mL) stirred at       
-78 °C under inert atmosphere NaHMDS (7.3 mL, 7.3 mmol, 1 M in THF) was added slowly 
dropwise for a period of 20 min via syringe pump and stirred for an hour. Methyl iodide (2.7 
g, 19.5 mmol) was added dropwise via syringe pump and stirred for 4.5 h at -78 °C. The 
reaction was quenched with saturated NH4Cl solution and allowed to warm up to the room 
temperature followed by extraction with ethyl acetate. The combined organic layers were 
washed with water and brine, dried with MgSO4, filtered, and concentrated in vacuo to obtain 
the crude product as dark colored oil. Purification of the crude product by flash column 
chromatography using 20:1 to 1:1 pentane/ethyl acetate gradient elution mixture afforded the 
desired methylated product as brown colored solid. Recrystallization of this material from 
ether/hexanes (2:1) afforded 83 as the cream colored solid.  
Yield: 898 mg (3.3 mmol, 85%, 99% d.e.). 
M.pt. = 56 – 60 °C. 
[α]D20.6 = - 88.6 (c 6.1, chloroform).  
Rf = 0.41 (pentane/ethyl acetate 2:1).  
EI-MS (70 eV): m/z (%): 272(3) [M+1]+, 271(13) [M]+, 270(4), 256(2), 185(7), 181(4), 
180(44), 178(3), 154(4), 137(3), 134(5), 132(6), 130(3), 128(3), 118(6), 117(30), 116(8), 
114(21), 104(3), 103(5), 96(8), 95(100), 94(6), 93(3), 92(18), 91(80), 90(4), 89(9), 86(19), 
79(4), 78(3), 77(10), 70(3), 68(3), 67(71), 66(19), 65(54), 64(2), 63(7), 58(4), 56(3), 55(7), 
52(3), 51(11), 42(10), 41(35), 40(7), 39(28), 38(3). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] =  7.31 - 7.37 (2H, m, H-15, 17), 7.24 - 7.30 
(1H, m, H-16), 7.18 - 7.23 (2H, m, H-14, 18), 4.71 (1H, ddt, J = 9.5 Hz, J = 7.2 Hz, J = 3.2 
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Hz, H-10), 4.21 (2H, dtd, J = 9.1 Hz, J = 7.2 Hz, J = 3.2 Hz, H-11), 3.93 (1H, dqd, J = 9.8 Hz, 
J = 7.0 Hz, J = 4.7 Hz, H-2), 3.27 (1H, dd, J = 13.3 Hz, J = 3.3 Hz, H-12), 2.78 (1H, dd, J = 
13.3 Hz, J = 9.6 Hz, H-12), 2.58 (1H, ddd, J = 16.8 Hz, J = 9.8 Hz, J = 2.7 Hz, H-3), 2.41 
(1H, ddd, J = 16.8 Hz, J = 6.8 Hz, J = 2.7 Hz, H-3), 1.99 (1H, t, J = 2.7 Hz, H-5), 1.33 (3H, d, 
J = 6.8 Hz, H-6). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 175.2 (C-1), 152.9 (C-8), 135.1 (C-13), 
129.4 (C-14, 18), 128.9 (C-15, 17), 127.4 (C-16), 81.6 (C-4), 69.7 (C-5), 66.2 (C-11), 55.2 
(C-10), 37.8 (C-12), 37.5 (C-2), 22.2 (C-3), 17.1 (C-6). 
6.2.35 (R)-4-Benzyl-3-((S)-2-methylpent-4-ynoyl)oxazolidin-2-one (90) 
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To a solution of diisopropylamine (1 mL, 7.1 mmol) in freshly distilled THF (5.5 mL), n-BuLi 
(4.1 mL, 6.4 mmol, 1.6 M in THF) was added under insert atmosphere at 0 °C. The reaction 
mixture was stirred for 30 min, cooled down to -78 °C followed by the addition of  HMPA       
(1 mL, 4.3 mmol), (R)-4-benzyl-3-propionyloxazolidin-2-one 65 (1 g, 4.3 mmol) in freshly 
distilled THF (2  mL) dropwise via syringe pump for 20 min at -78 °C. The resultant dark red 
colored solution was stirred for 30 min followed by the dropwise addition of propargylbromide 
89 (1.6 mL, 17.15 mmol) at -78 °C and stirred for 20 h. The reaction mixture was quenched 
with saturated NH4Cl solution and washed with water followed by the extraction with diethyl 
ether thrice. The combined organic extracts were washed with distilled water, dried with 
MgSO4, filtered, and concentrated in vacuo to obtain the crude product as dark colored oil. 
Purification of the crude oil by flash chromatography using gradient elution 10:1 to 2:1 
pentane/ethyl acetate mixture as eluent afforded the yellow colored powder. 
Recrystallization with ether/hexanes (2:1) afforded the desired product as cream colored 
solid. The absolute configuration of the product 90 was confirmed via X-ray structure 
analysis. 
Yield: 911 mg (3.36 mmol, 78%, 100% d.e.). 
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M.pt. = 52-54 °C. 
[α]D20 = +46.4 (c 2.6, chloroform). 
Rf = 0.45 (pentane/ethyl acetate 2:1).  
1H-NMR (300 MHz, CHLOROFORM-d) δ = 7.31 - 7.38 (2H, m, H-15, 17), 7.26 - 7.30 (1H, m, 
H-16), 7.20 - 7.26 (2H, m, H-14, 18), 4.70 (1H, ddt, J = 9.5 Hz, J = 7.1 Hz, J = 3.5 Hz, H-10), 
4.21 (2H, dtd, J = 9.1 Hz, J = 7.2 Hz, J = 3.6 Hz, H-11), 3.96 (1H, sxt, J = 6.8 Hz, H-2), 3.30 
(1H, dd, J = 13.4 Hz, J = 3.2 Hz, H-12), 2.80 (1H, dd, J = 13.4 Hz, J = 9.5 Hz, H-12), 2.62 
(1H, ddd, J = 16.8 Hz, J = 9.3 Hz, J = 2.7 Hz, H-3), 2.50 (1H, ddd, J = 16.7 Hz, J = 6.4 Hz, J 
= 2.7 Hz, H-3), 2.03 (1H, t, J = 2.7 Hz, H-5), 1.29 (3H, d, J = 6.8 Hz, H-6).  
13C-NMR (75 MHz, CHLOROFORM-d) δ = 175.1 (C-1), 153.0 (C-8), 135.1 (C-13), 129.4     
(C-14, 18), 128.9 (C-15, 17), 127.3 (C-16), 81.3 (C-4), 70.1 (C-5), 66.1 (C-11), 55.3 (C-10), 
37.9 (C-12), 37.2 (C-2), 22.5 (C-3), 16.5 (C-6). 
6.2.36 (R)-Ethyl 2-methylpent-4-ynoate (85) 
 
 
To the solution of 83 (62 mg, 0.23 mmol) in anhydrous ethanol (2 mL) stirred under inert 
atmosphere Titanium(IV) ethoxide 84 (100 mg, 0.44 mmol) was added and the resultant 
reaction mixture was heated to reflux for 20 h. All the volatiles were carefully evaporated at 
20 °C bath temperature (50 mbar) and the residue was purified by flash column 
chromatography using 20:1 pentane/diethyl ether mixture as eluent afforded the desired 
ester 85 as a fruity odor colorless liquid.[131]  
Yield: 27 mg (0.19 mmol, 85%, 99% ee). 
β-DEX chiral column, Injection mode: split ratio 20:1, Temperature program: 50 °C for 5 min, 
then with 5 °C/min up to 210 °C; Rt: 8.65 min.(major), 8.75 min.(minor). 
Rf = 0.78 (pentane/diethyl ether 2:1).  
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EI-MS (70 eV): m/z (%): 140(2) [M]+, 138(2), 126(4), 125(47), 113(3), 112(28), 110(17), 
98(7), 97(100), 96(6), 94(50), 94(2), 84(22), 83(7), 81(4), 79(8), 73(6), 70(3), 69(31), 68(14), 
67(84), 66(36), 65(58), 63(8), 62(4), 56(9), 55(16), 53(11), 52(6), 51(14), 50(9), 45(11), 
43(10), 42(8), 41(73), 40(14), 39(67), 38(10), 37(3).   
1H-NMR (600 MHz, CHLOROFORM-d) δ [ppm] = 4.16 (2H, qd, J = 7.2 Hz, J = 0.9 Hz, H-7), 
2.65 (1H, ddq, J = 13.4 Hz, J = 6.0 Hz, J = 1.5 Hz, H-2), 2.53 (1H, ddd, J = 16.8 Hz, J = 6.0 
Hz, J = 2.6 Hz, H-3), 2.37 (1H, ddd, J = 16.8 Hz, J = 7.5 Hz, J = 2.6 Hz, H-3), 1.99 (1H, t, J = 
2.6 Hz, H-5), 1.32 (3H, d, J = 7.0 Hz, H-6), 1.27 (3H, t, J = 7.0 Hz, H-8). 
13C-NMR (151 MHz, CHLOROFORM-d) δ [ppm] = 174.8 (C-1), 81.5 (C-4), 69.8 (C-5), 60.6 
(C-7), 38.7 (C-2), 22.6 (C-3), 16.3 (C-6), 14.2 (C-8). 
 6.2.37 (R)-2-Methylpent-4-ynoic acid (86)   
 
 
To the solution of 83 (214 mg, 0.79 mmol) dissolved in  16 mL of 3:1 THF/H2O at 0 °C under 
stirring 30 % aqueous H2O2 (0.4 mL, 4.7 mmol) and LiOH monohydrate (39 mg, 1.6 mmol) 
were added portionwise and allowed to stir at 0 °C for 2 h. The reaction was controlled by 
TLC and as soon the starting material was consumed the reaction mixture quenched by the 
careful and slow addition of 2 M solution of aqueous Na2S2O3 and allowed to stir for 20 min 
at 0 °C. The THF was evaporated in the rotavapor and the residue was extracted with 
dichloromethane 4 to 5 times. The combined organic layers were dried with MgSO4, filtered, 
and concentrated under reduced pressure to obtain the chiral auxiliary as light colored oil. 
Purification of the crude chiral auxiliary by flash chromatography with 2.1 pentane/ethyl 
acetate mixture afforded the chiral auxiliary 64 as colorless crystals. 
To the aqueous layer at 0 °C saturated solution of NaH2PO4.H2O was added and then 
acidified at 0 °C to pH 1-3 with 1N HCl solution followed by the extraction with diethyl ether 
five times. The combined organic layers were dried with MgSO4, filtered, and concentrated 
under reduced pressure to obtain 86 as light colored yellow liquid. Purification of the crude 
product by flash column chromatography with 1:1 pentane/diethyl ether mixture afforded the 
desired product 86 as colorless pungent odor liquid. 
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 Yield: 75 mg (0.67 mmol, 85%, 96% ee). 
β-DEX chiral column, Injection mode: split 20:1, Temperature program: 50 °C for 5 min, then 
with 5 °C/min up to 210 °C; Rt: 40.53 min.(major), 41.07 min.(minor).  
 Rf = 0.41(pentane/diethyl ether 1:1).  
EI-MS (70 eV): m/z (%): 111(10) [M-1]+, 98(5), 97(89), 84(8), 83(4), 79(7), 70(3), 69(40), 
67(20), 66(16), 65(25), 63(6), 62(4), 56(6), 55(19), 53(10), 52(4), 51(13), 50(10), 45(37), 
44(3), 43(13), 42(7), 41(80), 40(24), 39(100), 38(20), 37(10).  
EI-MS (70 eV) (MSTFA derivative): m/z (%): 184(2) [M]+, 171(5), 170(14), 169(78), 151(2), 
141(12), 130(5), 129(8), 127(6), 126(4), 125(31), 123(4), 117(12), 115(3), 112(4), 110(4), 
109(3), 101(10), 99(7), 98(3), 97(7), 95(3), 93(2), 86(6), 85(8), 83(9), 79(3), 77(8), 76(12), 
75(100), 74(18), 73(94), 71(2), 69(7), 67(12), 66(13), 65(16), 63(6), 62(4), 61(15), 60(5), 
59(19), 58(12), 57(4), 55(11), 51(9), 50(5), 47(19), 45(46), 44(7), 43(22), 42(6), 41(31), 
40(11), 39(55), 38(11), 37(3). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 11.07 (1H, br. s., -COOH), 2.70 (1H, qdd, 
J = 7.0 Hz, J = 5.9 Hz, J = 1.1 Hz, H-2), 2.56 (1H, ddd, J = 16.8 Hz, J = 5.9 Hz, J = 2.7 Hz, 
H-3), 2.40 (1H, ddd, J = 16.7 Hz, J = 10.2 Hz, J = 2.7 Hz, H-3), 2.02 (1H, t, J = 2.7 Hz, H-5), 
1.32 (3H, d, J = 7.0 Hz, H-6). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 180.6 (C-1), 81.2 (C-4), 70.0 (C-5), 38.5 
(C-2), 22.3 (C-3), 16.1 (C-6). 
6.2.38 (R)-N-Methoxy-N,2-dimethylpent-4-ynamide (87) 
 
 
To a stirred solution of 86 (50 mg, 0.45 mmol) in dichloromethane (2 mL) at room 
temperature under inert atmosphere 1,1'-carbonyldiimidazole 68 (73 mg, 0.45 mmol) was 
added and allowed to stir for 30 min followed by the addition of N,O-dimethylhyxdroxylamine 
hydrochloride 69 (44 mg, 0.45 mmol) in one portion. Stirring overnight for approx. 20 h, 
(monitored by the TLC) was needed for the consumption of the acid. The reaction mixture 
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was diluted with dichloromethane and the combined organic layers washed with 0.25 M HCl 
solution, saturated NaHCO3 solution, brine, dried with MgSO4, filtered, and concentrated 
under reduced pressure to obtain crude amide 87 as fruity odor colored liquid. Purification of 
the crude product by flash column chromatography using gradient elution 10:1 to 3:1 
pentane/diethyl ether mixture as eluent afforded the desired amide 87 as fruity odor 
colorless liquid.  
Yield: 55 mg (0.36 mmol, 80%, 98% ee). 
β-DEX chiral column, Injection mode: split ratio 20:1, Temperature program: 50 °C for 5 min, 
then with 5 °C/min up to 210 °C; Rt: 13.59 min.(major), 13.77 min.(minor).   
Rf = 0.22 (pentane/diethyl ether 1:1).  
EI-MS (70 eV): m/z (%): 140(5) [M-15]+, 125(11), 112(4), 97(9), 96(7), 95(63), 82(7), 68(11), 
67(100), 66(16), 65(66), 63(11), 62(8), 61(31), 60(10), 58(6), 56(21), 55(16), 53(4), 52(7), 
51(18), 50(12), 46(10), 45(16), 42(16), 41(93), 40(17), 39(95), 37(7), 33(8). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 3.73 (3H, s, H-8), 3.21 (3H, s, H-7), 3.08 
(1H, dqd, J = 13.6 Hz, J = 6.8 Hz, J = 3.3 Hz, H-2), 2.52 (1H, ddd, J = 16.8 Hz, J = 9.8 Hz, J 
= 2.8 Hz, H-3), 2.28 (1H, ddd, J = 16.6 Hz, J = 7.5 Hz, J = 2.8 Hz, H-3), 1.99 (1H, t, J = 2.6 
Hz, H-5), 1.22 (3H, d, J = 6.8 Hz, H-6).  
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 175.8 (C-1), 82.5 (C-4), 69.3 (C-5), 61.5 
(C-8), 35.2 (C-2), 32.1 (C-7), 22.5 (C-3), 16.9 (C-6). 
6.2.39 (R)-4-Methylhept-6-yn-3-one (88) 
 
 
To a stirred solution of 87 (25 mg, 0.16 mmol) in anhydrous THF (1 mL) at -20 °C under inert 
atmosphere ethyl magnesium bromide 71 (0.2 mL, 0.38 mmol, 3 M in diethyl ether) was 
added dropwise at -20 °C. Stirring was continued until the consumption of the amide was 
detected by TLC. The reaction mixture was quenched by slow addition of saturated NH4Cl 
solution and extracted with three to five times with diethyl ether. The combined organic 
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layers were dried with MgSO4, filtered, and concentrated in rotavapor to obtain the crude 
chiral allyl ketone. Purification of the crude product by flash chromatography using 5:1 
pentane/diethyl ether mixture as eluent afforded chiral allyl ketone 88 as fruity odor colorless 
volatile liquid.  
Yield: 14 mg (0.11 mmol, 70%, 98% ee). 
β-DEX chiral column, Injection mode: split ratio 20:1, Temperature program: 50 °C for 1 min, 
then with 5 °C/min up to 210 °C; Rt: 9.62 min.(major), 9.79 min.(minor). 
Rf = 0.55 (pentane/diethyl ether 1:1). 
EI-MS (70 eV): m/z (%): 124(5) [M]+, 122(8), 109(30), 96(7), 95(66), 68(4), 67(61), 66(10), 
65(33), 63(6), 58(4), 57(100), 55(7), 53(5), 52(5), 51(11), 50(8), 43(4), 42(5), 41(55), 40(10), 
39(57), 38(11), 37(4).   
1H-NMR (600 MHz, CHLOROFORM-d) δ [ppm] = 2.67 (1H, sxt, J = 7.2 Hz, H-4), 2.47 (2H, 
ddq, J = 21.6 Hz, J = 17.7 Hz, J = 7.2 Hz, H-2), 2.40 (1H, ddd, J = 16.9 Hz, J = 7.3 Hz, J = 
2.6 Hz, H-5), 2.21 (1H, ddd, J = 16.9 Hz, J = 7.3 Hz, J = 2.6 Hz, H-5), 1.90 (1H, t, J = 2.6 Hz, 
H-7), 1.12 - 1.14 (4H, m, H-8), 0.99 (3H, t, J = 7.3 Hz, H-1). 
13C-NMR (151 MHz, CHLOROFORM-d) δ [ppm] = 212.9 (C-3), 82.0 (C-6), 69.6 (C-7), 44.9 
(C-4), 34.1 (C-2), 22.3 (C-5), 16.3 (C-8), 7.6 (C-1).  
6.2.40 (R)-2-Methylpent-3-ynoic acid (78) 
 
 
KOtBu (0.4 g, 3.6 mmol), anhydrous DMSO (2 mL) were added to acid with terminal alkyne 
86 (200 mg, 1.8 mmol) under inert atmosphere at room temperature. The resulting solution 
changed from colorless to orange and stirred for 4 h monitored by GC/MS for completion of 
the reaction. The reaction mixture quenched with 2 M HCl solution to pH 2-3 and extracted 
five times with diethyl ether. The combined organic layers were dried with MgSO4, filtered, 
and concentrated in vacuo. Purification of the crude product by flash column 
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chromatography with 2:1 pentane/diethyl ether mixture as eluent afforded the internal alkyne 
78 as light yellow colored liquid.[96]  
Yield: 108 mg (0.9 mmol, 54%). 
Rf = 0.11 (pentane/diethyl ether 2:1).   
EI-MS (70 eV): m/z (%):112(26) [M]+, 111(15), 97(109, 95(3), 94(4), 84(6), 83(7), 69(16), 
67(27), 66(32), 65(32), 64(4), 62(15), 61(7), 57(2), 56(6), 55(10), 53(13), 52(14), 51(21), 
50(17), 49(4), 45(86), 43(6), 41(39), 40(17), 39(100), 38(32), 37(16).  
EI-MS (70 eV) (MSTFA derivative): m/z (%): 185(4) [M+1]+, 184(19) [M]+, 171(5), 170(14), 
169(100), 141(8), 125(12), 111(4), 95(39), 94(7), 85(7), 75(31), 73(30), 67(30), 66(17), 
65(19), 63(4), 59(8), 58(6), 51(3).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 10.48 (1H, br. s., -COOH), 3.43 (1H, q, J = 
6.9 Hz, H-2), 1.93 (3H, t, J = 2.7 Hz, H-5), 1.25 (3H, d, J = 7.0 Hz, H-6). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 177.9 (C-1), 82.1 (C-4), 69.2 (C-3), 33.2 
(C-2), 14.1 (C-6), 1.0 (C-5). 
6.2.41 (R)-N-Methoxy-N,2-dimethylpent-3-ynamide (79)  
 
 
To a stirred solution of 78 (50 mg, 0.45 mmol) in dichloromethane (2 mL) at room 
temperature under inert atmosphere 1,1'-carbonyldiimidazole 68 (73 mg, 0.45 mmol) was 
added and allowed to stir for 30 min followed by the addition of N,O-dimethylhyxdroxylamine 
hydrochloride 69 (44 mg, 0.45 mmol) in one portion. Stirring overnight for approx. 20 h, 
(monitored by the TLC) was need for the consumption of the acid. The reaction mixture was 
diluted with dichloromethane and the combined organic layers washed with 0.25 M HCl 
solution, saturated NaHCO3 solution and brine. The combined organic layers were dried with 
MgSO4, filtered, and concentrated under reduced pressure to obtain crude amide 79 as fruity 
odor light yellow colored liquid. Purification of the crude product by flash column 
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chromatography using gradient elution 10:1 to 3:1 pentane/diethyl ether mixture as eluent 
afforded the desired amide 79 as fruity odor colorless liquid.  
Yield: 16 mg (0.1 mmol, 78%, 99% ee). 
β-DEX chiral column, Injection mode: split ratio 20:1, Temperature program: 50 °C for 5 min, 
then with 10 °C/min up to 210 °C; Rt: 13.41 min.(major), 13.59 min.(minor).  
Rf  = 0.21 (pentane/ethyl acetate 1:1).  
EI-MS (70 eV): m/z (%): 155(6) [M]+, 125(3), 124(2), 96(6), 95(100), 68(4), 67(70), 66(10), 
65(26), 63(4), 56(3), 51(4), 41(34), 39(23).  
6.2.42 (R)-4-Methylhept-5-yn-3-one (80) 
 
 
To a stirred solution of 79 (10 mg, 0.06 mmol) in anhydrous THF (1 mL) at 0 °C under inert 
atmosphere ethyl magnesium bromide 71 (0.05 mL, 0.2 mmol, 3 M in diethyl ether) was 
added dropwise at -20 °C. Stirring was continued until the consumption of the amide was 
detected by TLC. The reaction mixture was quenched by slow addition of saturated NH4Cl 
solution and extracted three to five times with diethyl ether. The combined organic layers 
were dried with MgSO4, filtered, and concentrated in rotavapor to obtain the crude chiral allyl 
ketone. Purification of the crude product by flash chromatography using 5:1 pentane/diethyl 
ether mixture as eluent afforded chiral allyl ketone 80 as fruity odor light yellow volatile liquid 
with minor impurities as analyzed by GC/MS.  
Yield: ~ 5 mg (0.03 mmol, 50%). 
Rf = 0.55 (pentane/diethyl ether 1:1).  
EI-MS (70 eV): m/z (%): 124(44) [M]+, 109(4), 96(5), 95(96), 91(7), 85(8), 84(8), 81(13), 
79(8), 69(10), 67(6), 67(100), 66(16), 65(34), 57(6), 53(11), 51(7).  
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6.2.43 (4S,6S,7S)-7-Hydroxy-9-((4-methoxybenzyl)oxy)-4,6-dimethylnon-1-en-5-one (91) 
 
 
To a stirred solution of dicyclohexylborane (0.5 mL, 0.5 mmol, 1M in hexane) in dry 
diethylether (1 mL) under inert atmosphere at 0 °C, triethylamine (62 mg, 0.61 mmol) was 
added dropwise and stirred for 1 h. To this reaction mixture (S)-chiral ketone 61 (52 mg, 0.41 
mmol) in dry diethyl ether (1 mL) was added dropwise and stirred at 0 °C for 4 h. The 
reaction mixture cooled down to -78 °C, aldehyde 41 (110 mg, 0.57 mmol) in dry diethylether 
(1 mL) was added dropwise and stirred for 2 h. The reaction mixture was left overnight (16 h) 
in a freezer at -32 °C approx. temperature.[97]  
The reaction mixture was quenched at 0 °C with pH 7 buffer (4 mL) and extracted with 
diethylether (3 x 20 mL). The combined organic layers were concentrated in vacuo. The 
crude oil was suspended in methanol (5 mL) and pH 7 buffer (1 mL) followed by addition of 
hydrogen peroxide (1.5 mL, 30% aq.) dropwise at 0 °C. The reaction mixture was stirred for 
2 h, poured into water (8 mL) and extracted with dichloromethane (3 x 20 mL). The 
combined organic layers were washed with saturated aqueous NaHCO3 solution and brine, 
dried with MgSO4, filtered, and concentrated in vacuo. The crude product was purified by 
flash column chromatography with 10:1 diethyl ether/dichloromethane mixture as eluent to 
afford aldol product 91 as colorless oil.[63] 
Yield: 104 mg (0.32 mmol, 80%). 
Rf = 0.64 (diethyl ether/dichloromethane 10:1); 0.22 (pentane/ethyl acetate 5:1);  
Rf = 0.12 (pentane/diethyl ether 2:1). 
EI-MS (70 eV) (MSTFA derivative): m/z (%): 392(1) [M]+, 318(1), 267(2), 227(2), 211(2), 
209(8),  202(2), 183(2), 177(7), 176(42), 166(5), 157(7), 145(3), 137(25), 135(8), 131(9), 
122(25), 121(100), 119(2), 115(5), 109(4), 101(4), 97(22), 91(8), 78(9), 77(12), 75(16), 
73(23), 69(28), 67(3), 59(3), 55(3), 45(3), 41(13), 39(2).  
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1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.22 - 7.27 (2H, m, H-15, 19), 6.85 - 6.90 
(2H, m, H-16, 18), 5.71 (1H, dddd, J2,1 = 16.9 Hz, J2,1 = 10.1 Hz, J2,3 = 7.6 Hz, J2,3 = 6.6 Hz, 
H-2), 5.02 (2H, m, JE = 16.9 Hz, JZ = 9.1 Hz, 2J = 1.5 Hz, H-1), 4.44 (2H, s, H-13), 3.86 - 
3.95 (1H, m, J7,6 = 9.6 Hz, J = 7.1 Hz, J7,8b = 2.8 Hz, H-7), 3.80 (3H, s, H-20), 3.66 - 3.72 
(1H, m, J = 9.1, J = 7.1, J = 4.8, H-9), 3.58 - 3.65 (1H, m, J = 9.1, J = 7.1, J = 4.8, H-9), 3.26 
(1H, d, 3J12,7 = 4.5 Hz, H-12 major ds), 3.28 (1H, d, 3J12,7 = 4.5 Hz, H-12 minor ds), 2.79 (1H, 
m, J6,11 = 7.1 Hz, H-6), 2.71 (1H, qd, J4,3 = 7.6 Hz, J4,10 = 6.8 Hz, H-4), 2.42 (1H, tsxt, J = 
13.9 Hz, J3,4 = 7.6 Hz, J = 6.3 Hz, 4J = 1.52, H-3), 2.03 (1H, tsxt, J = 13.9 Hz, J3,4 = 7.6 Hz, J 
= 6.3 Hz, 4J = 1.26, H-3), 1.76 - 1.79 (1H, m, H-8b major ds), 1.80-1.83 (1H, m, H-8b minor 
ds), 1.65 - 1.74 (1H, m, J8a,7 = 2.8 Hz, H-8a), 1.08 (3H, d, J11,6 = 7.1 Hz, H-11), 1.06 (3H, d, 
J10,4 = 6.8 Hz, H-10). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 218.1 (C-5), 159.2 (C-17), 135.8 (C-2), 
130.0 (C-14), 129.4 (C-15, 19), 116.8 (C-1), 113.8 (C-16,18), 73.0 (C-13), 72.9 (C-7), 68.3 
(C-9), 55.3 (C-20), 50.4 (C-6), 45.9 (C-4), 36.6 (C-3), 33.8 (C-8), 15.6 (C-11), 13.7 (C-10). 
6.2.44 (S)-(3S,4S,6S)-1-((4-Methoxybenzyl)oxy)-4,6-dimethyl-5-oxonon-8-en-3-yl-3,3,3-
trifluoro-2-methoxy-2-phenylpropanoate (97) 
 
 
To a stirred solution of aldol product 91 (25 mg, 0.078 mmol) in dichloromethane (1 mL) 
under inert atmosphere at room temperature DMAP (5.24 mg, 0.043 mmol), triethylamine 
(39 mg, 0.39 mmol) and (R)-MTPACl 95 (37 µL, 0.20 mmol) were added. The reaction 
mixture was stirred for 16 h at room temperature. Stirring was continued until the 
consumption of the starting material was detected by TLC. The reaction mixture was purified 
by directly loading on the flash column chromatography using 50:1 to 10:1 gradient elution 
with pentane/diethyl ether mixture as eluent to afford 97 as colorless oil.[99] 
 Yield: 21 mg (0.039 mmol, 50%). 
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Rf = 0.31 (pentane/diethyl ether 2:1). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.46 – 7.50 (2H, m, H-25, 29), 7.36 – 7.40 
(2H, m, H-26, 28), 7.35 – 7.39 (1H, m, H-27), 7.19 – 7.24 (2H, m, H-16, 20), 6.97 – 6.98 
(CF3), 6.83 - 6.88 (2H, m, H-17, 19), 5.56 – 5.63 (1H, m, H-8), 5.46 – 5.50 (1H, m, H-3), 4.97 
– 5.00 (2H, m, H-9 major isomer), 4.93 – 4.96 (2H, m, H-9 minor isomer), 4.38 (2H, s, H-14), 
3.79 (3H, s, H-21), 3.45 (3H, s, H-22), 3.38 – 3.46 (2H, m, H-13), 3.09 – 3.15 (1H, m, H-4), 
2.62 – 2.68 (1H, m, H-6), 2.20 – 2.28 (1H, m, H-7), 1.78 – 1.98 (2H, m, H-12), 1.75 – 1.84 
(1H, m, H-7), 1.01 – 1.03 (3H, d, H-10), 0.96 – 0.98 (3H, d, H-11). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 213.1 (C-5), 166.0 (C-1), 159.2 (C-18), 
135.7 (C-8), 132.1 (C-24), 130.2 (C-15), 129.6 (C-27), 129.2 (C-16, 20), 128.4 (C-26, 28), 
127.5 (C-23), 127.3 (C-25, 29), 125.5 (C-23), 124.7 (C-23), 121.8 (C-23), 117.0 (C-9), 113.8 
(C-17, 19), 84.7 (C-2), 84.4 (C-2), 74.3 (C-3), 72.6 (C-14), 65.5 (C-13), 55.4 (C-22), 55.2 (C-
21), 47.2 (C-4), 45.0 (C-6), 36.4 (C-7), 30.0 (C-12), 15.9 (C-10), 11.2 (C-11).   
6.2.45 (R)-(3S,4S,6S)-1-((4-Methoxybenzyl)oxy)-4,6-dimethyl-5-oxonon-8-en-3-yl 3,3,3-
trifluoro-2-methoxy-2-phenylpropanoate (98) 
 
 
To a stirred solution of aldol product 91 (25 mg, 0.078 mmol) in dichloromethane (1 mL) 
under inert atmosphere at room temperature DMAP (5.24 mg, 0.043 mmol), triethylamine 
(39 mg, 0.39 mmol) and (S)-MTPACl 96 (37 µL, 0.20 mmol) were added. The reaction 
mixture was stirred for 16 h at room temperature. Stirring was continued until the 
consumption of the starting material was detected by TLC. The reaction mixture was purified 
by directly loading on the flash column chromatography using 50:1 to 5:1 gradient elution 
with pentane/diethyl ether mixture as eluent to afford 98 as colorless oil.[99] 
Yield: 37 mg (0.069 mmol, 88%). 
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Rf = 0.29 (pentane/diethyl ether 2:1). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.45 – 7.49 (2H, m, H-25, 29), 7.35 – 7.40 
(3H, m, H-26, 27, 28), 7.19 – 7.23 (2H, m, H-16, 20), 6.98 – 6.99 (s, CF3), 6.83 – 6.87 (2H, 
m, H-17, 19), 5.56 – 5.66 (1H, m, H-8), 5.49 – 5.51 (1H, m, H-3 minor ds), 5.46 – 5.48 (1H, 
m, H-3 major ds), 5.02 – 5.04 (2H, m, H-9 minor isomer), 4.93 – 5.01 (2H, m, H-9 major 
isomer), 4.38 (2H, s, H-14), 3.79 (3H, s, H-21), 3.47 (3H, s, H-22), 3.30 – 3.35 (1H, m, H-13), 
3.20 – 3.27 (1H, m ,H-13), 3.06 – 3.08 (1H, m, H-4 minor ds)  , 3.15 – 3.18 (1H, m, H-4 
major ds) , 2.64 – 2.71 (1H, m, H- 6), 2.29 -2.32 (1H, m, H-7 minor ds), 2.21 – 2.32 (1H, m, 
H-7 major ds), 1.96 – 2.00 (1H, m, H-7 minor ds), 1.82 – 1.87 (1H, m, H-7 major ds), 1.78 – 
1.90 (2H, m, H-12), 1.07 – 1.08 (3H, d, H-11), 1.04 – 1.06 (3H, d, H-10).   
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 213.3 (C-5), 166.1 (C-1), 159.1 (C-18), 
135.6 (C-8), 132.0 (C-24), 130.3 (C-15), 129.6 (C-27), 129.1 (C-16, 20), 128.4 (C-26, 28), 
127.3 (C-25, 29), 125.5 (C-23), 124.8 (C-23), 121.9 (C-23), 117.0 (C-9), 113.8 (C-17, 19), 
84.7 (C-2), 84.4 (C-2), 74.5 (C-3), 72.6 (C-14), 65.2 (C-13), 55.4 (C-22), 55.2 (C-21), 47.2 
(C-4), 45.1 (C-6), 36.5 (C-7), 29.8 (C-12), 15.9 (C-10), 11.6 (C-11).  
6.2.46 (4S,6S,7S)-7-Methoxy-9-((4-methoxybenzyl)oxy)-4,6-dimethylnon-1-en-5-one 
(99)  
 
 
To a stirred solution of proton sponge® (257 mg, 1.2 mmol) and trimethyloxonium 
tetrafluoroborate (177 mg, 1.2 mmol) in dichloromethane (12 mL), a solution of aldol 91 (48 
mg, 0.15 mmol) in dichloromethane (2 mL) was added at room temperature. The reaction 
mixture was stirred for 18 h and saturated aqueous NaHCO3 was added. Diethyl ether was 
added until the organic layer stayed on top. Layers were separated and the aqueous layer 
was extracted with diethyl ether (3 x 20 mL).The combined organic layers were washed 
several times with an aqueous KHSO4 solution (1.5 M) until the color of the organic layer 
faded from brown to nearly colorless. Then the organic layer was washed with brine, dried 
with MgSO4, filtered, and concentrated in vacuo. Purification by flash column 
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chromatography with 5:1 pentane/ethyl acetate mixture as eluent provided methylated 
product 99 as colorless oil.[102,103]  
Yield: 40 mg (0.12 mmol, 80%). 
Rf = 0.56 (pentane/ethyl acetate 5:1).  
 EI-MS (70 eV): m/z (%): 334(1) [M]+, 293(2), 181(1), 176(13), 166(2), 137(11), 136(4), 
135(7), 125(3), 122(13), 121(100), 109(3), 107(2), 97(11), 91(6), 89(3), 78(10), 77(11), 
72(3), 69(24), 67(4), 65(3), 63(2), 58(4), 57(2), 55(4), 52(3), 51(2), 43(3), 41(24), 39(6).  
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.23 - 7.28 (2H, m, H-15, 19), 6.86 - 6.90 
(2H, m, H-16, 18), 5.72 (1H, dddd, J = 13.6 Hz, 10.3 Hz, 6.8 Hz, 3.5 Hz, H-2), 4.97 - 5.07 
(2H, m, H-1), 4.43 (2H, s, H-13), 3.80 (3H, s, H-20), 3.57 - 3.60 (1H, m, H-7), 3.51 - 3.56 
(2H, m, H-9), 3.25 (3H, s, H-12), 2.91 (1H, qd, J = 7.0 Hz, 1.3 Hz, H-6), 2.69 (1H, qdd, J = 
6.8 Hz, 3.0 Hz, 1.3 Hz, H-4), 2.34 - 2.49 (1H, m, H-3), 1.97 - 2.09 (1H, m, H-3), 1.89 (1H, dtt, 
J = 14.4 Hz, 7.1 Hz, 3.4 Hz, H-8a), 1.58 - 1.69 (1H, m, H-8b), 1.07 (3H, d, J = 7.0 Hz, H-10), 
0.97 (3H, d, J = 7.0 Hz, H-11). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 216.2 (C-5), 159.1 (C-17), 136.1 (C-2), 
130.5 (C-14), 129.1 (C-15, 19), 116.5 (C-1), 113.7 (C-16, 18), 80.2 (C-7), 72.6 (C-13), 65.9 
(C-9), 58.2 (C-12), 55.2 (C-20), 48.3 (C-6), 46.3 (C-4), 36.2 (C-3), 31.1 (C-8), 15.7 (C-10), 
12.9 (C-11).  
6.2.47 bis(2,2,2-Trifluoroethyl) ethylphosphonate (105) 
 
 
To a stirred solution of trifluoroethanol 104 (5 mL, 66 mmol) and Et3N (11 mL, 79 mmol) in 
anhydrous THF (96 mL) at 0 °C under inert atmosphere, ethyl phosphonicdichloride 103 (8.7 
g, 59 mmmol) dissolved in anhydrous THF (15 mL) was added dropwise via a dropping 
funnel. The reaction mixture stirred vigorously at room temperature for 2 h 20 min and 
filtered. The filtered cake was washed with THF and concentrated in vacuo to obtain the 
crude product. Vacuum distillation of the crude product over oil bath at 50-160 °C (53 mbar) 
afforded the product 105 as a colorless oil.[107] 
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yield: 5 g (18.24 mmol, 31%). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] =  4.11 - 4.24 (4H, m, J = 12.5 Hz, J = 7.6 
Hz, J = 7.6 Hz, J = 7.6 Hz, J = 7.6 Hz, H-3, 4), 1.86 (2H, dq, J = 17.6 Hz, J = 6.8 Hz, H-2), 
1.33 (3H, dt, J = 19.1 Hz, J = 7.0 Hz, H-1).   
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] =121.9(2 x CF3), 60.0 (C-3, 4), 20.6 (C-2), 
14.2 (C-1). 
6.2.48 Ethyl 2-(bis(2,2,2-trifluoroethoxy)phosphoryl)propanoate (109) 
 
 
To the solution of LiHMDS (41 mL, 40.46 mmol, 1M in hexane) in freshly distilled THF(40 
mL) at -78 °C under inert atmosphere, triflouroethyl-ethyl phosphonate 105 (5 g, 18.24 
mmol) was added and stirred for 10 min. To the reaction mixture ethyl-chloroformate 106 (2 
mL, 20 mmol) was slowly added dropwise and stirred for 1 h and kept in a freezer (-20 °C) 
for overnight. The reaction mixture poured into 2 M HCl, equal amounts of crushed ice and 
dichloro methane. The organic layer was separated and aqueous layer was extracted with 
dichloro methane and the combined organic extracts were washed with water, brine, dried 
with MgSO4, filtered, and concentrated in vacuo. The crude product obtained was purified by 
flash column chromatography with 3:1 pentane/ethyl acetate mixture as eluent to afford the 
desired phosphonate ester 109 as colorless oil in 30% yield.[107]   
To the solution of NaH (60 % dispersed in oil, 1.6 g, 40.4 mmol) in freshly distilled THF       
(6 mL) at room temperature under inert atmosphere HMPA (6.1 mL, 35 mmol) was added. 
To this solution bis(2,2,2-Trifluoroethyl) phosphite 107 (5 g, 20.32 mmol) was aadded 
dropwise and stirred for 10 min. To the reaction mixture ethyl-2-bromo propionate 108 (2 mL, 
15.84 mmol) was slowly added and stirred for 5 h at room temperature. The reaction 
quenched with saturated NH4Cl solution extracted with TBME and the combined organic 
extracts were washed with water, brine, dried with MgSO4, filtered, and concentrated in 
vacuo. The crude product obtained was purified by flash column chromatography with 3:1 
pentane/ethyl acetate mixture as eluent afforded the desired phosphonate ester 109 as 
colorless oil.[105] 
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Yield: 2.4 g (7 mmol, 35%). 
Rf  = 0.74 (pentane/ethyl acetate 3:1). 
EI-MS (70 eV): m/z (%): 347(8) [M+1]+, 346(20) [M]+, 319(36), 302(17), 301(99), 300(9), 
280(27), 275(31), 274(100), 273(85), 271(3), 254(36), 253(11), 247(19), 246(99), 245(40) 
243(44), 226(22), 225(25), 219(11), 203(4), 193(6), 191(8), 176(9), 175(15), 174(5), 173(13), 
165(13), 163(50), 147(9), 143(16), 127(9), 115(13), 113(8), 101(7), 99(18), 93(12), 91(17), 
83(21), 81(10), 80(5), 73(8), 69(15), 67(7), 64(22), 61(13), 56(18), 55(14), 47(9), 45(8), 
43(6), 33(13). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 4.32 - 4.52 (4H, m, H-6, 7), 4.22 (2H, q, J 
= 7.2 Hz, H-4), 3.19 (1H, dq, J = 22.5 Hz, J = 7.4 Hz, H-2), 1.50 (3H, dd, J = 19.3 Hz, J = 7.4 
Hz, H-3), 1.30 (3H, t, J = 7.2 Hz, H-5).   
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 170.2 (C-1), 122.0(2xCF3), 62.2 (C-6, 7), 
61.2 (C-4), 39.5 (C-2), 14.1 (C-5), 11.5 (C-3).  
6.2.49 Ethyl 2-(dichlorophosphoryl)propanoate (112) 
 
  
To the solution of ethyl 2-(diethoxyphosphoryl)propanoate 110 (4.8 g, 18.9 mmol) in 
anhydrous benzene (35 mL) stirred at 0 °C (ice bath) under inert atmosphere, PCl5 111 (12 
g, 78 mmol)
 
was added slowly (exothermic reaction). After the addition the reaction mixture 
was heated to 75 °C for 10 h. The reaction mixture was carried for the next step without 
further purification.[109]  
EI-MS (70 eV): m/z (%): 218(2) [M+1]+, 217(3) [M]+, 194(2), 192(11), 190(5), 190(18), 
189(5), 173(2), 166(10), 165(6), 164(62), 163(25), 162(100), 161(32), 154(6), 153(4), 147(3), 
145(8), 143(5), 129(6), 128(7), 127(20), 126(18), 125(11), 119(4), 117(6), 111(6), 110(3), 
109(6), 108(8), 107(6),  101(10), 100(6), 99(28), 97(2), 92(12), 91(13), 90(34), 89(7), 85(6), 
83(17), 81(5), 79(5), 77(2), 73(2), 65(12), 64(9), 63(9), 62(26), 61(10), 55(9), 54(6), 53(5), 
48(3), 47(25), 45(11), 43(63), 42(6), 41(2). 
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6.2.50 Ethyl 2-(bis(o-tolyloxy)phosphoryl)propanoate (114) 
 
 
Dichloro phosphoryl propaonate 112 was cooled down to 0 °C under inert atmosphere Et3N 
(4.4 g, 43.6 mmol), o-cresol 113 (4.7 g, 43.65 mmol) in anhydrous benzene (12 mL) was 
added and stirred for 1 h at room temperature. The reaction mixture was filtered and the 
filtrate was extracted with ethyl acetate, washed with 1 M NaOH solution, saturated NH4Cl 
solution, dried with MgSO4, filtered, and concentrated in vacuo. Purification of the crude 
product by flash column chromatography with 8:1 hexane/ethyl acetate mixture afforded the 
desired di-tolyl phosphonate 114 as colorless oil.[109] 
Yield: 5.1 g (14.2 mmol, 75% over two steps). 
Rf = 0.23 (pentane/TBME 1:1).  
EI-MS (70 eV): m/z (%): 363(13) [M+1]+, 362(59) [M]+, 317(25), 316(8), 315(6), 289(6), 
288(8), 274(7), 273(39), 255(10), 228(11), 227(100), 209(14), 199(6), 198(7), 197(8), 
183(11), 182(7), 181(11), 180(10), 179(17), 178(10), 171(10), 165(8), 163(7), 153(7), 
135(10), 119(7), 117(6), 109(7), 108(23), 107(31), 105(7), 92(6), 91(65), 90(22), 89(18), 
79(15), 78(17), 77(38), 65(30), 63(6), 51(8), 39(7). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.20 - 7.32 (4H, m, H-8, 10, 15, 17), 7.15 
(1H, tt, J = 7.3 Hz, J = 2.0 Hz, H-7), 7.09 (1H, tt, J = 7.8 Hz, J = 1.5 Hz, H-14), 7.04 (2H, t,    
J = 7.3 Hz, H-9, 16), 4.21 (2H, q, J = 7.0 Hz, H-4), 3.44 (1H, dq, J = 23.8 Hz, J = 7.3 Hz,     
H-2), 2.19 (6H, d, J = 14.1 Hz, H-12, 19), 1.68 (3H, dd, J = 19.1 Hz, J = 7.3 Hz, H-3), 1.23 
(3H, t, J = 7.2 Hz, H-5). 
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 168.7 (C-1), 148.9 (C-6, 13), 131.3 (C-10, 
17), 129.2 (C-11, 18), 126.9 (C-8, 15), 125.0 (C-9, 16), 120.1 (C-7, 14), 61.7 (C-4), 39.9 (C-
2), 16.2 (C-12, 19), 13.9 (C-5), 11.8 (C-3).  
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6.2.51 (Z)-Ethyl 5-((4-methoxybenzyl)oxy)-2-methylpent-2-enoate (115) 
 
 
To a solution of phosphonoate reagent (2.02 g, 5.6 mmol) in freshly distilled THF (14 mL) 
stirred under inert atmosphere at 0 °C, NaI ( 1 g, 6.75 mmol) was added, followed by 
dropwise addition of DBU (822 mg, 5.4 mmol) and stirred for 10 minutes. The reaction 
mixture cooled down to -78 °C and aldehyde (1.1 g, 5.6 mmol) in freshly distilled THF (8 mL) 
was added slowly and stirred for 2 h at -78 °C. It was stirred further for 2h at room 
temperature. The reaction mixture quenched with saturated NH4Cl solution, extracted thrice 
with TBME. The combined organic extracts were washed with brine, dried with MgSO4, 
filtered, and concentrated in vacuo. The crude product was purified by flash column 
chromatography with 2:1 pentane/TBME mixture as eluent to afford the desired (Z)-
configured ester 115 exclusively as a fruity odor colorless liquid.[108] 
Yield: 1.31 g (4.7 mmol, 84%). 
Rf = 0.28 (pentane/TBME 1:1). 
EI-MS (70 eV): m/z (%): 278(1) [M]+, 260(1), 248(2), 234(1), 233(1), 232(2), 206(1), 205(8), 
204(1), 201(2), 187(1), 186(1), 161(2), 159(2), 142(5), 138(2), 137(4), 136(3), 135(5), 
122(9), 121(100), 114(3), 113(2), 111(2), 109(2), 107(2), 106(3), 98(3), 97(2), 94(2), 92(2), 
91(7), 90(2), 89(4), 84(2), 83(2), 82(3), 79(2), 78(17), 77(15), 71(1), 69(2), 67(4), 65(4), 
63(3), 55(5), 54(4), 53(6), 52(4), 51(4), 50(2), 45(1), 43(6), 41(5), 39(7). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.15 - 7.21 (2H, m, J = 8.7 Hz, H-8, 12), 
6.76 - 6.82 (2H, m, J = 8.7 Hz, J = 2.7 Hz, H-9, 11), 5.93 (1H, tq, J = 7.1 Hz, J = 1.4 Hz, H-
3), 4.37 (2H, s, H-6), 4.10 (2H, q, J = 7.2 Hz, H-15), 3.71 (3H, s, H-13), 3.43 (2H, t, J = 6.4 
Hz, 5), 2.69 (2H, dt, J = 7.8 Hz, J = 6.4 Hz, H-4), 1.83 (3H, q, J = 1.3 Hz, H-14), 1.21 (3H, t, 
J = 7.2 Hz, H-16). 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 167.8 (C-1), 159.1 (C-10), 139.3 (C-3), 
130.4 (C-7), 129.2 (C-8, 12), 128.6 (C-2), 113.7 (C-9, 11), 72.4 (C-6), 69.1 (C-5), 60.0 (C-
15), 55.2 (C-13), 30.1 (C-4), 20.6 (C-14), 14.2 (C-16).  
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6.2.52 (Z)-5-((4-Methoxybenzyl)oxy)-2-methylpent-2-en-1-ol (116) 
 
 
To the solution of ester 115 (876 mg, 3.15 mmol) in anhydrous diethyl ether (6 mL) under 
inert atmosphere at 0 °C, LAH (280 mg, 7.4 mmol) was added portion wise and stirred for 15 
minutes. The reaction quenched up with saturated Na2SO4 solution at 0 °C, stirred for 15 
minutes and the precipitated solid was filtered through a pad of celite, washed with diethyl 
ether. The organic extract was washed with brine, dried with MgSO4, filtered, and 
concentrated in vacuo. Purification of the crude product with flash column chromatography 
using 3:1 pentane/TBME as eluent afforded (Z)-allyl alcohol 116 as a colorless oil.    
Yield: 728 mg (3.1 mmol, 98%). 
Rf = 0.24 (pentane/TBME 1:1).  
EI-MS (70 eV): m/z (%): 236(1) [M]+, 218(1), 205(1), 152(4), 151(6), 149(1), 147(1), 138(4), 
137(20), 136(22), 135(14), 123(3), 122(36), 121(100), 119(1), 115(2), 109(4), 108(2), 107(6), 
106(4), 104(2), 94(3), 92(4), 91(12), 90(4), 89(5), 85(2), 83(2), 79(4), 78(24), 77(22), 67(4), 
65(5), 63(3), 57(3), 55(4), 53(4), 51(4), 43(9), 41(8), 39(6).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.20 - 7.28 (2H, m, J = 8.5 Hz, H-8, 12), 
6.84 - 6.91 (2H, m, J = 8.9 Hz, J = 2.3 Hz, H-9, 11), 5.31 (1H, td, J = 7.9 Hz, J = 1.5 Hz,     
H-3), 4.43 (2H, s, H-6), 4.01 (2H, d, J = 0.4 Hz, H-1), 3.79 (3H, s, H-13), 3.43 (2H, t, J = 6.1 
Hz, H-5), 2.25 - 2.39 (2H, m, J = 7.8 Hz, J = 6.8 Hz, H-4), 1.81 (3H, ddd, J = 3.6 Hz, J = 1.5 
Hz, J = 0.6 Hz, H-14).   
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.2 (C-10), 137.8 (C-2), 129.7 (C-7), 
129.4 (C-8, 12), 124.5 (C-3), 113.7 (C-9, 11), 72.7 (C-6), 68.8 (C-5), 61.0 (C-1), 55.1 (C-13), 
28.3 (C-4), 22.1 (C-14).  
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6.2.53 ((2R,3S)-3-(2-((4-Methoxybenzyl)oxy)ethyl)-2-methyloxiran-2-yl)methanol (117) 
 
 
To a suspension of activated 4 A° molecular sieves (55 mg, 20 wt %) in anhydrous DCM (5 
mL) at -30 °C under inert atmosphere Ti(Oi-Pr)4(330 mg, 1.2 mmol), (-)-DET (0.4 mL, 1.4 
mmol) was added and stirred for 30 minutes. Allylic alcohol 116 (273 mg, 1.2 mmol) in 
anhydrous DCM (4 mL) was added dropwise using a syringe pump over a period of 25 
minutes at -35 °C. The reaction mixture stirred for 30 minutes followed by the addition of 
TBHP (1.4 mL, 7.5 mmol, 5.5 M in nonane) at -35 °C and further stirred for 3h at -20 °C. The 
reaction was quenched by addition of water (7 mL) and allowed to warm up to room 
temperature. The reaction mixture further stirred for 1h, recooled to 0 °C. To this quenched 
reaction mixture NaOH (5 mL, 30 % w/v), saturated NaCl solution (6 mL) were added and 
stirred for 10 min at 0 °C followed by the removal of dichloromethane under reduced 
pressure. The residue extracted with diethyl ether, combined extracts washed with brine, 
dried with Na2SO4, filtered, and concentrated in vacuo. Purification of the crude product by 
flash column chromatography using gradient elution of 5:1 to 3:1 pentane/ethyl acetate 
mixture as eluent to afford pure epoxy alcohol 117 as a syrupy liquid.[112] 
Yield: 204 mg (0.81 mmol, 70%, 96% ee). 
Hydrodex-β-6-TBDMS chiral column; Injection mode: split ratio 20:1; Temperature program: 
50 °C for 5 min, then with 0.2 °C/min up to 220 °C; Rt: 450.71 min.(minor), 451.59 
min.(major).  
 Rf = 0.30 (pentane/ethyl acetate 1:1).  
EI-MS (70 eV): m/z (%): 252(1) [M]+, 236(1), 218(1), 177(1), 152(2), 147(1), 137(7), 136(7), 
135(5), 122(13), 121(100), 107(2), 101(2), 91(5), 89(2), 78(10), 77(9), 65(2), 57(2), 55(2), 
52(2), 43(4), 41(4), 39(3). 
1H-NMR (600 MHz, CHLOROFORM-d) δ [ppm] = 7.23 - 7.27 (2H, m, J = 8.7 Hz, H-8, 12), 
6.87 - 6.91 (2H, m, J = 8.7 Hz, J = 2.1 Hz, H-9, 11), 4.47 (2H, q, J = 11.5 Hz, H-6), 3.81 (3H, 
s, H-13), 3.63 (2H, ddd, J = 10.5 Hz, J = 9.4 Hz, J = 3.8 Hz, H-5), 3.30 (1H, d, J = 10.2 Hz,    
-OH), 2.79 (1H, dd, J = 9.8 Hz, J = 4.0 Hz, H-3), 2.09 (1H, dq, J = 14.7 Hz, J = 7.5 Hz, H-4), 
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1.71 - 1.79 (1H, m, J = 11.5 Hz, J = 10.5 Hz, J = 9.0 Hz, J = 4.1 Hz, J = 1.7 Hz, H-4), 1.42 
(3H, s, H-14).  
13C-NMR (151 MHz, CHLOROFORM-d) δ [ppm] = 159.5 (C-10), 129.7 (C-8, 12), 129.0 (C-
7), 113.9 (C-9, 11), 73.2 (C-6), 66.2 (C-5), 64.1 (C-1), 62.3 (C-2), 60.4 (C-3), 55.2 (C-13), 
29.0 (C-4), 20.4 (C-14). 
6.2.54 (2S,3S)-5-((4-Methoxybenzyl)oxy)-2-methyl-3-((triethylsilyl)oxy)pentanal (119) 
 
 
To the suspension of activated powdered 4 A° molecular sieves (100 mg, 49 wt%), epoxy 
alcohol 117 (202 mg, 0.80 mmol) in anhydrous dichloromethane (3 mL), DIPEA (155 mg, 1.2 
mmol) at room temperature under inert atmosphere were added and stirred for 10 minutes. 
TESOTf 118 (0.26 mL, 1.12 mmol) was added to this reaction mixture at -42 °C, stirred for 
90 minutes and poured into diethyl ether (80 mL). The resulting solution washed with water, 
saturated CuSO4 solution, 5% NaHCO3 solution, dried with MgSO4, filtered, and 
concentrated in vacuo to obtain the crude aldehyde 119.[132] 
Yield: 267 mg (0.73 mmol, 91%, 75% d.e.). 
EI-MS (70 eV): m/z (%): 337(1) [M-29]+, 332(2), 331(6), 316(1), 315(4), 303(1), 301(2), 
219(6), 217(15), 216(18), 215(100), 200(4), 199(24), 190(3), 189(14), 185(3), 173(3), 172(5), 
171(26), 161(7), 159(14), 157(5), 147(7), 145(11), 144(5), 143(36), 141(2), 137(5), 133(6), 
131(12), 129(7), 127(2), 123(3), 119(7), 117(16), 116(8), 115(67), 113(5), 109(4), 108(7), 
105(7), 103(17), 101(8), 99(3), 97(25), 95(4), 94(9), 93(3), 91(5), 89(5), 88(8), 87(70), 86(4), 
85(7), 83(27), 80(4), 75(26), 73(7), 71(3), 69(4), 67(4), 63(2), 61(5), 60(5), 59(60), 58(10), 
57(10), 55(6), 53(3), 47(18), 45(17), 43(15), 41(10), 40(4), 39(3). 
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6.2.55 (E)-Ethyl 5-((4-methoxybenzyl)oxy)-2-methylpent-2-enoate (124) 
 
 
To the solution of aldehyde 41 (324 mg, 1.6 mmol) in anhydrous dichloromethane (8 mL) at 
room temperature under inert atmosphere, stabilized ylide Ph3P=C(CH3)CO2Et 123 (1.2 g, 
3.3 mmol) was added and stirred for 34 h. The solvent was evaporated under reduced 
pressure and the residue was purified by flash column chromatography using gradient 
elution of 10:1 to 2:1 pentane/TBME mixture as eluent to afford the ester 124 as fruity odor 
yellow oil.[113] 
Yield: 418 mg (1.5 mmol, 90%). 
Rf = 0.30 (pentane/TBME 1:1). 
EI-MS (70 eV): m/z (%): 278(1) [M]+, 260(1), 248(2), 234(1), 233(1), 232(2), 206(1), 205(8), 
204(1), 201(2), 187(1), 186(1), 161(2), 159(2), 142(5), 138(2), 137(4), 136(3), 135(5), 
122(9), 121(100), 114(3), 113(2), 111(2), 109(2), 107(2), 106(3), 98(3), 97(2), 94(2), 92(2), 
91(7), 90(2), 89(4), 84(2), 83(2), 82(3), 79(2), 78(17), 77(15), 71(1), 69(2), 67(4), 65(4), 
63(3), 55(5), 54(4), 53(6), 52(4), 51(4), 50(2), 45(1), 43(6), 41(5), 39(7). 
1H-NMR (400 MHz, CHLOROFORM-d) δ [ppm] = 7.26 (2H, td, J = 8.3 Hz, J = 1.8 Hz, H-8, 
12), 6.88 (2H, td, J = 8.8 Hz, J = 2.0 Hz, H-9, 11), 6.78 (1H, tq, J = 7.0 Hz, J = 2.8 Hz, H-3), 
4.46 (2H, s, H-6), 4.19 (2H, qq, J = 7.0 Hz, J = 2.5 Hz, H-15), 3.80 (3H, s, H-13), 3.53 (2H, t, 
J = 6.8 Hz, H-5), 2.48 (2H, dt, J = 7.0 Hz, J = 0.8 Hz, H-4), 1.84 (3H, dt, J = 2.5 Hz, J = 0.8 
Hz, H-14), 1.29 (3H, td, J = 7.0 Hz, J = 0.8 Hz, H-16).  
13C-NMR (101 MHz, CHLOROFORM-d) δ [ppm] = 168.0 (C-1), 159.2 (C-10), 138.3 (C-3), 
130.2 (C-7), 129.4 (C-2), 129.2 (C-8, 12), 113.7 (C-9, 11), 72.6 (C-6), 68.3 (C-5), 60.4 (C-
15), 55.2 (C-13), 29.4 (C-4), 14.2 (C-16), 12.5 (C-14).  
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6.2.56 (E)-5-((4-Methoxybenzyl)oxy)-2-methylpent-2-en-1-ol (125) 
 
 
To the solution of ester 124 (390 mg, 1.4 mmol) in anhydrous diethyl ether (5 mL), at 0 °C 
under inert atmosphere, LAH (106 mg, 2.8 mmol) was added portion wise and stirred for 15 
minutes. The reaction mixture was quenched with saturated aqueous Na2SO4 solution at      
0 °C for 15 minutes. Precipitated solid was filtered through a short pad of celite and the filter 
cake was washed with diethyl ether. The filtrate and washings were combined and washed 
with brine, dried with MgSO4, filtered, and concentrated in vacuo. Purification of the crude 
product by flash column chromatography with 4:1 pentane/TBME mixture as eluent to afford 
the desired trans- allylic alcohol 125 exclusively as syrupy liquid. 
Yield: 287 mg (1.2 mmol, 87%). 
Rf = 0.43 (pentane/ ethyl acetate 1:1).  
EI-MS (70 eV): m/z (%): 236(1) [M]+, 218(1), 205(1), 143(2), 142(15), 137(3), 136(3), 135(7), 
127(1), 122(9), 121(100), 114(5), 113(1), 109(2), 107(2), 106(3), 105(1), 99(4), 94(2), 92(3), 
91(9), 90(3), 89(4), 84(3), 83(1), 82(4), 81(1), 79(3), 78(21), 77(18), 71(2), 69(3), 68(1), 
67(4), 66(2), 65(5), 64(2), 63(3), 56(1), 55(6), 54(5), 53(8), 52(5), 51(6), 50(2), 45(3), 43(7), 
40(2), 39(10).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.15 - 7.19 (2H, m, H-8, 12), 6.77 - 6.82 
(2H, m, H-9, 11), 5.33 (1H, qt, J = 7.2 Hz, J = 2.7 Hz, H-3), 4.36 (2H, s, H-6), 3.88 (2H, s, H-
1), 3.71 (3H, s, H-13), 3.37 (2H, t, J = 7.0 Hz, H-5), 2.26 (2H, tq, J = 7.0 Hz, J = 0.9 Hz, H-4), 
1.58 (3H, s, H-14).  
 
13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.0 (C-10), 136.6 (C-2), 130.3 (C-7), 
129.2 (C-8, 12), 121.7 (C-3), 113.7 (C-9, 11), 72.4 (C-6), 69.3 (C-1), 68.4 (C-5), 55.1 (C-13), 
28.2 (C-4), 13.7 (C-14).  
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6.2.57 ((2S,3S)-3-(2-((4-Methoxybenzyl)oxy)ethyl)-2-methyloxiran-2-yl)methanol (126) 
 
 
To a suspension of activated 4 A° molecular sieves (150 mg, 60 wt %) in anhydrous DCM (4 
mL) at -30 °C under inert atmosphere Ti(Oi-Pr)4(313 mg, 1.1 mmol), (+)-DET (0.3 mL, 1.32 
mmol) were added and stirred for 30 minutes. Allylic alcohol 125 (250 mg, 1.1 mmol) in 
anhydrous DCM (4 mL) was added dropwise using a syringe pump over a period of 25 
minutes at -35 °C. The reaction mixture stirred for 30 minutes followed by the adition of 
TBHP (0.6 mL, 3.3 mmol, 5.5 M in nonane) at -35 °C and stirred for 3h at -20 °C. The 
reaction was quenched with water (7 mL) and allowed to warm up to room temperature and 
stirred for 1h. The quenched reaction mixture was recooled to 0 °C followed by the addition 
of NaOH (8 mL, 30 % w/v), saturated NaCl solution (5 mL) and stirred for 10 min at 0 °C 
followed by the removal of dichloromethane under reduced pressure. The residue extracted 
with diethyl ether, combined extracts washed with brine, dried with Na2SO4, filtered, and 
concentrated in vacuo. Purification of the crude product by flash column chromatography 
using gradient elution of 4:1 to 2:1 pentane/ethyl acetate mixture as eluent to afford pure 
epoxy alcohol 126 as a cloudy liquid.[133] 
 Yield: 180 mg (0.72 mmol, 65%, 98% ee). 
Rf = 0.28 (pentane/ethyl acetate 1:1).  
EI-MS (70 eV) (MSTFA derivative): m/z (%): 324(1) [M]+, 306(1), 294(1), 278(1), 261(1), 
250(1), 233(1), 221(1), 209(1), 203(3), 159(1), 151(2), 145(1), 142(3), 138(2), 137(18), 
136(5), 135(6), 131(2), 130(2), 129(3), 122(10), 121(100), 116(1), 115(7), 113(2), 109(3), 
107(2), 106(2), 105(2), 103(5), 101(2), 99(2), 98(2), 94(2), 92(2), 91(6), 90(2), 89(3), 85(4), 
83(2), 82(3), 79(2),78(12), 77(12), 76(1), 75(13), 74(3), 73(25), 69(1), 67(3), 66(1), 65(3), 
63(2), 61(2), 59(6), 58(2), 57(3), 55(3), 53(1), 52(2), 51(2), 47(2), 45(5), 43(5), 41(3), 39(3).  
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.15 - 7.23 (2H, m, J = 8.7 Hz, H-8, 12), 
6.76 - 6.85 (2H, m, J = 8.7 Hz, J = 2.1 Hz, H-9, 11), 4.39 (2H, s, H-6), 3.73 (3H, s, H-13), 
3.54 (2H, t, J = 6.8 Hz, H-5), 3.43 - 3.63 (2H, m, J = 12.1 Hz, J = 3.2 Hz, J = 1.5 Hz, H-1), 
3.10 (1H, dd, J = 7.0 Hz, J = 5.3 Hz, H-3), 1.68 - 1.93 (2H, m, J = 14.2 Hz, J = 7.4 Hz, J = 
1.9 Hz, H-4), 1.21 (3H, s, H-14). 
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13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.2 (C-10), 130.3 (C-7), 129.2 (C-8, 12), 
113.8 (C-9, 11), 72.7 (C-6), 67.0 (C-5), 65.4 (C-1), 60.8 (C-2), 57.9 (C-3), 55.2 (C-13), 28.9 
(C-4), 14.3 (C-14). 
6.2.58 tert-Butyl(((2S,3S)-3-(2-((4-methoxybenzyl)oxy)ethyl)-2-methyloxiran-2-
yl)methoxy)dimethylsilane (130) 
 
  
To the solution of epoxy alcohol 126 (150 mg, 0.6 mmol) in anhydrous dichloromethane (2 
mL) at room temperature under inert atmosphere, imidazole (45 mg, 0.66 mmol), tert-
butyldimethylsilyl chloride 129 (199 mg, 1.32 mmol) were added successively and stirred for 
1 h. The reaction mixture diluted with dichloromethane, washed with water, saturated brine, 
dried with Na2SO4, filtered, and concentrated in vacuo. Purification of the crude product by 
flash column chromatography using gradient elution of 10:1 to 5:1 pentane/ TBME mixture 
as eluent afforded the TBDMS protected epoxy alcohol 130 as colorless liquid.[114]  
Yield: 215 mg (0.58 mmol, 98%, 98% d.e.). 
Rf  = 0.68 (pentane/TBME 1:1).  
EI-MS (70 eV): m/z (%): 366(1) [M]+, 350(1), 221(2), 1773(2), 171(2), 158(3), 143(2), 135(4), 
130(9), 129(3), 122(11), 121(100), 115(3), 113(3), 109(1), 107(3), 103(1), 101(4), 97(2), 
91(4), 89(4), 85(3), 78(8), 77(5), 75(8), 73(8), 65(2), 59(4), 58(3), 57(4), 51(3). 
1H-NMR (300 MHz, CHLOROFORM-d) δ [ppm] = 7.20 (2H, ddt, J = 8.7 Hz, J = 3.8 Hz,          
J = 2.1 Hz, H-8, 12), 6.81 (2H, dt, J = 8.7 Hz, J = 2.1 Hz, H-9, 11), 4.40 (2H, s, H-6), 3.74 
(3H, s, H-13), 3.55 (2H, dd, J = 5.9 Hz, J = 1.1 Hz, H-1), 3.52 (2H, t, J = 2.5 Hz, H-5), 2.95 
(1H, dd, J = 7.2 Hz, J = 5.3 Hz, H-3), 1.85 (1H, ddt, J = 14.0 Hz, J = 7.2 Hz, J = 5.3 Hz, H-4), 
1.73 (1H, ddt, J = 12.9 Hz, J = 7.0 Hz, J = 5.7 Hz, H-4), 1.21 (3H, s, H-14), 0.84 (9H, s, H-
16), 0.04 (6H, s, H-15). 
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13C-NMR (75 MHz, CHLOROFORM-d) δ [ppm] = 159.2 (C-10), 130.4 (C-7), 129.2 (C-8, 12), 
113.8 (C-9, 11), 72.8 (C-6), 67.8 (C-5), 67.3 (C-1), 60.9 (C-2), 58.4 (C-3), 55.3 (C-13), 29.2 
(C-4), 25.9 (C-16), 18.3 (C-17), 14.2 (C-14), -5.21 (C-15).  
6.2.59 (2R,3S)-1-((tert-Butyldimethylsilyl)oxy)-5-((4-methoxybenzyl)oxy)-2-
methylpentan-3-ol (131) 
 
 
To the mixture of Pd2(dba)3CHCl3 127 (7 mg, 5 mol%) and n-Bu3P (4 µL) in dioxane (244 µL) 
a mixture of HCOOH (25 µL) and Et3N (36 µL, 0.26 mmol) in dioxane (156 µL) at room 
temperature was added. The mixture was stirred for 15 minutes. The oxirane 130 (50 mg, 
0.13 mmol) in dioxane (330 µL) was added dropwise and monitored by TLC until the 
consumption of the oxirane 130. The reaction quenched with water and the aqueous layer 
was extracted with diethyl ether. The combined organic layers washed with saturated NH4Cl 
solution, brine dried with MgSO4, filtered, and concentrated in vacuo to afford the 131 as 
crude product.[115] 
Yield: 43 mg (0.12 mmol, 87%, 90% d.e.). 
Rf  = 0.34 (pentane/ethyl acetate 1:1).  
EI-MS (70 eV) (MSTFA derivative): m/z (%): 440(1) [M]+, 383(1), 360(1), 345(1), 329(1), 
309(1), 292(1), 279(1), 264(1), 221(1), 214(1), 201(1), 194(1), 171(1), 159(1), 143(3), 
137(5), 135(3), 131(4), 126(1), 122(10), 121(100), 115(9), 101(3), 99(2), 91(4), 89(3), 85(4), 
78(8), 77(9), 75(16), 73(8), 65(2), 59(5), 57(9), 55(4), 51(2), 45(4), 43(4), 41(9), 39(6).  
1H-NMR (600 MHz, CHLOROFORM-d) δ [ppm] = 7.22 (2H, ddd, J = 8.7 Hz, J = 4.9 Hz, J = 
2.8 Hz, H-8, 12), 6.83 (2H, ddt, J = 8.7 Hz, J = 3.2 Hz, J = 2.1 Hz, H-9, 11), 4.41 (2H, d, J = 
1.9 Hz, H-6), 3.78 (0H, td, J = 4.3 Hz, J = 1.9 Hz, H-3), 3.76 (3H, s, H-13), 3.57 (1H, d, J = 
1.3 Hz, H-1), 3.55 (2H, dd, J = 4.0 Hz, J = 2.4 Hz, H-5), 3.51 (1H, dd, J = 11.3 Hz, J = 3.8 
Hz, H-1), 1.87 (1H, dtd, J = 12.0 Hz, J = 7.5 Hz, J = 2.3 Hz, H-2), 1.76 (1H, dddt, J = 14.3 
Hz, J = 10.5 Hz, J = 4.7 Hz, J = 1.3 Hz, H-4), 1.69 (1H, td, J = 12.0 Hz, J = 4.7 Hz, H-4), 
0.85 - 0.94 (9H, s, H-16), 0.84 (3H, d, J = 6.8 Hz, H-14), 0.04 (6H, s, H-15).  
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13C-NMR (151 MHz, CHLOROFORM-d) δ [ppm] = 159.1 (C-10), 130.3 (C-7), 129.2 (C-8, 
12), 113.7 (C-9, 11), 72.8 (C-6), 72.7 (C-3),  67.6 (C-5), 67.0 (C-1), 55.2 (C-13), 38.5 (C-2), 
34.7 (C-4), 25.8 (C-16), 18.3 (C-17), 13.5 (C-14), -5.4 (C-15).  
 
 6.2.60 Methyl 9,10,16-trihydroxyhexadecanoate (137) 
 
 
Synthesis of diazomethane:  
Diazomethane was generated by addition of potassium hydroxide solution (1.08 M in 
methanol-H2O [1:1, 4 ml]) to a stirred Diazald® solution (0.52 M diethyl ether-
diethyleneglycol monoethyl ether [1:1, 4ml]) in a screw-cap glass vial with 
polytetrafluoroethylene (PTFE) tubing attached. The diazomethane evolved, which is yellow, 
was allowed to pass through a trap to avoid addition of by-products and then further into the 
glass vial containing the reaction mixture.[116] 
 
To aleuritic acid 135 (1 mg, 3.3 µmol) in MeOH and diethyl ether (1:1, 1 mL), Diazomethane 
136 gas was bubbled through the solution in excess while stirring at 0 °C for 1 h. The excess 
of diazomethane and solvent were removed under the stream of Nitrogen and the crude 
methyl ester 137 was analyzed by HPLC/MS.  
ESI-HRMS: [M+H]+ 319.20, [M+Na-H]+ 341.32, [2M-2H]+ 636.64.  
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6.2.61 (3R,4R,6R,E)-Methyl-8-((2S,3S,7R,10R,11R,E)-10,11-dihydroxy-3,7-dimethyl-12-
oxooxacyclododec-8-en-2-yl)-3-methoxy-4,6-dimethyl-5-oxonon-7-enoate (138) 
 
 
To carolacton 13 (1 mg, 2.13 µmol) in MeOH and diethyl ether (1:1, 1mL), Diazomethane 
136 gas was bubbled through the solution in excess while stirring at 0 °C for 1 h. The excess 
of diazomethane and solvent were removed under the stream of Nitrogen to obtain methyl 
ester 138 of carolacton and analyzed by HPLC/MS.[43] 
ESI-HRMS: [M+H]+ 483.28, [M+Na]+ 505.40, [2M+Na-H]+ 986.52. 
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8 Abbreviations 
 
α   Alpha 
[α]   Optical rotation 
br. s.   broad signal 
β   Beta 
CDA   Chiral derivatizing agent 
CoA   Coenzyme A 
δ   Chemical Shift (in ppm) 
d   Doublet 
d.e.   Diastereomeric excess 
d.r.   Diastereomeric ratio  
ds   Diastereomer 
ee.   Enantiomeric excess 
DBU   1,8-Diazabicyclo[5.4.0]undec-7-ene  
DET   Diethyl Tartarate 
DIBAL-H  Diisobutylaluminium hydride  
DIPEA   Diisopropylethylamine     
DMAP   4-Dimethylaminopyridine 
DMF   Dimethylformamide 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
EI   Electron impact 
EtMgBr  Ethylmagnesium bromide 
eV   Electron volt 
γ   Gamma 
GC   Gas chromatography 
GC/MS  Gas chromatography coupled with Mass spectrometry   
HMPA   Hexamethylphosphoramide 
HPLC   High performance liquid chromatography 
HPLC/MS  High performance liquid chromatography coupled with mass       
spectrometry    
IR   Infrared (Spectroscopy) 
KHMDS  Potassium hexamethyldisilazane 
KOtBu   Potassium tert-butoxide 
J   Coupling constant 
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LAH   Lithiumaluminiumhydride   
LDA   Lithium diisopropylamide 
LiHMDS  Lithium hexamethyldisilazane 
m   Multiplet 
MBp   Million base pairs 
MSTFA  (N-methyl-N-trimethylsilyltrifluoroacetamide) 
MPA   α-methoxy-α- phenylacetic acid  
MTPA   α-methoxy-α-trifluoromethyl-α-phenylacetic acid 
m/z   Mass-to-charge ratio 
MS   Mass spectrometry 
n-BuLi   n-Butyllithium  
NaHMDS  Sodium hexamethyldisilazane 
NMR   Nuclear magnetic resonance 
NOESY  Nuclear Overhauser Enhancement Spectroscopy 
PivCl   Pivaloylchloride 
PMB   para-Methoxybenzyl 
q   Quartet  
quin   Quintet 
Rf    Retention factor (Ratio of fronts) 
rt   room temperature  
s   Singlet 
S.mutans  Streptococcus mutans 
t   Triplet 
TBDMS  tert-Butyldimethylsilyl 
TBHP   tert-Butyl hydroperoxide 
TBME   tert-Butylmethylether 
TES   Triethylsilyl 
TESOTf  Triethylsilyltriflate 
THF   Tetrahydrofuran 
THP   Tetrahydropyran 
TLC   Thin layer chromatography 
TMS   Trimethylsilyl 
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9 Appendix 
 
9.1 Mass spectra 
 
 
Figure 80: Mass spectrum of (4RS,6RS,7RS)-7-Methoxy-9-((4-methoxybenzyl)oxy)-4,6-
dimethylnonane-2,5-dione (53)  
 
Figure 81: Mass spectrum of (R)-4-Methylhept-6-en-3-one (61) 
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Figure 82: Mass spectrum of corresponding MSTFA derivative of (4S,6S,7S)-7-Hydroxy-9-
((4-methoxybenzyl)oxy)-4,6-dimethylnon-1-en-5-one (91) 
 
  
 
 
Figure 83: Mass spectrum of (4S,6S,7S)-7-methoxy-9-((4-methoxybenzyl)oxy)-4,6-
dimethylnon-1-en-5-one (99)  
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